NO773968L - LITHIUM SALTS OF 1,4-BENZDIAZEPINES AND PROCEDURES FOR PRODUCING THE SAME - Google Patents
LITHIUM SALTS OF 1,4-BENZDIAZEPINES AND PROCEDURES FOR PRODUCING THE SAMEInfo
- Publication number
- NO773968L NO773968L NO773968A NO773968A NO773968L NO 773968 L NO773968 L NO 773968L NO 773968 A NO773968 A NO 773968A NO 773968 A NO773968 A NO 773968A NO 773968 L NO773968 L NO 773968L
- Authority
- NO
- Norway
- Prior art keywords
- radical
- cyanidan
- substituted
- acid
- groups
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims description 55
- 229910003002 lithium salt Inorganic materials 0.000 title 1
- 159000000002 lithium salts Chemical class 0.000 title 1
- -1 aromatic-aliphatic Chemical group 0.000 claims description 232
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 150
- 150000001875 compounds Chemical class 0.000 claims description 78
- 239000002253 acid Substances 0.000 claims description 61
- 125000004432 carbon atom Chemical group C* 0.000 claims description 56
- 229910052757 nitrogen Inorganic materials 0.000 claims description 53
- 125000003545 alkoxy group Chemical group 0.000 claims description 52
- 125000000217 alkyl group Chemical group 0.000 claims description 44
- 150000003839 salts Chemical class 0.000 claims description 41
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 35
- 125000003118 aryl group Chemical group 0.000 claims description 32
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 30
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical class C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 claims description 28
- 125000001931 aliphatic group Chemical group 0.000 claims description 28
- 239000001257 hydrogen Substances 0.000 claims description 27
- 229910052739 hydrogen Inorganic materials 0.000 claims description 27
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 26
- 229910052801 chlorine Inorganic materials 0.000 claims description 25
- 239000000460 chlorine Substances 0.000 claims description 25
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims description 24
- 125000001153 fluoro group Chemical group F* 0.000 claims description 23
- 125000005843 halogen group Chemical group 0.000 claims description 23
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 20
- 125000004453 alkoxycarbonyl group Chemical group 0.000 claims description 19
- 125000003282 alkyl amino group Chemical group 0.000 claims description 19
- 125000003277 amino group Chemical group 0.000 claims description 19
- 125000004423 acyloxy group Chemical group 0.000 claims description 17
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 claims description 16
- 125000000623 heterocyclic group Chemical group 0.000 claims description 15
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 claims description 13
- 150000002148 esters Chemical class 0.000 claims description 13
- CIUQDSCDWFSTQR-UHFFFAOYSA-N [C]1=CC=CC=C1 Chemical compound [C]1=CC=CC=C1 CIUQDSCDWFSTQR-UHFFFAOYSA-N 0.000 claims description 12
- 229910000147 aluminium phosphate Inorganic materials 0.000 claims description 10
- 125000001589 carboacyl group Chemical group 0.000 claims description 10
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 9
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims description 9
- 238000002360 preparation method Methods 0.000 claims description 9
- BDHFUVZGWQCTTF-UHFFFAOYSA-N sulfonic acid Chemical compound OS(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-N 0.000 claims description 9
- 125000005237 alkyleneamino group Chemical group 0.000 claims description 8
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims description 8
- 230000008569 process Effects 0.000 claims description 8
- 150000001735 carboxylic acids Chemical class 0.000 claims description 7
- TWBYWOBDOCUKOW-UHFFFAOYSA-N isonicotinic acid Chemical compound OC(=O)C1=CC=NC=C1 TWBYWOBDOCUKOW-UHFFFAOYSA-N 0.000 claims description 7
- 125000004430 oxygen atom Chemical group O* 0.000 claims description 7
- KKFDJZZADQONDE-UHFFFAOYSA-N (hydridonitrato)hydroxidocarbon(.) Chemical compound O[C]=N KKFDJZZADQONDE-UHFFFAOYSA-N 0.000 claims description 6
- 125000004093 cyano group Chemical group *C#N 0.000 claims description 6
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 6
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims description 6
- 150000007522 mineralic acids Chemical class 0.000 claims description 6
- 239000004215 Carbon black (E152) Substances 0.000 claims description 5
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 claims description 5
- 125000004429 atom Chemical group 0.000 claims description 5
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 claims description 5
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 5
- 150000004678 hydrides Chemical class 0.000 claims description 5
- 229930195733 hydrocarbon Natural products 0.000 claims description 5
- 229920006395 saturated elastomer Polymers 0.000 claims description 5
- 125000005236 alkanoylamino group Chemical group 0.000 claims description 4
- 125000003368 amide group Chemical group 0.000 claims description 4
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 claims description 4
- 125000000118 dimethyl group Chemical group [H]C([H])([H])* 0.000 claims description 4
- 229910052731 fluorine Inorganic materials 0.000 claims description 4
- 125000004043 oxo group Chemical group O=* 0.000 claims description 4
- LEVJVKGPFAQPOI-UHFFFAOYSA-N phenylmethanone Chemical compound O=[C]C1=CC=CC=C1 LEVJVKGPFAQPOI-UHFFFAOYSA-N 0.000 claims description 4
- 125000006619 (C1-C6) dialkylamino group Chemical group 0.000 claims description 3
- ZOXJGFHDIHLPTG-UHFFFAOYSA-N Boron Chemical compound [B] ZOXJGFHDIHLPTG-UHFFFAOYSA-N 0.000 claims description 3
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 claims description 3
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 claims description 3
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims description 3
- 239000005864 Sulphur Substances 0.000 claims description 3
- 125000003342 alkenyl group Chemical group 0.000 claims description 3
- SRSXLGNVWSONIS-UHFFFAOYSA-N benzenesulfonic acid Chemical group OS(=O)(=O)C1=CC=CC=C1 SRSXLGNVWSONIS-UHFFFAOYSA-N 0.000 claims description 3
- 229910052796 boron Inorganic materials 0.000 claims description 3
- 239000011737 fluorine Substances 0.000 claims description 3
- 125000004433 nitrogen atom Chemical group N* 0.000 claims description 3
- 239000003960 organic solvent Substances 0.000 claims description 3
- 125000000286 phenylethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])* 0.000 claims description 3
- 229910052698 phosphorus Inorganic materials 0.000 claims description 3
- 239000011574 phosphorus Substances 0.000 claims description 3
- SNICXCGAKADSCV-JTQLQIEISA-N (-)-Nicotine Chemical compound CN1CCC[C@H]1C1=CC=CN=C1 SNICXCGAKADSCV-JTQLQIEISA-N 0.000 claims description 2
- 125000001309 chloro group Chemical group Cl* 0.000 claims description 2
- 150000001924 cycloalkanes Chemical class 0.000 claims description 2
- 125000000753 cycloalkyl group Chemical group 0.000 claims description 2
- 125000004177 diethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 2
- 229960002715 nicotine Drugs 0.000 claims description 2
- SNICXCGAKADSCV-UHFFFAOYSA-N nicotine Natural products CN1CCCC1C1=CC=CN=C1 SNICXCGAKADSCV-UHFFFAOYSA-N 0.000 claims description 2
- 125000005740 oxycarbonyl group Chemical group [*:1]OC([*:2])=O 0.000 claims description 2
- 125000004076 pyridyl group Chemical group 0.000 claims description 2
- 125000002943 quinolinyl group Chemical group N1=C(C=CC2=CC=CC=C12)* 0.000 claims description 2
- 230000009467 reduction Effects 0.000 claims description 2
- 125000001412 tetrahydropyranyl group Chemical group 0.000 claims description 2
- 125000006273 (C1-C3) alkyl group Chemical group 0.000 claims 1
- LMBFAGIMSUYTBN-MPZNNTNKSA-N teixobactin Chemical compound C([C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H]1C(N[C@@H](C)C(=O)N[C@@H](C[C@@H]2NC(=N)NC2)C(=O)N[C@H](C(=O)O[C@H]1C)[C@@H](C)CC)=O)NC)C1=CC=CC=C1 LMBFAGIMSUYTBN-MPZNNTNKSA-N 0.000 claims 1
- 238000002560 therapeutic procedure Methods 0.000 claims 1
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 201
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 118
- 239000000203 mixture Substances 0.000 description 110
- 239000000243 solution Substances 0.000 description 104
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 97
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 96
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 84
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 83
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 78
- 238000002844 melting Methods 0.000 description 73
- 230000008018 melting Effects 0.000 description 73
- 150000003254 radicals Chemical class 0.000 description 60
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 56
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 52
- 238000003756 stirring Methods 0.000 description 47
- 239000000047 product Substances 0.000 description 41
- 235000002639 sodium chloride Nutrition 0.000 description 40
- 239000002904 solvent Substances 0.000 description 39
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 36
- HEMHJVSKTPXQMS-UHFFFAOYSA-M sodium hydroxide Inorganic materials [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 35
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 34
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 33
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 32
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 30
- 239000003054 catalyst Substances 0.000 description 29
- 238000006243 chemical reaction Methods 0.000 description 27
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 26
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 24
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 24
- 239000002244 precipitate Substances 0.000 description 23
- 239000000725 suspension Substances 0.000 description 23
- 229910052763 palladium Inorganic materials 0.000 description 22
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 21
- 239000003921 oil Substances 0.000 description 21
- 239000000706 filtrate Substances 0.000 description 18
- 125000004356 hydroxy functional group Chemical group O* 0.000 description 18
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 18
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 17
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 17
- SHFJWMWCIHQNCP-UHFFFAOYSA-M hydron;tetrabutylazanium;sulfate Chemical compound OS([O-])(=O)=O.CCCC[N+](CCCC)(CCCC)CCCC SHFJWMWCIHQNCP-UHFFFAOYSA-M 0.000 description 17
- 239000012071 phase Substances 0.000 description 17
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 16
- 150000007513 acids Chemical class 0.000 description 16
- 239000001110 calcium chloride Substances 0.000 description 16
- 229910001628 calcium chloride Inorganic materials 0.000 description 16
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 16
- 235000019341 magnesium sulphate Nutrition 0.000 description 16
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 16
- 229910000104 sodium hydride Inorganic materials 0.000 description 16
- 238000001816 cooling Methods 0.000 description 15
- 238000001035 drying Methods 0.000 description 14
- 239000012074 organic phase Substances 0.000 description 14
- 238000001914 filtration Methods 0.000 description 13
- 238000005984 hydrogenation reaction Methods 0.000 description 13
- PIBWKRNGBLPSSY-UHFFFAOYSA-L palladium(II) chloride Chemical compound Cl[Pd]Cl PIBWKRNGBLPSSY-UHFFFAOYSA-L 0.000 description 13
- 230000002829 reductive effect Effects 0.000 description 13
- 125000001424 substituent group Chemical group 0.000 description 13
- AGEZXYOZHKGVCM-UHFFFAOYSA-N benzyl bromide Chemical compound BrCC1=CC=CC=C1 AGEZXYOZHKGVCM-UHFFFAOYSA-N 0.000 description 12
- 239000003208 petroleum Substances 0.000 description 11
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Substances [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 11
- 239000007864 aqueous solution Substances 0.000 description 10
- 238000010438 heat treatment Methods 0.000 description 10
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 10
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 9
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 9
- 229960001760 dimethyl sulfoxide Drugs 0.000 description 9
- 239000013067 intermediate product Substances 0.000 description 9
- 239000007787 solid Substances 0.000 description 9
- 239000000126 substance Substances 0.000 description 9
- XNWFRZJHXBZDAG-UHFFFAOYSA-N 2-METHOXYETHANOL Chemical compound COCCO XNWFRZJHXBZDAG-UHFFFAOYSA-N 0.000 description 8
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 8
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 8
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 8
- 238000009835 boiling Methods 0.000 description 8
- 239000006185 dispersion Substances 0.000 description 8
- 239000012153 distilled water Substances 0.000 description 8
- 230000000694 effects Effects 0.000 description 8
- 238000001704 evaporation Methods 0.000 description 8
- 239000012312 sodium hydride Substances 0.000 description 8
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 8
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 7
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 7
- 238000004821 distillation Methods 0.000 description 7
- 230000008020 evaporation Effects 0.000 description 7
- 229910052500 inorganic mineral Inorganic materials 0.000 description 7
- 235000010755 mineral Nutrition 0.000 description 7
- 239000011707 mineral Substances 0.000 description 7
- 238000010992 reflux Methods 0.000 description 7
- 229940086542 triethylamine Drugs 0.000 description 7
- 238000005406 washing Methods 0.000 description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 6
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 6
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 6
- 125000004414 alkyl thio group Chemical group 0.000 description 6
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 6
- KCXMKQUNVWSEMD-UHFFFAOYSA-N benzyl chloride Chemical compound ClCC1=CC=CC=C1 KCXMKQUNVWSEMD-UHFFFAOYSA-N 0.000 description 6
- 229940073608 benzyl chloride Drugs 0.000 description 6
- BTANRVKWQNVYAZ-UHFFFAOYSA-N butan-2-ol Chemical compound CCC(C)O BTANRVKWQNVYAZ-UHFFFAOYSA-N 0.000 description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 238000002425 crystallisation Methods 0.000 description 6
- 230000008025 crystallization Effects 0.000 description 6
- 238000000354 decomposition reaction Methods 0.000 description 6
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 6
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 6
- 125000002950 monocyclic group Chemical group 0.000 description 6
- 125000001820 oxy group Chemical group [*:1]O[*:2] 0.000 description 6
- 239000011734 sodium Substances 0.000 description 6
- GETQZCLCWQTVFV-UHFFFAOYSA-N trimethylamine Chemical compound CN(C)C GETQZCLCWQTVFV-UHFFFAOYSA-N 0.000 description 6
- FJKROLUGYXJWQN-UHFFFAOYSA-N 4-hydroxybenzoic acid Chemical compound OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 5
- 241000700159 Rattus Species 0.000 description 5
- 239000002585 base Substances 0.000 description 5
- 125000002619 bicyclic group Chemical group 0.000 description 5
- 230000037396 body weight Effects 0.000 description 5
- 229910000027 potassium carbonate Inorganic materials 0.000 description 5
- 235000011181 potassium carbonates Nutrition 0.000 description 5
- 239000011541 reaction mixture Substances 0.000 description 5
- 229910052708 sodium Inorganic materials 0.000 description 5
- 239000007858 starting material Substances 0.000 description 5
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 5
- 238000011282 treatment Methods 0.000 description 5
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 4
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 4
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 4
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical group [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 4
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 4
- RWZYAGGXGHYGMB-UHFFFAOYSA-N anthranilic acid Chemical compound NC1=CC=CC=C1C(O)=O RWZYAGGXGHYGMB-UHFFFAOYSA-N 0.000 description 4
- 230000015556 catabolic process Effects 0.000 description 4
- HGCIXCUEYOPUTN-UHFFFAOYSA-N cyclohexene Chemical compound C1CCC=CC1 HGCIXCUEYOPUTN-UHFFFAOYSA-N 0.000 description 4
- 150000004820 halides Chemical class 0.000 description 4
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 4
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 4
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 4
- 239000011976 maleic acid Substances 0.000 description 4
- 231100000252 nontoxic Toxicity 0.000 description 4
- 230000003000 nontoxic effect Effects 0.000 description 4
- NROKBHXJSPEDAR-UHFFFAOYSA-M potassium fluoride Chemical compound [F-].[K+] NROKBHXJSPEDAR-UHFFFAOYSA-M 0.000 description 4
- 238000001953 recrystallisation Methods 0.000 description 4
- 239000011780 sodium chloride Substances 0.000 description 4
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 4
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 3
- XEZNGIUYQVAUSS-UHFFFAOYSA-N 18-crown-6 Chemical compound C1COCCOCCOCCOCCOCCO1 XEZNGIUYQVAUSS-UHFFFAOYSA-N 0.000 description 3
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 description 3
- SLRMQYXOBQWXCR-UHFFFAOYSA-N 2154-56-5 Chemical compound [CH2]C1=CC=CC=C1 SLRMQYXOBQWXCR-UHFFFAOYSA-N 0.000 description 3
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 3
- NLHHRLWOUZZQLW-UHFFFAOYSA-N Acrylonitrile Chemical compound C=CC#N NLHHRLWOUZZQLW-UHFFFAOYSA-N 0.000 description 3
- 239000005711 Benzoic acid Substances 0.000 description 3
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 3
- 102000008186 Collagen Human genes 0.000 description 3
- 108010035532 Collagen Proteins 0.000 description 3
- 229920002472 Starch Polymers 0.000 description 3
- DKGAVHZHDRPRBM-UHFFFAOYSA-N Tert-Butanol Chemical compound CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 description 3
- 239000013543 active substance Substances 0.000 description 3
- 125000003302 alkenyloxy group Chemical group 0.000 description 3
- 229910021529 ammonia Inorganic materials 0.000 description 3
- 235000010233 benzoic acid Nutrition 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 3
- 229910052794 bromium Inorganic materials 0.000 description 3
- 229920001436 collagen Polymers 0.000 description 3
- 239000012043 crude product Substances 0.000 description 3
- UCQFCFPECQILOL-UHFFFAOYSA-N diethyl hydrogen phosphate Chemical compound CCOP(O)(=O)OCC UCQFCFPECQILOL-UHFFFAOYSA-N 0.000 description 3
- 239000003085 diluting agent Substances 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 208000035475 disorder Diseases 0.000 description 3
- 238000006266 etherification reaction Methods 0.000 description 3
- 125000003754 ethoxycarbonyl group Chemical group C(=O)(OCC)* 0.000 description 3
- 208000006454 hepatitis Diseases 0.000 description 3
- 239000000543 intermediate Substances 0.000 description 3
- INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 description 3
- 230000002248 lipoperoxidative effect Effects 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 210000004185 liver Anatomy 0.000 description 3
- 239000012528 membrane Substances 0.000 description 3
- 229910052751 metal Inorganic materials 0.000 description 3
- 239000002184 metal Substances 0.000 description 3
- 239000002808 molecular sieve Substances 0.000 description 3
- 239000011664 nicotinic acid Substances 0.000 description 3
- 229960003512 nicotinic acid Drugs 0.000 description 3
- 235000001968 nicotinic acid Nutrition 0.000 description 3
- 239000000825 pharmaceutical preparation Substances 0.000 description 3
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 description 3
- 235000019260 propionic acid Nutrition 0.000 description 3
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 3
- 239000012429 reaction media Substances 0.000 description 3
- 239000000741 silica gel Substances 0.000 description 3
- 229910002027 silica gel Inorganic materials 0.000 description 3
- 239000000377 silicon dioxide Substances 0.000 description 3
- 235000012239 silicon dioxide Nutrition 0.000 description 3
- URGAHOPLAPQHLN-UHFFFAOYSA-N sodium aluminosilicate Chemical compound [Na+].[Al+3].[O-][Si]([O-])=O.[O-][Si]([O-])=O URGAHOPLAPQHLN-UHFFFAOYSA-N 0.000 description 3
- 238000004809 thin layer chromatography Methods 0.000 description 3
- 125000003396 thiol group Chemical group [H]S* 0.000 description 3
- 229920002554 vinyl polymer Polymers 0.000 description 3
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 description 2
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 2
- VFWCMGCRMGJXDK-UHFFFAOYSA-N 1-chlorobutane Chemical compound CCCCCl VFWCMGCRMGJXDK-UHFFFAOYSA-N 0.000 description 2
- 125000004343 1-phenylethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])(*)C([H])([H])[H] 0.000 description 2
- MSWZFWKMSRAUBD-GASJEMHNSA-N 2-amino-2-deoxy-D-galactopyranose Chemical compound N[C@H]1C(O)O[C@H](CO)[C@H](O)[C@@H]1O MSWZFWKMSRAUBD-GASJEMHNSA-N 0.000 description 2
- JRQAAYVLPPGEHT-UHFFFAOYSA-N 2-bromoethylcyclohexane Chemical compound BrCCC1CCCCC1 JRQAAYVLPPGEHT-UHFFFAOYSA-N 0.000 description 2
- WXUAQHNMJWJLTG-UHFFFAOYSA-N 2-methylbutanedioic acid Chemical compound OC(=O)C(C)CC(O)=O WXUAQHNMJWJLTG-UHFFFAOYSA-N 0.000 description 2
- WLJVXDMOQOGPHL-PPJXEINESA-N 2-phenylacetic acid Chemical compound O[14C](=O)CC1=CC=CC=C1 WLJVXDMOQOGPHL-PPJXEINESA-N 0.000 description 2
- XJMMNTGIMDZPMU-UHFFFAOYSA-N 3-methylglutaric acid Chemical compound OC(=O)CC(C)CC(O)=O XJMMNTGIMDZPMU-UHFFFAOYSA-N 0.000 description 2
- ALYNCZNDIQEVRV-PZFLKRBQSA-N 4-amino-3,5-ditritiobenzoic acid Chemical compound [3H]c1cc(cc([3H])c1N)C(O)=O ALYNCZNDIQEVRV-PZFLKRBQSA-N 0.000 description 2
- WUBBRNOQWQTFEX-UHFFFAOYSA-N 4-aminosalicylic acid Chemical compound NC1=CC=C(C(O)=O)C(O)=C1 WUBBRNOQWQTFEX-UHFFFAOYSA-N 0.000 description 2
- 229940090248 4-hydroxybenzoic acid Drugs 0.000 description 2
- BPYKTIZUTYGOLE-IFADSCNNSA-N Bilirubin Chemical compound N1C(=O)C(C)=C(C=C)\C1=C\C1=C(C)C(CCC(O)=O)=C(CC2=C(C(C)=C(\C=C/3C(=C(C=C)C(=O)N\3)C)N2)CCC(O)=O)N1 BPYKTIZUTYGOLE-IFADSCNNSA-N 0.000 description 2
- KZMGYPLQYOPHEL-UHFFFAOYSA-N Boron trifluoride etherate Chemical compound FB(F)F.CCOCC KZMGYPLQYOPHEL-UHFFFAOYSA-N 0.000 description 2
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 2
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Chemical compound CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 2
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- 235000021355 Stearic acid Nutrition 0.000 description 2
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 2
- KKEYFWRCBNTPAC-UHFFFAOYSA-N Terephthalic acid Chemical compound OC(=O)C1=CC=C(C(O)=O)C=C1 KKEYFWRCBNTPAC-UHFFFAOYSA-N 0.000 description 2
- XSTXAVWGXDQKEL-UHFFFAOYSA-N Trichloroethylene Chemical group ClC=C(Cl)Cl XSTXAVWGXDQKEL-UHFFFAOYSA-N 0.000 description 2
- DHKHKXVYLBGOIT-UHFFFAOYSA-N acetaldehyde Diethyl Acetal Natural products CCOC(C)OCC DHKHKXVYLBGOIT-UHFFFAOYSA-N 0.000 description 2
- 230000001154 acute effect Effects 0.000 description 2
- 125000002252 acyl group Chemical group 0.000 description 2
- WNLRTRBMVRJNCN-UHFFFAOYSA-N adipic acid Chemical compound OC(=O)CCCCC(O)=O WNLRTRBMVRJNCN-UHFFFAOYSA-N 0.000 description 2
- 230000001476 alcoholic effect Effects 0.000 description 2
- 229910052783 alkali metal Inorganic materials 0.000 description 2
- 150000003973 alkyl amines Chemical class 0.000 description 2
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 2
- 229960004909 aminosalicylic acid Drugs 0.000 description 2
- 150000003863 ammonium salts Chemical class 0.000 description 2
- 239000008346 aqueous phase Substances 0.000 description 2
- 229910052786 argon Inorganic materials 0.000 description 2
- 235000010323 ascorbic acid Nutrition 0.000 description 2
- 239000011668 ascorbic acid Substances 0.000 description 2
- 229960005070 ascorbic acid Drugs 0.000 description 2
- NDKBVBUGCNGSJJ-UHFFFAOYSA-M benzyltrimethylammonium hydroxide Chemical compound [OH-].C[N+](C)(C)CC1=CC=CC=C1 NDKBVBUGCNGSJJ-UHFFFAOYSA-M 0.000 description 2
- MSWZFWKMSRAUBD-UHFFFAOYSA-N beta-D-galactosamine Natural products NC1C(O)OC(CO)C(O)C1O MSWZFWKMSRAUBD-UHFFFAOYSA-N 0.000 description 2
- 239000004305 biphenyl Substances 0.000 description 2
- WTEOIRVLGSZEPR-UHFFFAOYSA-N boron trifluoride Chemical compound FB(F)F WTEOIRVLGSZEPR-UHFFFAOYSA-N 0.000 description 2
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 2
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 159000000007 calcium salts Chemical class 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 235000015165 citric acid Nutrition 0.000 description 2
- 210000002808 connective tissue Anatomy 0.000 description 2
- 125000000000 cycloalkoxy group Chemical group 0.000 description 2
- NZNMSOFKMUBTKW-UHFFFAOYSA-N cyclohexanecarboxylic acid Chemical compound OC(=O)C1CCCCC1 NZNMSOFKMUBTKW-UHFFFAOYSA-N 0.000 description 2
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 2
- HCAJEUSONLESMK-UHFFFAOYSA-N cyclohexylsulfamic acid Chemical class OS(=O)(=O)NC1CCCCC1 HCAJEUSONLESMK-UHFFFAOYSA-N 0.000 description 2
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 2
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 description 2
- SBZXBUIDTXKZTM-UHFFFAOYSA-N diglyme Chemical compound COCCOCCOC SBZXBUIDTXKZTM-UHFFFAOYSA-N 0.000 description 2
- VAYGXNSJCAHWJZ-UHFFFAOYSA-N dimethyl sulfate Chemical class COS(=O)(=O)OC VAYGXNSJCAHWJZ-UHFFFAOYSA-N 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- 229940088598 enzyme Drugs 0.000 description 2
- 230000032050 esterification Effects 0.000 description 2
- 238000005886 esterification reaction Methods 0.000 description 2
- CCIVGXIOQKPBKL-UHFFFAOYSA-M ethanesulfonate Chemical compound CCS([O-])(=O)=O CCIVGXIOQKPBKL-UHFFFAOYSA-M 0.000 description 2
- RIFGWPKJUGCATF-UHFFFAOYSA-N ethyl chloroformate Chemical compound CCOC(Cl)=O RIFGWPKJUGCATF-UHFFFAOYSA-N 0.000 description 2
- 125000000524 functional group Chemical group 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 210000003494 hepatocyte Anatomy 0.000 description 2
- 125000005842 heteroatom Chemical group 0.000 description 2
- 230000007062 hydrolysis Effects 0.000 description 2
- 238000006460 hydrolysis reaction Methods 0.000 description 2
- 239000005457 ice water Substances 0.000 description 2
- 239000012535 impurity Substances 0.000 description 2
- 238000011065 in-situ storage Methods 0.000 description 2
- SUMDYPCJJOFFON-UHFFFAOYSA-N isethionic acid Chemical compound OCCS(O)(=O)=O SUMDYPCJJOFFON-UHFFFAOYSA-N 0.000 description 2
- KQNPFQTWMSNSAP-UHFFFAOYSA-N isobutyric acid Chemical compound CC(C)C(O)=O KQNPFQTWMSNSAP-UHFFFAOYSA-N 0.000 description 2
- QQVIHTHCMHWDBS-UHFFFAOYSA-N isophthalic acid Chemical compound OC(=O)C1=CC=CC(C(O)=O)=C1 QQVIHTHCMHWDBS-UHFFFAOYSA-N 0.000 description 2
- 239000004310 lactic acid Substances 0.000 description 2
- 235000014655 lactic acid Nutrition 0.000 description 2
- 230000002132 lysosomal effect Effects 0.000 description 2
- 210000003712 lysosome Anatomy 0.000 description 2
- 230000001868 lysosomic effect Effects 0.000 description 2
- 239000011777 magnesium Substances 0.000 description 2
- 229910052749 magnesium Inorganic materials 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- 239000001630 malic acid Substances 0.000 description 2
- 235000011090 malic acid Nutrition 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- 125000001160 methoxycarbonyl group Chemical group [H]C([H])([H])OC(*)=O 0.000 description 2
- 125000004184 methoxymethyl group Chemical group [H]C([H])([H])OC([H])([H])* 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 2
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 2
- BDJRBEYXGGNYIS-UHFFFAOYSA-N nonanedioic acid Chemical compound OC(=O)CCCCCCCC(O)=O BDJRBEYXGGNYIS-UHFFFAOYSA-N 0.000 description 2
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 2
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 2
- 150000007530 organic bases Chemical class 0.000 description 2
- WLJNZVDCPSBLRP-UHFFFAOYSA-N pamoic acid Chemical compound C1=CC=C2C(CC=3C4=CC=CC=C4C=C(C=3O)C(=O)O)=C(O)C(C(O)=O)=CC2=C1 WLJNZVDCPSBLRP-UHFFFAOYSA-N 0.000 description 2
- 239000003444 phase transfer catalyst Substances 0.000 description 2
- IMACFCSSMIZSPP-UHFFFAOYSA-N phenacyl chloride Chemical class ClCC(=O)C1=CC=CC=C1 IMACFCSSMIZSPP-UHFFFAOYSA-N 0.000 description 2
- XNGIFLGASWRNHJ-UHFFFAOYSA-N phthalic acid Chemical compound OC(=O)C1=CC=CC=C1C(O)=O XNGIFLGASWRNHJ-UHFFFAOYSA-N 0.000 description 2
- SIOXPEMLGUPBBT-UHFFFAOYSA-N picolinic acid Chemical compound OC(=O)C1=CC=CC=N1 SIOXPEMLGUPBBT-UHFFFAOYSA-N 0.000 description 2
- WLJVNTCWHIRURA-UHFFFAOYSA-N pimelic acid Chemical compound OC(=O)CCCCCC(O)=O WLJVNTCWHIRURA-UHFFFAOYSA-N 0.000 description 2
- 239000011698 potassium fluoride Substances 0.000 description 2
- 235000003270 potassium fluoride Nutrition 0.000 description 2
- 159000000001 potassium salts Chemical class 0.000 description 2
- WGYKZJWCGVVSQN-UHFFFAOYSA-N propylamine Chemical group CCCN WGYKZJWCGVVSQN-UHFFFAOYSA-N 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 150000003856 quaternary ammonium compounds Chemical class 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- CXMXRPHRNRROMY-UHFFFAOYSA-N sebacic acid Chemical compound OC(=O)CCCCCCCCC(O)=O CXMXRPHRNRROMY-UHFFFAOYSA-N 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- NDVLTYZPCACLMA-UHFFFAOYSA-N silver oxide Chemical compound [O-2].[Ag+].[Ag+] NDVLTYZPCACLMA-UHFFFAOYSA-N 0.000 description 2
- 229910000033 sodium borohydride Inorganic materials 0.000 description 2
- 239000012279 sodium borohydride Substances 0.000 description 2
- 235000017550 sodium carbonate Nutrition 0.000 description 2
- 229910000029 sodium carbonate Inorganic materials 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 239000008117 stearic acid Substances 0.000 description 2
- TYFQFVWCELRYAO-UHFFFAOYSA-N suberic acid Chemical compound OC(=O)CCCCCCC(O)=O TYFQFVWCELRYAO-UHFFFAOYSA-N 0.000 description 2
- 239000011975 tartaric acid Substances 0.000 description 2
- 235000002906 tartaric acid Nutrition 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 230000003313 weakening effect Effects 0.000 description 2
- DSGKWFGEUBCEIE-UHFFFAOYSA-N (2-carbonochloridoylphenyl) acetate Chemical compound CC(=O)OC1=CC=CC=C1C(Cl)=O DSGKWFGEUBCEIE-UHFFFAOYSA-N 0.000 description 1
- KMOUUZVZFBCRAM-OLQVQODUSA-N (3as,7ar)-3a,4,7,7a-tetrahydro-2-benzofuran-1,3-dione Chemical compound C1C=CC[C@@H]2C(=O)OC(=O)[C@@H]21 KMOUUZVZFBCRAM-OLQVQODUSA-N 0.000 description 1
- PQMFVUNERGGBPG-UHFFFAOYSA-N (6-bromopyridin-2-yl)hydrazine Chemical compound NNC1=CC=CC(Br)=N1 PQMFVUNERGGBPG-UHFFFAOYSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- LCFFREMLXLZNHE-GBOLQPHISA-N (e)-2-[(3r)-3-[4-amino-3-(2-fluoro-4-phenoxyphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]piperidine-1-carbonyl]-4-methyl-4-[4-(oxetan-3-yl)piperazin-1-yl]pent-2-enenitrile Chemical compound C12=C(N)N=CN=C2N([C@@H]2CCCN(C2)C(=O)C(/C#N)=C/C(C)(C)N2CCN(CC2)C2COC2)N=C1C(C(=C1)F)=CC=C1OC1=CC=CC=C1 LCFFREMLXLZNHE-GBOLQPHISA-N 0.000 description 1
- WBYWAXJHAXSJNI-VOTSOKGWSA-M .beta-Phenylacrylic acid Natural products [O-]C(=O)\C=C\C1=CC=CC=C1 WBYWAXJHAXSJNI-VOTSOKGWSA-M 0.000 description 1
- BIAAQBNMRITRDV-UHFFFAOYSA-N 1-(chloromethoxy)-2-methoxyethane Chemical compound COCCOCCl BIAAQBNMRITRDV-UHFFFAOYSA-N 0.000 description 1
- LZSYGJNFCREHMD-UHFFFAOYSA-N 1-bromo-2-(bromomethyl)benzene Chemical compound BrCC1=CC=CC=C1Br LZSYGJNFCREHMD-UHFFFAOYSA-N 0.000 description 1
- WPWHSFAFEBZWBB-UHFFFAOYSA-N 1-butyl radical Chemical group [CH2]CCC WPWHSFAFEBZWBB-UHFFFAOYSA-N 0.000 description 1
- OBQPKGCVMCIETH-UHFFFAOYSA-N 1-chloro-1-(1-chloroethoxy)ethane Chemical compound CC(Cl)OC(C)Cl OBQPKGCVMCIETH-UHFFFAOYSA-N 0.000 description 1
- YAYNEUUHHLGGAH-UHFFFAOYSA-N 1-chlorododecane Chemical compound CCCCCCCCCCCCCl YAYNEUUHHLGGAH-UHFFFAOYSA-N 0.000 description 1
- DZMDPHNGKBEVRE-UHFFFAOYSA-N 1-chloroheptane Chemical compound CCCCCCCCl DZMDPHNGKBEVRE-UHFFFAOYSA-N 0.000 description 1
- CLWAXFZCVYJLLM-UHFFFAOYSA-N 1-chlorohexadecane Chemical compound CCCCCCCCCCCCCCCCCl CLWAXFZCVYJLLM-UHFFFAOYSA-N 0.000 description 1
- VUQPJRPDRDVQMN-UHFFFAOYSA-N 1-chlorooctadecane Chemical compound CCCCCCCCCCCCCCCCCCCl VUQPJRPDRDVQMN-UHFFFAOYSA-N 0.000 description 1
- LOTKRQAVGJMPNV-UHFFFAOYSA-N 1-fluoro-2,4-dinitrobenzene Chemical compound [O-][N+](=O)C1=CC=C(F)C([N+]([O-])=O)=C1 LOTKRQAVGJMPNV-UHFFFAOYSA-N 0.000 description 1
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- RTBFRGCFXZNCOE-UHFFFAOYSA-N 1-methylsulfonylpiperidin-4-one Chemical compound CS(=O)(=O)N1CCC(=O)CC1 RTBFRGCFXZNCOE-UHFFFAOYSA-N 0.000 description 1
- LNETULKMXZVUST-UHFFFAOYSA-N 1-naphthoic acid Chemical compound C1=CC=C2C(C(=O)O)=CC=CC2=C1 LNETULKMXZVUST-UHFFFAOYSA-N 0.000 description 1
- 125000001637 1-naphthyl group Chemical group [H]C1=C([H])C([H])=C2C(*)=C([H])C([H])=C([H])C2=C1[H] 0.000 description 1
- 125000005976 1-phenylethyloxy group Chemical group 0.000 description 1
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 1
- FALRKNHUBBKYCC-UHFFFAOYSA-N 2-(chloromethyl)pyridine-3-carbonitrile Chemical compound ClCC1=NC=CC=C1C#N FALRKNHUBBKYCC-UHFFFAOYSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- FKJSFKCZZIXQIP-UHFFFAOYSA-N 2-bromo-1-(4-bromophenyl)ethanone Chemical compound BrCC(=O)C1=CC=C(Br)C=C1 FKJSFKCZZIXQIP-UHFFFAOYSA-N 0.000 description 1
- IQEIGQFNDLINOT-UHFFFAOYSA-N 2-chloro-1-(4-phenylphenyl)ethanone Chemical compound C1=CC(C(=O)CCl)=CC=C1C1=CC=CC=C1 IQEIGQFNDLINOT-UHFFFAOYSA-N 0.000 description 1
- 125000001731 2-cyanoethyl group Chemical group [H]C([H])(*)C([H])([H])C#N 0.000 description 1
- 125000004200 2-methoxyethyl group Chemical group [H]C([H])([H])OC([H])([H])C([H])([H])* 0.000 description 1
- UOBYKYZJUGYBDK-UHFFFAOYSA-N 2-naphthoic acid Chemical compound C1=CC=CC2=CC(C(=O)O)=CC=C21 UOBYKYZJUGYBDK-UHFFFAOYSA-N 0.000 description 1
- VMZCDNSFRSVYKQ-UHFFFAOYSA-N 2-phenylacetyl chloride Chemical compound ClC(=O)CC1=CC=CC=C1 VMZCDNSFRSVYKQ-UHFFFAOYSA-N 0.000 description 1
- 125000000094 2-phenylethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000005975 2-phenylethyloxy group Chemical group 0.000 description 1
- 125000001494 2-propynyl group Chemical group [H]C#CC([H])([H])* 0.000 description 1
- 125000004105 2-pyridyl group Chemical group N1=C([*])C([H])=C([H])C([H])=C1[H] 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- BUTKIHRNYUEGKB-UHFFFAOYSA-N 3,3-dimethylbutanoyl chloride Chemical compound CC(C)(C)CC(Cl)=O BUTKIHRNYUEGKB-UHFFFAOYSA-N 0.000 description 1
- ZLWMGDNHFWGWLW-UHFFFAOYSA-N 3,4-bis(phenylmethoxy)benzoyl chloride Chemical compound C=1C=CC=CC=1COC1=CC(C(=O)Cl)=CC=C1OCC1=CC=CC=C1 ZLWMGDNHFWGWLW-UHFFFAOYSA-N 0.000 description 1
- XMZQWZJMTBCUFT-UHFFFAOYSA-N 3-bromopropylbenzene Chemical compound BrCCCC1=CC=CC=C1 XMZQWZJMTBCUFT-UHFFFAOYSA-N 0.000 description 1
- 125000004975 3-butenyl group Chemical group C(CC=C)* 0.000 description 1
- VDAVARPTDLMJIC-UHFFFAOYSA-N 3-ethylpentanedioic acid Chemical compound OC(=O)CC(CC)CC(O)=O VDAVARPTDLMJIC-UHFFFAOYSA-N 0.000 description 1
- QOXOZONBQWIKDA-UHFFFAOYSA-N 3-hydroxypropyl Chemical group [CH2]CCO QOXOZONBQWIKDA-UHFFFAOYSA-N 0.000 description 1
- 125000006201 3-phenylpropyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000003349 3-pyridyl group Chemical group N1=C([H])C([*])=C([H])C([H])=C1[H] 0.000 description 1
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- PXACTUVBBMDKRW-UHFFFAOYSA-N 4-bromobenzenesulfonic acid Chemical compound OS(=O)(=O)C1=CC=C(Br)C=C1 PXACTUVBBMDKRW-UHFFFAOYSA-N 0.000 description 1
- 125000006281 4-bromobenzyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1Br)C([H])([H])* 0.000 description 1
- 125000006283 4-chlorobenzyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1Cl)C([H])([H])* 0.000 description 1
- CZKLEJHVLCMVQR-UHFFFAOYSA-N 4-fluorobenzoyl chloride Chemical compound FC1=CC=C(C(Cl)=O)C=C1 CZKLEJHVLCMVQR-UHFFFAOYSA-N 0.000 description 1
- 125000004176 4-fluorobenzyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1F)C([H])([H])* 0.000 description 1
- 125000004217 4-methoxybenzyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1OC([H])([H])[H])C([H])([H])* 0.000 description 1
- 125000006181 4-methyl benzyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1C([H])([H])[H])C([H])([H])* 0.000 description 1
- YYROPELSRYBVMQ-UHFFFAOYSA-N 4-toluenesulfonyl chloride Chemical compound CC1=CC=C(S(Cl)(=O)=O)C=C1 YYROPELSRYBVMQ-UHFFFAOYSA-N 0.000 description 1
- XVMSFILGAMDHEY-UHFFFAOYSA-N 6-(4-aminophenyl)sulfonylpyridin-3-amine Chemical compound C1=CC(N)=CC=C1S(=O)(=O)C1=CC=C(N)C=N1 XVMSFILGAMDHEY-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 208000010266 Aggressive Periodontitis Diseases 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical class [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- 241000416162 Astragalus gummifer Species 0.000 description 1
- NOWKCMXCCJGMRR-UHFFFAOYSA-N Aziridine Chemical compound C1CN1 NOWKCMXCCJGMRR-UHFFFAOYSA-N 0.000 description 1
- 229910015900 BF3 Inorganic materials 0.000 description 1
- CZNJCCVKDVCRKF-UHFFFAOYSA-N Benzyl sulfate Chemical class OS(=O)(=O)OCC1=CC=CC=C1 CZNJCCVKDVCRKF-UHFFFAOYSA-N 0.000 description 1
- 101800004538 Bradykinin Proteins 0.000 description 1
- COVZYZSDYWQREU-UHFFFAOYSA-N Busulfan Chemical compound CS(=O)(=O)OCCCCOS(C)(=O)=O COVZYZSDYWQREU-UHFFFAOYSA-N 0.000 description 1
- KZBUYRJDOAKODT-UHFFFAOYSA-N Chlorine Chemical compound ClCl KZBUYRJDOAKODT-UHFFFAOYSA-N 0.000 description 1
- XJUZRXYOEPSWMB-UHFFFAOYSA-N Chloromethyl methyl ether Chemical compound COCCl XJUZRXYOEPSWMB-UHFFFAOYSA-N 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 206010008909 Chronic Hepatitis Diseases 0.000 description 1
- WBYWAXJHAXSJNI-SREVYHEPSA-N Cinnamic acid Chemical compound OC(=O)\C=C/C1=CC=CC=C1 WBYWAXJHAXSJNI-SREVYHEPSA-N 0.000 description 1
- 102000029816 Collagenase Human genes 0.000 description 1
- 108060005980 Collagenase Proteins 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 229920002261 Corn starch Polymers 0.000 description 1
- 241000699800 Cricetinae Species 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- ZNZYKNKBJPZETN-WELNAUFTSA-N Dialdehyde 11678 Chemical compound N1C2=CC=CC=C2C2=C1[C@H](C[C@H](/C(=C/O)C(=O)OC)[C@@H](C=C)C=O)NCC2 ZNZYKNKBJPZETN-WELNAUFTSA-N 0.000 description 1
- BUDQDWGNQVEFAC-UHFFFAOYSA-N Dihydropyran Chemical compound C1COC=CC1 BUDQDWGNQVEFAC-UHFFFAOYSA-N 0.000 description 1
- 241000790917 Dioxys <bee> Species 0.000 description 1
- SNRUBQQJIBEYMU-UHFFFAOYSA-N Dodecane Natural products CCCCCCCCCCCC SNRUBQQJIBEYMU-UHFFFAOYSA-N 0.000 description 1
- 208000002197 Ehlers-Danlos syndrome Diseases 0.000 description 1
- KRHYYFGTRYWZRS-UHFFFAOYSA-M Fluoride anion Chemical compound [F-] KRHYYFGTRYWZRS-UHFFFAOYSA-M 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- QXZGBUJJYSLZLT-UHFFFAOYSA-N H-Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe-Arg-OH Natural products NC(N)=NCCCC(N)C(=O)N1CCCC1C(=O)N1C(C(=O)NCC(=O)NC(CC=2C=CC=CC=2)C(=O)NC(CO)C(=O)N2C(CCC2)C(=O)NC(CC=2C=CC=CC=2)C(=O)NC(CCCN=C(N)N)C(O)=O)CCC1 QXZGBUJJYSLZLT-UHFFFAOYSA-N 0.000 description 1
- 208000026350 Inborn Genetic disease Diseases 0.000 description 1
- 102100035792 Kininogen-1 Human genes 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 208000001393 Lathyrism Diseases 0.000 description 1
- 102000004895 Lipoproteins Human genes 0.000 description 1
- 108090001030 Lipoproteins Proteins 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 244000151018 Maranta arundinacea Species 0.000 description 1
- 235000010804 Maranta arundinacea Nutrition 0.000 description 1
- 208000001826 Marfan syndrome Diseases 0.000 description 1
- CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 description 1
- 239000012359 Methanesulfonyl chloride Substances 0.000 description 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- LGRFSURHDFAFJT-UHFFFAOYSA-N Phthalic anhydride Natural products C1=CC=C2C(=O)OC(=O)C2=C1 LGRFSURHDFAFJT-UHFFFAOYSA-N 0.000 description 1
- 208000005374 Poisoning Diseases 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 208000004210 Pressure Ulcer Diseases 0.000 description 1
- 239000012891 Ringer solution Substances 0.000 description 1
- 206010039710 Scleroderma Diseases 0.000 description 1
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 1
- 206010072170 Skin wound Diseases 0.000 description 1
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 235000012419 Thalia geniculata Nutrition 0.000 description 1
- 229920001615 Tragacanth Polymers 0.000 description 1
- 102000003929 Transaminases Human genes 0.000 description 1
- 108090000340 Transaminases Proteins 0.000 description 1
- GLNADSQYFUSGOU-GPTZEZBUSA-J Trypan blue Chemical compound [Na+].[Na+].[Na+].[Na+].C1=C(S([O-])(=O)=O)C=C2C=C(S([O-])(=O)=O)C(/N=N/C3=CC=C(C=C3C)C=3C=C(C(=CC=3)\N=N\C=3C(=CC4=CC(=CC(N)=C4C=3O)S([O-])(=O)=O)S([O-])(=O)=O)C)=C(O)C2=C1N GLNADSQYFUSGOU-GPTZEZBUSA-J 0.000 description 1
- 244000126014 Valeriana officinalis Species 0.000 description 1
- 235000013832 Valeriana officinalis Nutrition 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- JEYNYBYEOGOUAM-UHFFFAOYSA-N [2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3,4-dihydro-2H-chromen-3-yl] dihydrogen phosphate Chemical compound O1C2=CC(O)=CC(O)=C2CC(OP(O)(O)=O)C1C1=CC=C(O)C(O)=C1 JEYNYBYEOGOUAM-UHFFFAOYSA-N 0.000 description 1
- ZWFXPDBXPLHJIS-UHFFFAOYSA-N [2-[3,4-bis(phenylmethoxy)phenyl]-5,7-bis(phenylmethoxy)-3,4-dihydro-2H-chromen-3-yl] dihydrogen phosphate Chemical compound C1=C(OCC=2C=CC=CC=2)C=C2OC(C=3C=C(OCC=4C=CC=CC=4)C(OCC=4C=CC=CC=4)=CC=3)C(OP(O)(=O)O)CC2=C1OCC1=CC=CC=C1 ZWFXPDBXPLHJIS-UHFFFAOYSA-N 0.000 description 1
- XAKBSHICSHRJCL-UHFFFAOYSA-N [CH2]C(=O)C1=CC=CC=C1 Chemical group [CH2]C(=O)C1=CC=CC=C1 XAKBSHICSHRJCL-UHFFFAOYSA-N 0.000 description 1
- YKTSYUJCYHOUJP-UHFFFAOYSA-N [O--].[Al+3].[Al+3].[O-][Si]([O-])([O-])[O-] Chemical compound [O--].[Al+3].[Al+3].[O-][Si]([O-])([O-])[O-] YKTSYUJCYHOUJP-UHFFFAOYSA-N 0.000 description 1
- 150000001241 acetals Chemical class 0.000 description 1
- 125000000738 acetamido group Chemical group [H]C([H])([H])C(=O)N([H])[*] 0.000 description 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
- 125000001539 acetonyl group Chemical group [H]C([H])([H])C(=O)C([H])([H])* 0.000 description 1
- 231100000354 acute hepatitis Toxicity 0.000 description 1
- 125000005073 adamantyl group Chemical group C12(CC3CC(CC(C1)C3)C2)* 0.000 description 1
- 125000005075 adamantyloxy group Chemical group C12(CC3CC(CC(C1)C3)C2)O* 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 239000001361 adipic acid Substances 0.000 description 1
- 235000011037 adipic acid Nutrition 0.000 description 1
- 239000003463 adsorbent Substances 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- 150000007933 aliphatic carboxylic acids Chemical class 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 150000001447 alkali salts Chemical class 0.000 description 1
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 1
- 150000001336 alkenes Chemical class 0.000 description 1
- 125000005194 alkoxycarbonyloxy group Chemical group 0.000 description 1
- 125000005115 alkyl carbamoyl group Chemical group 0.000 description 1
- 150000001350 alkyl halides Chemical class 0.000 description 1
- 150000008051 alkyl sulfates Chemical class 0.000 description 1
- 239000002168 alkylating agent Substances 0.000 description 1
- 229940100198 alkylating agent Drugs 0.000 description 1
- 125000005530 alkylenedioxy group Chemical group 0.000 description 1
- BHELZAPQIKSEDF-UHFFFAOYSA-N allyl bromide Chemical compound BrCC=C BHELZAPQIKSEDF-UHFFFAOYSA-N 0.000 description 1
- 125000005336 allyloxy group Chemical group 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- DFNYGALUNNFWKJ-UHFFFAOYSA-N aminoacetonitrile Chemical compound NCC#N DFNYGALUNNFWKJ-UHFFFAOYSA-N 0.000 description 1
- 150000008064 anhydrides Chemical class 0.000 description 1
- JFCQEDHGNNZCLN-UHFFFAOYSA-N anhydrous glutaric acid Natural products OC(=O)CCCC(O)=O JFCQEDHGNNZCLN-UHFFFAOYSA-N 0.000 description 1
- 150000001450 anions Chemical class 0.000 description 1
- 239000000010 aprotic solvent Substances 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 125000005161 aryl oxy carbonyl group Chemical group 0.000 description 1
- 150000005840 aryl radicals Chemical class 0.000 description 1
- 239000012298 atmosphere Substances 0.000 description 1
- 229940092714 benzenesulfonic acid Drugs 0.000 description 1
- 238000005574 benzylation reaction Methods 0.000 description 1
- 125000000051 benzyloxy group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])O* 0.000 description 1
- 235000021028 berry Nutrition 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 235000010290 biphenyl Nutrition 0.000 description 1
- QXZGBUJJYSLZLT-FDISYFBBSA-N bradykinin Chemical compound NC(=N)NCCC[C@H](N)C(=O)N1CCC[C@H]1C(=O)N1[C@H](C(=O)NCC(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CO)C(=O)N2[C@@H](CCC2)C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)CCC1 QXZGBUJJYSLZLT-FDISYFBBSA-N 0.000 description 1
- 150000001649 bromium compounds Chemical class 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 239000002021 butanolic extract Substances 0.000 description 1
- JHIWVOJDXOSYLW-UHFFFAOYSA-N butyl 2,2-difluorocyclopropane-1-carboxylate Chemical compound CCCCOC(=O)C1CC1(F)F JHIWVOJDXOSYLW-UHFFFAOYSA-N 0.000 description 1
- DVECBJCOGJRVPX-UHFFFAOYSA-N butyryl chloride Chemical compound CCCC(Cl)=O DVECBJCOGJRVPX-UHFFFAOYSA-N 0.000 description 1
- CJZGTCYPCWQAJB-UHFFFAOYSA-L calcium stearate Chemical compound [Ca+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CJZGTCYPCWQAJB-UHFFFAOYSA-L 0.000 description 1
- 235000013539 calcium stearate Nutrition 0.000 description 1
- 239000008116 calcium stearate Substances 0.000 description 1
- 230000004856 capillary permeability Effects 0.000 description 1
- 150000004649 carbonic acid derivatives Chemical class 0.000 description 1
- KXDHJXZQYSOELW-UHFFFAOYSA-N carbonic acid monoamide Natural products NC(O)=O KXDHJXZQYSOELW-UHFFFAOYSA-N 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 238000009903 catalytic hydrogenation reaction Methods 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 239000012295 chemical reaction liquid Substances 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- HPNSNYBUADCFDR-UHFFFAOYSA-N chromafenozide Chemical compound CC1=CC(C)=CC(C(=O)N(NC(=O)C=2C(=C3CCCOC3=CC=2)C)C(C)(C)C)=C1 HPNSNYBUADCFDR-UHFFFAOYSA-N 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 229930016911 cinnamic acid Natural products 0.000 description 1
- 235000013985 cinnamic acid Nutrition 0.000 description 1
- 125000000490 cinnamyl group Chemical group C(C=CC1=CC=CC=C1)* 0.000 description 1
- 229960002424 collagenase Drugs 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 239000008120 corn starch Substances 0.000 description 1
- 229940099112 cornstarch Drugs 0.000 description 1
- LDHQCZJRKDOVOX-NSCUHMNNSA-N crotonic acid Chemical compound C\C=C\C(O)=O LDHQCZJRKDOVOX-NSCUHMNNSA-N 0.000 description 1
- 150000003983 crown ethers Chemical class 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 238000009109 curative therapy Methods 0.000 description 1
- 201000010251 cutis laxa Diseases 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 125000000392 cycloalkenyl group Chemical group 0.000 description 1
- 125000001995 cyclobutyl group Chemical group [H]C1([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- VZFUCHSFHOYXIS-UHFFFAOYSA-N cycloheptane carboxylic acid Natural products OC(=O)C1CCCCCC1 VZFUCHSFHOYXIS-UHFFFAOYSA-N 0.000 description 1
- 125000006622 cycloheptylmethyl group Chemical group 0.000 description 1
- QSAWQNUELGIYBC-UHFFFAOYSA-N cyclohexane-1,2-dicarboxylic acid Chemical compound OC(=O)C1CCCCC1C(O)=O QSAWQNUELGIYBC-UHFFFAOYSA-N 0.000 description 1
- IPIVAXLHTVNRBS-UHFFFAOYSA-N decanoyl chloride Chemical compound CCCCCCCCCC(Cl)=O IPIVAXLHTVNRBS-UHFFFAOYSA-N 0.000 description 1
- 125000002704 decyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 239000002274 desiccant Substances 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 239000008121 dextrose Substances 0.000 description 1
- LGTLXDJOAJDFLR-UHFFFAOYSA-N diethyl chlorophosphate Chemical compound CCOP(Cl)(=O)OCC LGTLXDJOAJDFLR-UHFFFAOYSA-N 0.000 description 1
- 125000001664 diethylamino group Chemical group [H]C([H])([H])C([H])([H])N(*)C([H])([H])C([H])([H])[H] 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 125000005982 diphenylmethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])(*)C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 125000003438 dodecyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 125000006575 electron-withdrawing group Chemical group 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 150000002118 epoxides Chemical class 0.000 description 1
- 125000004185 ester group Chemical group 0.000 description 1
- 239000012374 esterification agent Substances 0.000 description 1
- AQZNBAIWDZHJNK-UHFFFAOYSA-N ethanimidoyl cyanide Chemical compound CC(=N)C#N AQZNBAIWDZHJNK-UHFFFAOYSA-N 0.000 description 1
- 125000005745 ethoxymethyl group Chemical group [H]C([H])([H])C([H])([H])OC([H])([H])* 0.000 description 1
- QUPDWYMUPZLYJZ-UHFFFAOYSA-N ethyl Chemical compound C[CH2] QUPDWYMUPZLYJZ-UHFFFAOYSA-N 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 239000007903 gelatin capsule Substances 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 208000016361 genetic disease Diseases 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- 150000002367 halogens Chemical class 0.000 description 1
- 206010019692 hepatic necrosis Diseases 0.000 description 1
- 230000007866 hepatic necrosis Effects 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 231100000334 hepatotoxic Toxicity 0.000 description 1
- 230000003082 hepatotoxic effect Effects 0.000 description 1
- 150000002391 heterocyclic compounds Chemical class 0.000 description 1
- ARBOVOVUTSQWSS-UHFFFAOYSA-N hexadecanoyl chloride Chemical compound CCCCCCCCCCCCCCCC(Cl)=O ARBOVOVUTSQWSS-UHFFFAOYSA-N 0.000 description 1
- 229960001340 histamine Drugs 0.000 description 1
- 239000000852 hydrogen donor Substances 0.000 description 1
- 125000002768 hydroxyalkyl group Chemical group 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 230000003308 immunostimulating effect Effects 0.000 description 1
- 239000012442 inert solvent Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 230000000302 ischemic effect Effects 0.000 description 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- 239000012948 isocyanate Substances 0.000 description 1
- 150000002513 isocyanates Chemical class 0.000 description 1
- 125000004491 isohexyl group Chemical group C(CCC(C)C)* 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 125000001972 isopentyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000000555 isopropenyl group Chemical group [H]\C([H])=C(\*)C([H])([H])[H] 0.000 description 1
- 125000005928 isopropyloxycarbonyl group Chemical group [H]C([H])([H])C([H])(OC(*)=O)C([H])([H])[H] 0.000 description 1
- 239000000644 isotonic solution Substances 0.000 description 1
- 125000000842 isoxazolyl group Chemical group 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- HCWCAKKEBCNQJP-UHFFFAOYSA-N magnesium orthosilicate Chemical compound [Mg+2].[Mg+2].[O-][Si]([O-])([O-])[O-] HCWCAKKEBCNQJP-UHFFFAOYSA-N 0.000 description 1
- 239000000391 magnesium silicate Substances 0.000 description 1
- 229910052919 magnesium silicate Inorganic materials 0.000 description 1
- 235000019792 magnesium silicate Nutrition 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000010907 mechanical stirring Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 150000002730 mercury Chemical class 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 229910000000 metal hydroxide Inorganic materials 0.000 description 1
- 150000004692 metal hydroxides Chemical class 0.000 description 1
- 229940098779 methanesulfonic acid Drugs 0.000 description 1
- QARBMVPHQWIHKH-UHFFFAOYSA-N methanesulfonyl chloride Chemical compound CS(Cl)(=O)=O QARBMVPHQWIHKH-UHFFFAOYSA-N 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- WBYWAXJHAXSJNI-UHFFFAOYSA-N methyl p-hydroxycinnamate Natural products OC(=O)C=CC1=CC=CC=C1 WBYWAXJHAXSJNI-UHFFFAOYSA-N 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000003136 n-heptyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000001280 n-hexyl group Chemical group C(CCCCC)* 0.000 description 1
- SNMVRZFUUCLYTO-UHFFFAOYSA-N n-propyl chloride Chemical compound CCCCl SNMVRZFUUCLYTO-UHFFFAOYSA-N 0.000 description 1
- 210000003739 neck Anatomy 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 229910017604 nitric acid Inorganic materials 0.000 description 1
- YTAQPYGKYMDEEZ-UHFFFAOYSA-N nitroformyl cyanide Chemical group [O-][N+](=O)C(=O)C#N YTAQPYGKYMDEEZ-UHFFFAOYSA-N 0.000 description 1
- 239000012299 nitrogen atmosphere Substances 0.000 description 1
- 125000001400 nonyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- ZWLPBLYKEWSWPD-UHFFFAOYSA-N o-toluic acid Chemical compound CC1=CC=CC=C1C(O)=O ZWLPBLYKEWSWPD-UHFFFAOYSA-N 0.000 description 1
- 125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 150000002902 organometallic compounds Chemical class 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 201000008482 osteoarthritis Diseases 0.000 description 1
- 230000002642 osteogeneic effect Effects 0.000 description 1
- 125000002971 oxazolyl group Chemical group 0.000 description 1
- 125000006505 p-cyanobenzyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1C#N)C([H])([H])* 0.000 description 1
- 238000007911 parenteral administration Methods 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 125000001147 pentyl group Chemical group C(CCCC)* 0.000 description 1
- 230000000737 periodic effect Effects 0.000 description 1
- 201000006727 periodontosis Diseases 0.000 description 1
- 229940021222 peritoneal dialysis isotonic solution Drugs 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- LIGACIXOYTUXAW-UHFFFAOYSA-N phenacyl bromide Chemical compound BrCC(=O)C1=CC=CC=C1 LIGACIXOYTUXAW-UHFFFAOYSA-N 0.000 description 1
- 125000006678 phenoxycarbonyl group Chemical group 0.000 description 1
- ZUOUZKKEUPVFJK-UHFFFAOYSA-N phenylbenzene Natural products C1=CC=CC=C1C1=CC=CC=C1 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 229940081066 picolinic acid Drugs 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 125000003367 polycyclic group Chemical group 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 229940072033 potash Drugs 0.000 description 1
- 235000015320 potassium carbonate Nutrition 0.000 description 1
- NTTOTNSKUYCDAV-UHFFFAOYSA-N potassium hydride Chemical compound [KH] NTTOTNSKUYCDAV-UHFFFAOYSA-N 0.000 description 1
- 229910000105 potassium hydride Inorganic materials 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000000069 prophylactic effect Effects 0.000 description 1
- 238000011321 prophylaxis Methods 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- UORVCLMRJXCDCP-UHFFFAOYSA-N propynoic acid Chemical compound OC(=O)C#C UORVCLMRJXCDCP-UHFFFAOYSA-N 0.000 description 1
- 125000006239 protecting group Chemical group 0.000 description 1
- 125000004309 pyranyl group Chemical group O1C(C=CC=C1)* 0.000 description 1
- ATBIAJXSKNPHEI-UHFFFAOYSA-N pyridine-3-carbonyl chloride Chemical compound ClC(=O)C1=CC=CN=C1 ATBIAJXSKNPHEI-UHFFFAOYSA-N 0.000 description 1
- 125000001453 quaternary ammonium group Chemical group 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 229940100486 rice starch Drugs 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 229930195734 saturated hydrocarbon Natural products 0.000 description 1
- 206010039722 scoliosis Diseases 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 239000004332 silver Substances 0.000 description 1
- 229910001923 silver oxide Inorganic materials 0.000 description 1
- 238000001577 simple distillation Methods 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- ODZPKZBBUMBTMG-UHFFFAOYSA-N sodium amide Chemical compound [NH2-].[Na+] ODZPKZBBUMBTMG-UHFFFAOYSA-N 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 1
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 230000007863 steatosis Effects 0.000 description 1
- 231100000240 steatosis hepatitis Toxicity 0.000 description 1
- 125000005504 styryl group Chemical group 0.000 description 1
- 239000001384 succinic acid Substances 0.000 description 1
- 229940014800 succinic anhydride Drugs 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- RVEZZJVBDQCTEF-UHFFFAOYSA-N sulfenic acid Chemical compound SO RVEZZJVBDQCTEF-UHFFFAOYSA-N 0.000 description 1
- BUUPQKDIAURBJP-UHFFFAOYSA-N sulfinic acid Chemical compound OS=O BUUPQKDIAURBJP-UHFFFAOYSA-N 0.000 description 1
- 150000003462 sulfoxides Chemical class 0.000 description 1
- 125000004434 sulfur atom Chemical group 0.000 description 1
- 239000000829 suppository Substances 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 235000012222 talc Nutrition 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 125000005931 tert-butyloxycarbonyl group Chemical group [H]C([H])([H])C(OC(*)=O)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 125000005922 tert-pentoxy group Chemical group 0.000 description 1
- 125000005934 tert-pentyloxycarbonyl group Chemical group 0.000 description 1
- 150000003510 tertiary aliphatic amines Chemical class 0.000 description 1
- 150000003512 tertiary amines Chemical class 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- DLYUQMMRRRQYAE-UHFFFAOYSA-N tetraphosphorus decaoxide Chemical compound O1P(O2)(=O)OP3(=O)OP1(=O)OP2(=O)O3 DLYUQMMRRRQYAE-UHFFFAOYSA-N 0.000 description 1
- 125000000335 thiazolyl group Chemical group 0.000 description 1
- 125000001544 thienyl group Chemical group 0.000 description 1
- QERYCTSHXKAMIS-UHFFFAOYSA-N thiophene-2-carboxylic acid Chemical compound OC(=O)C1=CC=CS1 QERYCTSHXKAMIS-UHFFFAOYSA-N 0.000 description 1
- KJAMZCVTJDTESW-UHFFFAOYSA-N tiracizine Chemical compound C1CC2=CC=CC=C2N(C(=O)CN(C)C)C2=CC(NC(=O)OCC)=CC=C21 KJAMZCVTJDTESW-UHFFFAOYSA-N 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- LDHQCZJRKDOVOX-UHFFFAOYSA-N trans-crotonic acid Natural products CC=CC(O)=O LDHQCZJRKDOVOX-UHFFFAOYSA-N 0.000 description 1
- 229910052723 transition metal Inorganic materials 0.000 description 1
- 150000003624 transition metals Chemical class 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- UBOXGVDOUJQMTN-UHFFFAOYSA-N trichloroethylene Natural products ClCC(Cl)Cl UBOXGVDOUJQMTN-UHFFFAOYSA-N 0.000 description 1
- 125000002469 tricosyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- ITMCEJHCFYSIIV-UHFFFAOYSA-M triflate Chemical compound [O-]S(=O)(=O)C(F)(F)F ITMCEJHCFYSIIV-UHFFFAOYSA-M 0.000 description 1
- ITMCEJHCFYSIIV-UHFFFAOYSA-N triflic acid Chemical compound OS(=O)(=O)C(F)(F)F ITMCEJHCFYSIIV-UHFFFAOYSA-N 0.000 description 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 description 1
- 125000002221 trityl group Chemical group [H]C1=C([H])C([H])=C([H])C([H])=C1C([*])(C1=C(C(=C(C(=C1[H])[H])[H])[H])[H])C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 1
- 125000002948 undecyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229930195735 unsaturated hydrocarbon Natural products 0.000 description 1
- 235000016788 valerian Nutrition 0.000 description 1
- 230000008728 vascular permeability Effects 0.000 description 1
- 230000006442 vascular tone Effects 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
- 229940100445 wheat starch Drugs 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
Landscapes
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Description
Fremgangsmåte for fremstilling av O-substituerteProcess for the preparation of O-substituted
derivater av (+)-cyanidan-3-ol.derivatives of (+)-cyanidan-3-ol.
Foreliggende oppfinnelse angår nye O-substituerte derivater av (+)-cyanidan-3_ol3spesielt 3_0-substituerte derivater av (+)-cyanidan-3-ol som tilsvarer formel I The present invention relates to new O-substituted derivatives of (+)-cyanidan-3-ol3, especially 3-0-substituted derivatives of (+)-cyanidan-3-ol which correspond to formula I
hvor R representerer where R represents
et eventuelt substituert hydrokarbonradikal; et akylradikal av en organisk karboksylsyre med minst 2 karbonatomer}av en karbonsyre eller en organisk sulfonsyre; eller et an optionally substituted hydrocarbon radical; an alkyl radical of an organic carboxylic acid with at least 2 carbon atoms} of a carboxylic acid or an organic sulfonic acid; or a
'radikal av en uorganisk syre inneholdende minst et oksygen-atora med unntak av et glukosidisk radikal; 'radical of an inorganic acid containing at least one oxygen atom with the exception of a glucosidic radical;
samt salter av nevnte forbindelser, en fremgangsmåte for deres fremstilling samt deres anvendelse i terapeutika og medisiner som inneholder disse nye produkter. as well as salts of said compounds, a method for their preparation as well as their use in therapeutics and medicines containing these new products.
Med begrepet "lavere" radikaler forstås radikaler, med opptil 7 karbonatomer, mer spesielt opptil ^ karbonatomer. By the term "lower" radicals are meant radicals, with up to 7 carbon atoms, more particularly up to ^ carbon atoms.
Et eventuelt substituert hydrokarbonradikal representert ved gruppen R kan f.eks. være et alifatisk, cykloalifatisk, cykloalifatisk-alifatisk,.aromatisk, aromatisk-alifatisk, heterocyklisk eller heterocyklisk-alifatisk hydrokarbonradikal. Disse radikaler kan være substituerte og kan inneholde fra 1 An optionally substituted hydrocarbon radical represented by the group R can e.g. be an aliphatic, cycloaliphatic, cycloaliphatic-aliphatic, aromatic, aromatic-aliphatic, heterocyclic or heterocyclic-aliphatic hydrocarbon radical. These radicals can be substituted and can contain from 1
til 24 karbonatomer.to 24 carbon atoms.
Et akylradikal av en karboksylisk syre, kan mer spesielt være et alifatisk, cykloalifatisk, cykloalifatisk-alifatisk, aromatisk, aromatisk-alifatisk, heterocyklisk eller hete.rocyklisk-alifatisk syreradikal med fra 2 til 24 karbonatomer og som eventuelt kan være substituert. An alkyl radical of a carboxylic acid can more particularly be an aliphatic, cycloaliphatic, cycloaliphatic-aliphatic, aromatic, aromatic-aliphatic, heterocyclic or heterocyclic-aliphatic acid radical with from 2 to 24 carbon atoms and which may optionally be substituted.
Et karbonsyreradikal representert ved gruppen R kan f.eks. være et radikal av en forestret eller amidert karbonsyre. A carboxylic acid radical represented by the group R can e.g. be a radical of an esterified or amidated carboxylic acid.
Et organisk sulfonisk syreradikal kan f.eks. være et eventuelt substituert alifatisk, aromatisk eller aromatisk-alifatisk sulfonsyreradikal inneholdende fra 1 til 12 karbonatomer. An organic sulphonic acid radical can e.g. be an optionally substituted aliphatic, aromatic or aromatic-aliphatic sulfonic acid radical containing from 1 to 12 carbon atoms.
Et uorganisk syreradikal kan f.eks. være et radikal fra en syre som hovedatom har et atom fra ett av gruppene III, IV, V eller VI i det periodiske system, da spesielt fra periodene 1 og 2. Eksempler på slike hovedatomer er svovel, fosfor, bor og nitrogen. An inorganic acid radical can e.g. be a radical from an acid whose main atom has an atom from one of groups III, IV, V or VI in the periodic table, especially from periods 1 and 2. Examples of such main atoms are sulphur, phosphorus, boron and nitrogen.
Et alifatisk hydrokarbonradikal kan spesielt være et mettet hydrokarbonradikal, såsom et alkylradikal eller et umettet hydrokarbonradikal såsom et alkenyl- eller alkynylradikal. Disse kan være lineære eller grenede. Slike radikaler kan, hvis det er ønskelig, være monosubstituerte, disubstituerte eller polysubstituerte ved hjelp av funksjonelle grupper, i An aliphatic hydrocarbon radical may in particular be a saturated hydrocarbon radical, such as an alkyl radical or an unsaturated hydrocarbon radical such as an alkenyl or alkynyl radical. These can be linear or branched. Such radicals may, if desired, be monosubstituted, disubstituted or polysubstituted by means of functional groups, in
Et eventuelt substituert cykloalifatisk eller cykloalifatisk-alifatisk hydrokarbonradikal kan f.eks. være et monocyklisk, bicyklisk eller polycyklisk cykloalkyl eller cykloalkenylradikal, eller et cykloalkyl-laverealkyl, cykloalkenyl-laverealkyl, cykloalkyl-laverealkenyl eller cykloalkenyl-laverealkenylradikal, hvor et cykloalkylradikal kan f.eks. inneholde opptil 12 karbonatomer, f.eks.- fra 3 til 8, fortrinnsvis fra 3 til 6 ringkarbonatomer, mens et cykloalkenylradikal kan f.eks. inneholde .opptil 12, f.eks. fra 3 til 8, fortrinnsvis fra 5 eller 6 ringkarbonatomer så vel som en eller to dobbeltbindinger, mens den alifatiske gruppen av et cyklo-alif atisk-alif atiskradikal kan f.eks. inneholde opptil 7, fortrinnsvis opptil 4 karbonatomer. De ovennevnte cykloalifatiske eller cykloalifatisk-alifatiske radikaler kan hvis det er ønskelig, være monosubstituerte, disubstituerte eller polysubstituerte. An optionally substituted cycloaliphatic or cycloaliphatic-aliphatic hydrocarbon radical can e.g. be a monocyclic, bicyclic or polycyclic cycloalkyl or cycloalkenyl radical, or a cycloalkyl-lower alkyl, cycloalkenyl-lower alkyl, cycloalkyl-lower alkenyl or cycloalkenyl-lower alkenyl radical, where a cycloalkyl radical can e.g. contain up to 12 carbon atoms, e.g. from 3 to 8, preferably from 3 to 6 ring carbon atoms, while a cycloalkenyl radical can e.g. contain .up to 12, e.g. from 3 to 8, preferably from 5 or 6 ring carbon atoms as well as one or two double bonds, while the aliphatic group of a cyclo-aliphatic-aliphatic radical can e.g. contain up to 7, preferably up to 4 carbon atoms. The above-mentioned cycloaliphatic or cycloaliphatic-aliphatic radicals can, if desired, be monosubstituted, disubstituted or polysubstituted.
Et eventuelt substituert aromatisk hydrokarbonradikal kan f.eks. være et monocyklisk, bicyklisk eller polycyklisk aromatisk hydrokarbonradikal, mer spesielt et fenylradikal, men kan også være et naftylradikal som hvis det er ønskelig, kan være monosubstituert, disubstituert eller poly-substituert. An optionally substituted aromatic hydrocarbon radical can e.g. be a monocyclic, bicyclic or polycyclic aromatic hydrocarbon radical, more particularly a phenyl radical, but may also be a naphthyl radical which, if desired, may be monosubstituted, disubstituted or polysubstituted.
Et eventuelt substituert aromatisk-alifatisk hydrokarbonradikal kan f.eks. være et eventuelt substituert alifatisk hydrokarbonradikal med opptil 3 eventuelt substituerte monocykliske, bicykliske eller polycykliske aromatiske hydrokarbonradikaler, og kan være representert ved et fenyl-laverealkylradikal, men kan også være et fenyl-laverealkenylradikal eller et fenyl-laverealkynylradikal og slike radikaler kan f.eks. inneholde fra 1 til 3 fenylgrupper, og kan hvis det er ønskelig, være monosubstituert, disubstituert eller poly-substituert i den aromatiske og/eller alifatiske delen. An optionally substituted aromatic-aliphatic hydrocarbon radical can e.g. be an optionally substituted aliphatic hydrocarbon radical with up to 3 optionally substituted monocyclic, bicyclic or polycyclic aromatic hydrocarbon radicals, and can be represented by a phenyl-lower alkyl radical, but can also be a phenyl-lower alkenyl radical or a phenyl-lower alkynyl radical and such radicals can e.g. contain from 1 to 3 phenyl groups, and can, if desired, be monosubstituted, disubstituted or polysubstituted in the aromatic and/or aliphatic part.
Et heterocyklisk radikal kan f.eks. være et monocyklisk radikal, men kan være et bicyklisk eller polycyklisk, fortrinnsvis et mettet eller umettet aza-, tia-, oksa-, tiaza-, oksaza- eller diaza-cyklisk radikal, f.eks. av en aromatisk natur, og som fortrinnsvis har fra 2 til 7 karbonatomer, og som kan hvis det er ønskelig, være. monosubstituert, disubstituert eller polysubstituert. Den alifatiske gruppen i et heterocyklisk-alifatisk radikal kan f.eks. ha den betydning som er angitt ovenfor for den alifatiske gruppen i de tilsvarende cykloalifatiske-alifatiske eller aromatiske-alifatiske radikaler. A heterocyclic radical can e.g. be a monocyclic radical, but may be a bicyclic or polycyclic, preferably a saturated or unsaturated aza-, thia-, oxa-, thiaza-, oxaza- or diaza-cyclic radical, e.g. of an aromatic nature, and which preferably has from 2 to 7 carbon atoms, and which may, if desired, be monosubstituted, disubstituted or polysubstituted. The aliphatic group in a heterocyclic-aliphatic radical can e.g. have the meaning given above for the aliphatic group in the corresponding cycloaliphatic-aliphatic or aromatic-aliphatic radicals.
Akylradikalene R av en alifatisk karboksylsyre kan f.eks. være•radikaler av alkankarboksylsyrer, spesielt av laverealkankarboksylsyrer, men kan også være radikaler av alkenkarboksylsyrer, da spesielt av laverealkenkarboksylsyrer, og dessuten av laverealkandikarboksylsyrer eller av'lavere-alkendikarboksylsyrer. The acyl radicals R of an aliphatic carboxylic acid can e.g. be•radicals of alkanecarboxylic acids, especially of lower alkanecarboxylic acids, but can also be radicals of alkenecarboxylic acids, then especially of loweralkenecarboxylic acids, and also of loweralkanedicarboxylic acids or of'lower-alkenedicarboxylic acids.
Akylradikalene-R av en cykloalifatisk, cykloalifatisk-alifatisk, aromatisk, aromatisk-alifatisk, heterocyklisk eller heterocyklisk-alifatisk karboksylsyre har, i ringen og/ eller det alifatiske radikal, samme betydning som angitt oven for for de cykloalifatiske, aromatiske eller heterocykliske radikaler eller de tilsvarende alifatiske radikaler. De kan ha substituenter. The acyl radicals-R of a cycloaliphatic, cycloaliphatic-aliphatic, aromatic, aromatic-aliphatic, heterocyclic or heterocyclic-aliphatic carboxylic acid have, in the ring and/or the aliphatic radical, the same meaning as stated above for the cycloaliphatic, aromatic or heterocyclic radicals or the corresponding aliphatic radicals. They may have substituents.
Akylradikalene R av en forestret eller amidert karbonsyre kan være alifatiske, aromatiske eller aralifatiske estre av karbonsyre, såsom en laverealkoksykarbonyl, aryloksy-karbonyl eller aryl-laverealk.oksykarb.onylgruppe eller av en karbaminsyre, fortrinnsvis mono- eller di-substituert med alifatiske, aromatiske eller aralifatiske radikaler. The acyl radicals R of an esterified or amidated carboxylic acid can be aliphatic, aromatic or araliphatic esters of carboxylic acid, such as a lower alkoxycarbonyl, aryloxycarbonyl or aryl-loweralk.oxycarbonyl group or of a carbamic acid, preferably mono- or di-substituted with aliphatic, aromatic or araliphatic radicals.
De funksjonelle grupper som kan opptre som kom-plementære substituenter i ett eller flere av de radikaler The functional groups that can act as complementary substituents in one or more of the radicals
som er nevnt ovenfor kan f.eks. være frie, forestrede eller foretrede hydroksy eller merkaptogrupper, såsom laverealkoksy, laverealkenyloksy, laverealkylmerkaptogrupper, eventuelt substituerte ■fenylmerkaptogrupper eller fenyl-lavereålkylmerkap-togrupper, laverealkoksykarbonyloksygrupper eller laverealkanoyloksygrupper så vel som halogenatomer og dessuten nitrogrupper, eventuelt substituerte aminogrupper, akylgrupper, såsom laverealkanoylgrupper eller eventuelt funksjonelt modi-fiserte karboksygrupper, såsom laverealkoksykarbonylgrupper, eventuelt N-substituerte karbamoylgrupper eller.cyanogrupper. De aromatiske eller heterocykliske radikaler-kan også bære which is mentioned above can e.g. be free, esterified or etherified hydroxy or mercapto groups, such as lower alkoxy, lower alkenyloxy, lower alkyl mercapto groups, optionally substituted ■phenyl mercapto groups or phenyl-lower alkyl mercapto groups, lower alkoxycarbonyloxy groups or lower alkanoyloxy groups as well as halogen atoms and also nitro groups, optionally substituted amino groups, alkyl groups, such as lower alkanoyl groups or optionally functional modified carboxy groups, such as lower alkoxycarbonyl groups, optionally N-substituted carbamoyl groups or cyano groups. The aromatic or heterocyclic radicals can also carry
som substituenter alkylradikaler, fortrinnsvis laverealkylradikaler. as substituents alkyl radicals, preferably lower alkyl radicals.
Med foretrede hydroksygrupper forstås spesielt laverealkoksygrupper så vel som substituerte laverealkoksygrupper såsom halogen-laverealkoksygrupper foruten lavere-alkenyloksygrupper, laverealkendioksygrupper, cykloalkoksy-grupper, fenyloksygrupper, fenyl-laverealkoksygrupper eller laverealkoksygrupper substituert med monocykliske mono-aza-, mono-oksa- eller mono-tia-cykliske grupper av aromatisk natur, såsom pyridyl-laverealkoksygrupper, furyl-1'averealkoksygrupper eller tienyl-laverealkoksygrupper. By ethereal hydroxy groups is meant in particular lower alkoxy groups as well as substituted lower alkoxy groups such as halogen-lower alkoxy groups in addition to lower alkenyloxy groups, lower alkenedioxy groups, cycloalkoxy groups, phenyloxy groups, phenyl-lower alkoxy groups or lower alkoxy groups substituted with monocyclic mono-aza-, mono-oxa- or mono-thia- cyclic groups of an aromatic nature, such as pyridyl-lower alkyl groups, furyl-1'averyl oxy groups or thienyl lower alkyl groups.
Som foretrede merkaptogrupper kan nevnes laverealkylmerkaptogrupper, fenylmerkaptogrupper eller fenyl-laverealkylmerkaptogrupper. Preferred mercapto groups can be mentioned lower alkyl mercapto groups, phenyl mercapto groups or phenyl-lower alkyl mercapto groups.
De forestrede hydroksygrupper kan spesielt være halogenatomer så vel som laverealkanoyloksygrupper. The esterified hydroxy groups can in particular be halogen atoms as well as lower alkanoyloxy groups.
De substituerte aminogrupper er monosubstituerte eller disubstituerte aminogrupper hvor substituentene eventuelt representerer substituerte monovalente eller bivalente alifatiske, cykloalifatiske, cykloalifatiske-alifatiske, aromatiske eller aralifatiske hydrokarbonradikaler så vel som akylgrupper. Slike aminogrupper kan f.eks. være laverealkylaminogrupper The substituted amino groups are monosubstituted or disubstituted amino groups where the substituents optionally represent substituted monovalent or bivalent aliphatic, cycloaliphatic, cycloaliphatic-aliphatic, aromatic or araliphatic hydrocarbon radicals as well as alkyl groups. Such amino groups can e.g. be lower alkylamino groups
eller di-laverealkylaminogrupper eller laverealkylenamino-grupper eventuelt avbrutt av heteroatomer såsom oksygenatomer, svovelatomer eller hvis det er ønskelig, eventuelt substituerte nitrogenatomer, f.eks. med laverealkylgrupper foruten akyl-aminogrupper, da spesielt laverealkanoylaminogrupper. or di-lower alkylamino groups or lower alkyleneamino groups optionally interrupted by heteroatoms such as oxygen atoms, sulfur atoms or, if desired, optionally substituted nitrogen atoms, e.g. with lower alkyl groups in addition to alkyl amino groups, then especially lower alkanoyl amino groups.
I det ovennevnte og i det følgende kan de gene-relle begreper ha følgende betydning: Et alkylradikal er fortrinnsvis et laverealkylradikal, f.eks. en metyl, etyl, n-propyl, isopropyl, n-butyl, isobutyl, sekundærbutyl eller tertiærbutylradikal, men også et pentyl, isopentyl, n-heksyl, isoheksyl, n-heptyl, oktyl, nonyl, dekyl, undekyl, dodekyl, trikosyl eller tetrakosyl-radikal og isomerer av disse,' mens et alkenylradikal fortrinnsvis er et laverealkenylradikal, og kan f.eks. være et vinyl, allyl, n-propenyl, isopropenyl, 2- eller 3-metallyl eller 3-butenylgruppe, og et alkynylradikal kan f.eks. være propar-gyl eller 2-butyrylradikal .. In the above and in the following, the general terms can have the following meaning: An alkyl radical is preferably a lower alkyl radical, e.g. a methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, secondary butyl or tertiary butyl radical, but also a pentyl, isopentyl, n-hexyl, isohexyl, n-heptyl, octyl, nonyl, decyl, undecyl, dodecyl, tricosyl or tetracosyl radical and isomers thereof, while an alkenyl radical is preferably a lower alkenyl radical, and can e.g. be a vinyl, allyl, n-propenyl, isopropenyl, 2- or 3-methallyl or 3-butenyl group, and an alkynyl radical can e.g. be propar-gyl or 2-butyryl radical..
De substituerte alifatiske hydrokarbonradikaler innbefatter fortrinnsvis hydroksygrupper, laverealkoksygrupper og halogenatomer og kan være hydroksy-laverealkoksy eller laverealkoksy-laverealkoksyradikaler, hvor hydroksygruppene eller de laverealkoksygruppene er skilt, fortrinnsvis med minst to karbonatomer fra det pksygenatom som bærer et lavere-alifatisk radikal substituert på denne måten, såsom 2-hydroksyTetyl, 2-hydroksypropyl; 3_hydroksypropy1, 2,3-dihydroksypropyl, 2-metoksyetyl, 2-etoksyety1, 2-metoksypropy1, 3_metoksypropy1 eller 3-etoksypropylradikaler så vel som hydroksymetylradi-kaler. The substituted aliphatic hydrocarbon radicals preferably include hydroxy groups, lower methoxy groups and halogen atoms and can be hydroxy-lower oxy or lower alkoxy-lower oxy radicals, where the hydroxy groups or the lower alkoxy groups are separated, preferably by at least two carbon atoms from the oxygen atom carrying a lower aliphatic radical substituted in this way, such as 2-hydroxyTetyl, 2-hydroxypropyl; 3-hydroxypropyl, 2,3-dihydroxypropyl, 2-methoxyethyl, 2-ethoxyethyl, 2-methoxypropyl, 3-methoxypropyl or 3-ethoxypropyl radicals as well as hydroxymethyl radicals.
Et cykloalkylradikal kan f.eks. være cyklopropyl, cyklobutyl, cyklopentyl, cykloheksyl eller cykloheptylradi-kaler så vel som en adamantylgruppe, og en cykloalkenylgruppe kan f.eks. være en 2- eller 3-cyklopentenylgruppe, eller en 1-, 2- eller 3-cykloheksenylgruppe,■ eller en 3-cykloheptenyl-gruppe så vel som en 2-cyklopropenylgruppe. Et cykloalkyl- laverealkylradikal eller cykloalkyl-laverealkenylradikal kan f.eks. være et cyklopropyl-, cyklopentyl-, cykloheksyl- eller cykloheptyl-mety1, -1,1- eller -1,2-etyl, -1,1-, -1,2- eller A cycloalkyl radical can e.g. be cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl or cycloheptyl radicals as well as an adamantyl group, and a cycloalkenyl group can e.g. be a 2- or 3-cyclopentenyl group, or a 1-, 2- or 3-cyclohexenyl group,■ or a 3-cycloheptenyl group as well as a 2-cyclopropenyl group. A cycloalkyl-lower alkyl radical or cycloalkyl-lower alkenyl radical can e.g. be a cyclopropyl, cyclopentyl, cyclohexyl or cycloheptylmethyl, -1,1- or -1,2-ethyl, -1,1-, -1,2- or
-1,3-propyl, -vinyl eller -allylradikal, mens et cykloalkeny1-laverealkyl eller cykloalkenyl-laverealkenylradikal representerer f.eks. et 1-, 2- eller 3-cyklopentenyl-, 1-, 2-'eller -1,3-propyl, -vinyl or -allyl radical, while a cycloalkeny1-lower alkyl or cycloalkenyl-lower alkenyl radical represents e.g. a 1-, 2- or 3-cyclopentenyl-, 1-, 2-'or
3-cykloheksenyl- eller 1-, 2- eller 3-cykloheptenyl-metyl, -1,1- eller -1,2-etyl, -1,1-, -1,2- eller -1,3-propyl, -vinyl eller -allylradikal. 3-cyclohexenyl- or 1-, 2- or 3-cycloheptenyl-methyl, -1,1- or -1,2-ethyl, -1,1-, -1,2- or -1,3-propyl, - vinyl or -allyl radical.
Et naftylradikal er et 1- eller 2-naftylradikal A naphthyl radical is a 1- or 2-naphthyl radical
mens et difenylradikal kan f.eks. være et 4-difenylradikal. while a diphenyl radical can e.g. be a 4-diphenyl radical.
Et fenyl-laverealkyl eller fenyl-laverealkenylradikal kan f.eks. være et benzylradikal sa vel som 1- eller 2- fenyletyl, 1-, 2- eller 3-fenylpropy1, difenylmetyl, tri-tyl, 1- eller 2-naftylmetyl, styryl eller cinnamylradikal. A phenyl-lower alkyl or phenyl-lower alkenyl radical can e.g. be a benzyl radical as well as 1- or 2-phenylethyl, 1-, 2- or 3-phenylpropyl, diphenylmethyl, trityl, 1- or 2-naphthylmethyl, styryl or cinnamyl radical.
Et substituert fenyl-laverealkylradikal kan være et benzylradikal som kan være mono-, di- eller polysubstituert i fenylkjernen, og substituentene kan være like eller forskjellige. Som substituenter kan f.eks. nevnes halogenatomer eller laverealkylgrupper så vel som laverealkoksygrupper eller trifluor-metylgrupper, mens benzylradikalene i den substituerte kjernen kan bære en substituent, fortrinnsvis i para^stillingen. A substituted phenyl lower alkyl radical can be a benzyl radical which can be mono-, di- or polysubstituted in the phenyl ring, and the substituents can be the same or different. As substituents, e.g. halogen atoms or lower alkyl groups as well as lower alkoxy groups or trifluoromethyl groups are mentioned, while the benzyl radicals in the substituted nucleus can carry a substituent, preferably in the para position.
Som heterocykliske radikaler kan man f.eks. nevne monocykliske mono-aza-, mono-tia- eller mono-oksa-cykliske■ radikaler av aromatisk natur, så som pyridylradikaler, f.eks. 2-pyridyl, 3-pyridyl eller 4-pyridylradikaler, tienylradikaler, f.eks. 2-tienylradikaler eller furylradikaler, f.eks.•2-furylradikaler eller bicykliske mono-aza-cykliske radikaler av aromatisk natur, såsom kinolinylradikaler eller 2-kinolinylradikaler eller 4-kinolinylradikaler eller isokinolinylradikaler, f.eks. 1-isokinolinylradikaler eller monocykliske tiaza- eller oksaza-cykliske radikaler av aromatisk natur så vel som diaza-cykliske radikaler av samme type, såsom oksazolyl, isoksazolyl, tiazolyl eller isotiazolylrådikaler, As heterocyclic radicals, one can e.g. mention monocyclic mono-aza-, mono-thia- or mono-oxa-cyclic ■ radicals of an aromatic nature, such as pyridyl radicals, e.g. 2-pyridyl, 3-pyridyl or 4-pyridyl radicals, thienyl radicals, e.g. 2-thienyl radicals or furyl radicals, e.g. 2-furyl radicals or bicyclic mono-aza-cyclic radicals of an aromatic nature, such as quinolinyl radicals or 2-quinolinyl radicals or 4-quinolinyl radicals or isoquinolinyl radicals, e.g. 1-isoquinolinyl radicals or monocyclic thiaza- or oxaza-cyclic radicals of an aromatic nature as well as diaza-cyclic radicals of the same type, such as oxazolyl, isoxazolyl, thiazolyl or isothiazolyl radicals,
foruten pyrimidinylradikaler. 'Alifatiske heterocykliske radikaler er laverealkyl eller laverealkenylradikaler inneholdende heterocykliske radikaler, spesielt de som er angitt ovenfor. besides pyrimidinyl radicals. Aliphatic heterocyclic radicals are lower alkyl or lower alkenyl radicals containing heterocyclic radicals, especially those indicated above.
Akylradikalene av alkankarboksylsyrer kan f.eks. The acyl radicals of alkane carboxylic acids can e.g.
være propionsyre, smørsyre, isosmørsyre eller valeriansyre og høyere homologer opptil stearinsyre, mens de av alkandikarboksyl-syrer kan f.eks. inneholde fra 2 til 10, fortrinnsvis fra 3 til 6, karbonatomer, eller av alkendikarboksyliske syrer kan f.eks. inneholde fra 4 til 7 karbonatomer, .f.eks. av 2-metyl-ravsyre, glutarsyre, 3-metylglutarsyre, 3-etylglutarsyre, adipinsyre, pimelinsyre, suberinsyre, azelainsyre eller sebacin-syre, fortrinnsvis maleonsyre og ravsyre: videre kan nevnes akylradikaler av umettede alifatiske syrer såsom akrylsyre, propiolinsyre, metakrylsyre, krotonsyre eller oljesyre, da spesielt maleinsyre eller fumarsyre. be propionic acid, butyric acid, isobutyric acid or valerian acid and higher homologues up to stearic acid, while those of alkanedicarboxylic acids can e.g. contain from 2 to 10, preferably from 3 to 6, carbon atoms, or of alkenedicarboxylic acids can e.g. contain from 4 to 7 carbon atoms, e.g. of 2-methylsuccinic acid, glutaric acid, 3-methylglutaric acid, 3-ethylglutaric acid, adipic acid, pimelic acid, suberic acid, azelaic acid or sebacic acid, preferably maleic acid and succinic acid: mention may also be made of alkyl radicals of unsaturated aliphatic acids such as acrylic acid, propiolic acid, methacrylic acid, crotonic acid or oleic acid, then especially maleic acid or fumaric acid.
Akylradikalene av karboksylsyrer kan f.eks. være cykloheksankarboksylsyre og benzosyre som kan være substituert, f.eks.- med en laverealkylgruppe såsom metyl, med en alkoksy-gruppe, såsom metoksy- eller etoksy eller en karboksygruppe, The acyl radicals of carboxylic acids can e.g. be cyclohexanecarboxylic acid and benzoic acid which may be substituted, e.g. with a lower alkyl group such as methyl, with an alkoxy group such as methoxy or ethoxy or a carboxy group,
og av disse kan man nevne ftalsyre, is-oftalsyre, tereftalsyre, kanelsyre eller toluinsyre, så vel som 1- eller 2- naftoin-syre eller 1,2-cykloheksandikarboksylsyre. and of these one can mention phthalic acid, isophthalic acid, terephthalic acid, cinnamic acid or toluic acid, as well as 1- or 2-naphthoic acid or 1,2-cyclohexanedicarboxylic acid.
Akylradikalene av heterocykliske syrer kan f.eks. være de av furoinsyre, tenoinsyre, nikotinsyre, isonikotinsyre og pikolinsyre. The acyl radicals of heterocyclic acids can e.g. be those of furoic acid, tenoic acid, nicotinic acid, isonicotinic acid and picolinic acid.
En laverealkoksykarbonylgruppe kan f.eks. væreA lower alkoxycarbonyl group can e.g. be
en metoksykarbonyl, etoksykarbonyl, n-propoksykarbonyl, iso-propoksykarbonyl, tert.-butoksykarbonyl -eller tert.-pentyl-oksykarbonylgruppe. a methoxycarbonyl, ethoxycarbonyl, n-propoxycarbonyl, iso-propoxycarbonyl, tert-butoxycarbonyl or tert-pentyloxycarbonyl group.
Den eventuelt N-substituerte karbamoylgruppenThe optionally N-substituted carbamoyl group
kan f.eks. være N-laverealkyl- eller N,N-di-laverealkyl-karbamoylgrupper, såsom N-metyl-, N-etyl-,' N,N-dimetyl- eller N,N-dietyl-karbamoylgrupper, N-aryl-, N,N-diaryl- eller N-aryl-N-alky1-karbamoylgrupper, såsom N-fenyl-, N,N-difenyl- eller N-fenyl-N-metyl- eller -etylkarbamoylgrupper, eventuelt substituert eller usubstituert i fenylkjernen. can e.g. be N-lower alkyl or N,N-di-lower alkyl carbamoyl groups, such as N-methyl, N-ethyl,' N,N-dimethyl or N,N-diethyl carbamoyl groups, N-aryl, N, N-diaryl or N-aryl-N-alkylcarbamoyl groups, such as N-phenyl-, N,N-diphenyl- or N-phenyl-N-methyl- or -ethylcarbamoyl groups, optionally substituted or unsubstituted in the phenyl nucleus.
En laverealkoksygruppe kan f.eks. være en metoksy, etoksy, n-propoksy, isopropoksy, n-butoksy, isobutoksy, sek.-butoksy, tert.-butoksy, n-pentyloksy eller tert.pentyloksy-gruppe. A lower alkoxy group can e.g. be a methoxy, ethoxy, n-propoxy, isopropoxy, n-butoxy, isobutoxy, sec-butoxy, tert-butoxy, n-pentyloxy or tert-pentyloxy group.
En laverealkenyloksygruppe kan f.eks. være vinyloksy eller allyloksygruppe. A lower alkenyloxy group can e.g. be vinyloxy or allyloxy group.
En laverealkylendioksygruppe kan f.eks. være metylendioksy eller etylendioksygruppe så'vel som en isopropy- A lower alkylenedioxy group can e.g. be methylenedioxy or ethylenedioxy group as well as an isopropyl
lidendioksygruppe.lidene dioxy group.
En cykloalkoksygruppe. kan f.eks. være cyklo-pentyloksy, cykloheksyloksy eller adamantyloksygruppe. A cycloalkoxy group. can e.g. be cyclopentyloxy, cyclohexyloxy or adamantyloxy group.
En fenyl-laverealkoksygruppe kan f.eks. være en benzyloksy eller 1- eller 2-fenyletoksygruppe. A phenyl-lower oxy group can e.g. be a benzyloxy or 1- or 2-phenylethoxy group.
En pyridyl-laverealkoksygruppe kan f.eks. være 2-, 3- eller 4-pyridylmetoksygruppe. A pyridyl-lower oxy group can e.g. be 2-, 3- or 4-pyridylmethoxy group.
En fury1-laverealkoksygruppe kan f.eks. være furfuryloksygruppen. .En tieny1-laverealkoksygruppe kan f.eks. være 2-tienyloksygruppen. A fury1 lower-area oxy group can e.g. be the furfuryloxy group. .A tieny1-lower oxy group can e.g. be the 2-thienyloxy group.
En laverealkylmerkaptogruppe kan f.eks. være metylmerkapto eller etylmerkaptogruppen. A lower alkyl mercapto group can e.g. be the methyl mercapto or the ethyl mercapto group.
En fenyl-laverealkylmerkaptogruppe kan f.eks. være benzylmerkapto eller 1- eller 2-fenyletylmerkaptogruppe. A phenyl lower alkyl mercapto group can e.g. be benzyl mercapto or 1- or 2-phenylethyl mercapto group.
Et halogenatom kan f.eks. være et brom- eller jod-og mer spesielt klor- eller fluoratom. A halogen atom can e.g. be a bromine or iodine and more particularly a chlorine or fluorine atom.
En mono- eller di-laverealkylaminogruppe kan f.eks. være metylamino, dimetylamino, etylamino eller dietylamino-gruppe. A mono- or di-lower alkylamino group can e.g. be methylamino, dimethylamino, ethylamino or diethylamino group.
En laverealkylenaminogruppe eventuelt avbruttA lower alkylene amino group optionally interrupted
av et heteroatom, kan f.eks. være en pyrrolidino, piperidino, morfolino, tiamorfoliho eller 4-mety1-piperazinogruppe. of a heteroatom, can e.g. be a pyrrolidino, piperidino, morpholino, thiamorfoliho or 4-methyl-piperazino group.
En laverealkanoylaminogruppe kan f.eks. være acetylamino eller propionylaminogruppen. A lower alkanoylamino group can e.g. be the acetylamino or propionylamino group.
Akylradikalene av mineralsyre kan f.eks. væreThe acyl radicals of mineral acid can e.g. be
de av sulfonsyre, sulfinsyre, sulfensyre, fosforsyre, borsyre eller salpetersyre. those of sulfonic, sulfinic, sulfenic, phosphoric, boric or nitric acid.
Forbindelser ifølge foreliggende oppfinnelse som innbefatter et radikal inneholdende en saltdannende gruppe, kan også være i form av salter. Compounds according to the present invention which include a radical containing a salt-forming group can also be in the form of salts.
Salter av forbindelser inneholdende en fri karboksygruppe kan f.eks. være metallsalter, da spesielt alkalimetallsalter,. f.eks. natrium- eller kaliumsalter, så vel som jordalkalimetallsalter, f.eks. magnesium- eller kalsiumsalter, så vel som salter av overgangsmetaller såsom sink, kopper, jern, sølv eller kvikksølvsalter eller ammoniumsalter, f.eks. de av ammoniakk og organiske baser såsom tri-laverealkylaminer, f.eks. trimetylamin eller trietylamin, da spesielt . farmasøytisk akseptable ikke-toksiske salter av den ovennevnte type. Salts of compounds containing a free carboxy group can e.g. be metal salts, especially alkali metal salts. e.g. sodium or potassium salts, as well as alkaline earth metal salts, e.g. magnesium or calcium salts, as well as salts of transition metals such as zinc, copper, iron, silver or mercury salts or ammonium salts, e.g. those of ammonia and organic bases such as tri-lower alkylamines, e.g. trimethylamine or triethylamine, then especially . pharmaceutically acceptable non-toxic salts of the above type.
Forbindelser ifølge foreliggende oppfinnelse som innbefatter basiske grupper kan også være i form av addisjons-salter med syrer, da spesielt i form av farmasøytisk akseptable ikke-toksiske salter, f.eks. med mineralsyre såsom saltsyre, hydrobromsyre, svovelsyre eller fosforsyre, eller' med organiske sulfoniske eller karboksyliske syrer såsom alifatiske, cykloalifatiske, cykloalifatiske-alifatiske, aromatiske, aralifatiske, heterocykliske eller heterocykliske-alifatiske syrer, f.eks. eddiksyre, propionsyre, ravsyre, glykolinsyre,, melkesyre, malinsyre, tartarsyre, sitronsyre, askorbinsyre, maleinsyre, fenyleddiksyre, benzosyre, 4-amino-benzosyre, antranilinsyre, 4-hydroksybenzosyre, sålicylsyre, aminosalicylsyre, emboninsyre eller nikotinsyre, så vel som metansulfonsyre, etansulfonsyre, 2-hydroksyetan-sulfonsyre, fenylsulfon-, 4-metylfenylsulfon-, naftalensulfon-, sulfanilin- eller cykloheksylsulfaminsyrer. Compounds according to the present invention which include basic groups can also be in the form of addition salts with acids, as especially in the form of pharmaceutically acceptable non-toxic salts, e.g. with mineral acid such as hydrochloric acid, hydrobromic acid, sulfuric acid or phosphoric acid, or with organic sulphonic or carboxylic acids such as aliphatic, cycloaliphatic, cycloaliphatic-aliphatic, aromatic, araliphatic, heterocyclic or heterocyclic-aliphatic acids, e.g. acetic acid, propionic acid, succinic acid, glycolic acid,, lactic acid, malic acid, tartaric acid, citric acid, ascorbic acid, maleic acid, phenylacetic acid, benzoic acid, 4-amino-benzoic acid, anthranilic acid, 4-hydroxybenzoic acid, salicylic acid, aminosalicylic acid, embonic acid or nicotinic acid, as well as methanesulfonic acid, ethanesulfonic acid, 2-hydroxyethanesulfonic acid, phenylsulfonic, 4-methylphenylsulfonic, naphthalenesulfonic, sulfaniline or cyclohexylsulfamic acids.
Forbindelser som inneholder basiske grupper kan også være i form av sine kvaternære ammoniumforbindelser. Compounds containing basic groups may also be in the form of their quaternary ammonium compounds.
De nye forbindelser har verdifulle farmakologiske egenskaper. Mer spesielt har de verdifull aktivitet ved at de hindrer hepatisk nekrose og hemmer lipoperoksydasjon. De foreliggende forbindelser er også i stand til å hemme både nedbrytningen av kollagen og aktiviteten av lysosomale enzymer ved at man øker stabiliteten på membranen i lysosomene. De • foreliggende derivater er også i stand til å påvirke kar-permeabiliteten samt tonus. The new compounds have valuable pharmacological properties. More particularly, they have valuable activity in that they prevent hepatic necrosis and inhibit lipoperoxidation. The present compounds are also capable of inhibiting both the breakdown of collagen and the activity of lysosomal enzymes by increasing the stability of the membrane in the lysosomes. The • present derivatives are also capable of influencing vascular permeability and tone.
Verdien av de nye forbindelser fremgår ved behandling av forskjellige leverlidelser såsom akutt hepatitt (virustypen, alkoholisk eller toksisk) steatose og kronisk hepatitt, da spesielt av alkoholisk opprinnelse. Verdien av de foreliggende forbindelser er også tydelige ved behandling av lidelser som innbefatter en nedbrytning eller svékking av det sammenbindende vev, da spesielt genetiske lidelser a<y>kollagen såsom Ehlers-Danlos-sykdom, Marfan's syndrom, cutis laxa, osteogenetisk imperfecta, men også scoliose, osteoporose, scleroderma, parodontose, samt leging av sår, da spesielt liggesår, foruten forskjellige former av reumatisme, da spesielt artrose. Verdien av de nye forbindelser er også vist seg ved lidelser som angår sirkulasjonssystemet, og dette gjelder både vener og arterier. The value of the new compounds is evident in the treatment of various liver disorders such as acute hepatitis (of the viral type, alcoholic or toxic) steatosis and chronic hepatitis, especially of alcoholic origin. The value of the present compounds is also evident in the treatment of disorders involving a breakdown or weakening of the connective tissue, especially genetic disorders a<y>collagen such as Ehlers-Danlos disease, Marfan's syndrome, cutis laxa, osteogenetic imperfecta, but also scoliosis, osteoporosis, scleroderma, periodontosis, as well as wound healing, especially bedsores, in addition to various forms of rheumatism, especially osteoarthritis. The value of the new compounds has also been shown in disorders that concern the circulatory system, and this applies to both veins and arteries.
Således kan f.eks. effekten på den normale eller patologiske metabolisme som man finner i hepatocyttene i levende rotter vises i rottehepatocytter isolert slik det er beskrevet av Berry og Friend'(J. Cell. Biol. 4_3, 506-520 Thus, e.g. the effect on the normal or pathological metabolism found in the hepatocytes of living rats is shown in isolated rat hepatocytes as described by Berry and Friend' (J. Cell. Biol. 4_3, 506-520
(1969)), som ble inkubert i 2 ml fysiologisk Krebs-Ringer-oppløsning i nærvær av de nye produkter i mengder som varierte fra 0,5 til. 5 mg, og til hvilken oppløsning man tilsatte forskjellige hepatotoksiske forbindelser, eller hemmingen av lipoperoksydasjon ved karbontetraklorid slik dette kan vises ved fremgangsmåten som er beskrevet av Comporti, Sacconi og Danzani (Enzymologia 28, 185-203 (1965)), og hvor intensiteten på lipoperoksydasjonen i nærvær av de nye produkter i mengder på fra 5 til 50 u<g.>pr, 4 ml ble bedømt ved den mengde malonsyre-dialdehyd som ble dannet. Modifikasjonen a.v en eksperimentell hepatitis sem var indusert ved galaktosamin, karbontetraklorid eller etanol kan vises' i rotter som på forhånd var behandlet oralt eller intra-peritonealt med.de nye produkter i doser som varierte fra 100 til 500 mg/kg.og dette gjelder både akutt eller kroniske lidelser og ved profylaktisk eller hel-bredende behandling. Ved undersøkelsen omkring akutte lidelser ble dyrene drept 24 eller 48 timer etter tilførselen av de toksiske stoffer, og leverens funksjonering ble bedømt ved følgende prøver: BSP-fjerning, bilirubin-nivået i plasmaet, transaminase-nivået i plasmaet, totalt nivå av triglycerider og lipider i leveren samt i serum og nivået av lipoproteiner i serum. De foreliggende forbindelser er også i stand til å fremme en leverregenerering og utøver dessuten en immunostimu-lerende effekt. (1969)), which were incubated in 2 ml of physiological Krebs-Ringer solution in the presence of the new products in amounts varying from 0.5 to. 5 mg, and to which solution different hepatotoxic compounds were added, or the inhibition of lipoperoxidation by carbon tetrachloride as can be demonstrated by the method described by Comporti, Sacconi and Danzani (Enzymologia 28, 185-203 (1965)), and where the intensity of the lipoperoxidation in the presence of the new products in amounts of from 5 to 50 u<g.>per, 4 ml was judged by the amount of malonic acid dialdehyde formed. The modification of an experimental hepatitis that was induced by galactosamine, carbon tetrachloride or ethanol can be shown in rats that were previously treated orally or intra-peritoneally with the new products in doses that varied from 100 to 500 mg/kg, and this applies to both acute or chronic disorders and for prophylactic or curative treatment. In the investigation of acute disorders, the animals were killed 24 or 48 hours after the administration of the toxic substances, and the functioning of the liver was assessed by the following tests: BSP removal, the bilirubin level in the plasma, the transaminase level in the plasma, total level of triglycerides and lipids in the liver as well as in serum and the level of lipoproteins in serum. The present compounds are also capable of promoting liver regeneration and also exert an immunostimulating effect.
De nye forbindelsers evne til å beskytte det sammenbindende vev kan vises ved at de hemmer nedbrytningen av kollagen ved kollagenase i mengder av foreliggende forbindelse som varierer fra 0,1 til 5 mg pr. 2 ml, eller ved at de hemmer aktiviteten'for lysosomalenzymer og øker stabilitetén■på membranen i lysosomene i mengder på fra 0,05 til 0,2 mg av de nye forbindelser pr. 1 ml slik det er beskrevet av P. Niebes og Ponard (Biochem. Pharmacol. 24, 905 (1975)) eller ved The ability of the new compounds to protect the connective tissue can be demonstrated by the fact that they inhibit the breakdown of collagen by collagenase in amounts of the present compound varying from 0.1 to 5 mg per 2 ml, or by the fact that they inhibit the activity of lysosomal enzymes and increase the stability of the membrane in the lysosomes in amounts of from 0.05 to 0.2 mg of the new compounds per 1 ml as described by P. Niebes and Ponard (Biochem. Pharmacol. 24, 905 (1975)) or by
■eksperimentell latyrisme hos rotter som var gitt toksisk amino-acetonitril per os i en dose på 100 mg/kg kroppsvekt/døgn eller iminopropionitril subkutinøst i en dose på 250 mg/kg kroppsvekt/døgn i 7 døgn eller p-aminopropionitril.oralt i en dose på 600 mg/kg kroppsvekt/døgn i 3 uker og som var gitt orale doser på fra 100 til 500 mg/kg kroppsvekt/døgn av de nye produkter i 3 uker'før, under og etter forgiftningen. I doser som ble tilført parenteralt eller oralt og som varierte fra 100. til 500 mg/kg kroppsvekt, viser disse stoffene seg til å være i stand i disse dyreforsøkene til a.a) redusere det eksperimentelle ødem •som var indusert av galaktosaminet og dekstran, b) redusere den kapillære permeabiliteten hos rotter, målt ved diffusjonen av trypan blått (teknikk fra V.L. Beach og B.G. Steinetz, J. Pharmacol. Exp. Ther. 131, 400 (1961)) eller ved hudsår hos en hamster som var underkastet en lesjon indusert ved bradykinin, histamin eller serontonin, c) å redusere den retroaurikulære venøse strømmen i øret hos en kanin, d) fremme vevsmelkerensningen i den iskjemiske poten hos en hund. ■experimental lathyrism in rats that had been given toxic amino-acetonitrile orally in a dose of 100 mg/kg body weight/day or iminopropionitrile subcutaneously in a dose of 250 mg/kg body weight/day for 7 days or p-aminopropionitrile orally for one dose of 600 mg/kg body weight/day for 3 weeks and who had been given oral doses of from 100 to 500 mg/kg body weight/day of the new products for 3 weeks' before, during and after the poisoning. In doses that were administered parenterally or orally and that varied from 100 to 500 mg/kg body weight, these substances proved to be able in these animal experiments to a.a) reduce the experimental edema •which was induced by the galactosamine and dextran, b ) reduce the capillary permeability in rats, as measured by the diffusion of trypan blue (technique of V.L. Beach and B.G. Steinetz, J. Pharmacol. Exp. Ther. 131, 400 (1961)) or by skin wounds in a hamster subjected to a lesion induced by bradykinin, histamine or serontonin, c) to reduce the retroauricular venous flow in the ear of a rabbit, d) to promote tissue clearance in the ischemic paw of a dog.
Aktiviteten i de foreliggende nye forbindelser var hittil ikke kjent med hensyn til disse indikasjoner. Det er kjent for tiden at (+)-cyanidan-3_ol har én leverbeskyttende effekt, men det er overraskende at disse nye derivater har en umettet og langt bedre aktivitet enn nevnte forbindelse. The activity of the present new compounds was hitherto unknown with respect to these indications. It is currently known that (+)-cyanidan-3_ol has one liver-protective effect, but it is surprising that these new derivatives have an unsaturated and far better activity than said compound.
Foreliggende oppfinnelse angår spesielt forbindelser med formel I, hvor R er The present invention relates in particular to compounds of formula I, where R is
en alifatisk, cykloalifatisk, cykloalifatisk-alifatisk, aromatisk, aromatisk-alifatisk,'heterocyklisk eller heterocyklisk-alifatisk hydrokarbonradikal,- an aliphatic, cycloaliphatic, cycloaliphatic-aliphatic, aromatic, aromatic-aliphatic, heterocyclic or heterocyclic-aliphatic hydrocarbon radical,
et radikal av en alifatisk, cykloalifatisk, cykloalifatisk-alifatisk, aromatisk, aromatisk-alifatisk, heterocyklisk eller heterocyklisk-alifatisk karboksylsyre, a radical of an aliphatic, cycloaliphatic, cycloaliphatic-aliphatic, aromatic, aromatic-aliphatic, heterocyclic or heterocyclic-aliphatic carboxylic acid,
et radikal av en forestret eller amidert karbonsyre,a radical of an esterified or amidated carboxylic acid,
et radikal av en alifatisk, aromatisk eller aromatisk-alifatisk sulfonsyre eller a radical of an aliphatic, aromatic or aromatic-aliphatic sulphonic acid or
et radikal av en uorganisk syre som har som hovedatom ét a radical of an inorganic acid which has as its main atom one
svovel-, fosfor-, bor- eller nitrogenatom,sulphur, phosphorus, boron or nitrogen atom,
samt salter av disse forbindelser.as well as salts of these compounds.
Foreliggende oppfinnelse angår spesielt forbindelser med formel I, hvor R er The present invention relates in particular to compounds of formula I, where R is
et alkyl eller alkenylradikal som er usubstituert eller an alkyl or alkenyl radical which is unsubstituted or
■substituert med hydroksy, laverealkanoyloksy, laverealkoksy, laverealkanoyl, cyano, amino, mono- eller di-laverealkylamino, laverealkylenamino, oksa- eller aza-laverealkylenamino, amido eller mono- eller di-laverealkylamidogrupper eller med halogenatomer; et cykloalifatisk radikal med fra 3 til 6 ringkarbonatomer som kan være usubstituerte eller substituerte med en eller ■substituted with hydroxy, lower alkanoyloxy, lower alkoxy, lower alkanoyl, cyano, amino, mono- or di-lower alkylamino, lower alkyleneamino, oxa- or aza-lower alkyleneamino, amido or mono- or di-lower alkylamido groups or with halogen atoms; a cycloaliphatic radical with from 3 to 6 ring carbon atoms which may be unsubstituted or substituted with one or
flere hydroksy, laverealkoksy, laverealkyl, karboksy, okso, laverealkanoylamino,' mono- eller di-laverealkylamino eller more hydroxy, lower alkoxy, lower alkyl, carboxy, oxo, lower alkanoylamino,' mono- or di-lower alkylamino or
laverealkoksykarbonylgrupper; lower alkoxycarbonyl groups;
et laverecykloalifatisk-alkylradikal med. fra 3 til 6 ringkarbonatomer som kan være usubstituert eller substituert med-minst en laverealkylgruppe-; a lower cycloaliphatic-alkyl radical with. from 3 to 6 ring carbon atoms which may be unsubstituted or substituted with at least one lower alkyl group;
et fenyl eller naftylradikal som kan være usubstituert eller mono- eller di- eller tri-substituert med hydroksy, laverealkoksy, karboksy, laverealkoksykarbony1, nitro, arriino eller mono- eller di-laverealkylaminogrupper, eller, med halogenatomer; a phenyl or naphthyl radical which may be unsubstituted or mono- or di- or tri-substituted with hydroxy, lower alkoxy, carboxy, lower alkoxycarbonyl, nitro, arriino or mono- or di-lower alkylamino groups, or, with halogen atoms;
et fenyl-laverealkyl. eller naftyl-laverealkylradikal eller feny1-laverealkeny1 eller nafty1-laverealkenylradikal som kan være usubstituert eller mono-, di- eller tri-substituert i den aromatiske kjernen med hydroksy, laverealkoksy, karboksy, laverealkoksykarbonyl, laverealkanoyl, nitro, a phenyl lower alkyl. or naphthyl-lower alkyl radical or phenyl1-lower alkeny1 or naphthy1-lower alkenyl radical which may be unsubstituted or mono-, di- or tri-substituted in the aromatic nucleus with hydroxy, lower alkoxy, carboxy, lower alkoxycarbonyl, lower alkanoyl, nitro,
amino, mono- eller di-laverealkylamino, amido eller mono-eller di-laverealkylamidogrupper eller med halogenatomer; amino, mono- or di-lower alkylamino, amido or mono- or di-lower alkylamido groups or with halogen atoms;
en umettet -eller mettet aza-, tia-, oksa-, tiaza-, oksaza-eller diaza-cyklisk radikal som kan være kondensert til en fenylkjerne og som har fra. 2 til 7 karbonatomer i dén heterocykliske kjernen og som kan være mono- eller di- eller polysubstituert med laverealkyl, hydroksy, laverealkoksy, nitro, karboksy, laverealkoksykarbonyl eller laverealkanoyloksygrupper; an unsaturated or saturated aza-, thia-, oxa-, thiaza-, oxaza- or diaza-cyclic radical which may be condensed to a phenyl nucleus and which has from 2 to 7 carbon atoms in the heterocyclic nucleus and which may be mono- or di- or poly-substituted with lower alkyl, hydroxy, lower alkoxy, nitro, carboxy, lower alkoxycarbonyl or lower alkanoyloxy groups;
et heterocyklisk-laverealkylradikal hvor den heterocykliske delen kan være en av de som er beskrevet ovenfor, et radikal av en alkankarboksylsyre, en laverealkenkarboksylsyre, en laverealkandikarboksylsyre, en laverealkendikarboksyl- a heterocyclic-lower alkyl radical where the heterocyclic part can be one of those described above, a radical of an alkanecarboxylic acid, a lower alkenecarboxylic acid, a lower alkanedicarboxylic acid, a lower alkenedicarboxylic acid
syre, en laverecykloalkankarboksylsyre som kan være usubstituert eller substituert med en eller flere hydroksy, lavere alkoksy, karboksy, laverealkoksykarbonyl, lavere-alkyl, laverealkanoyl eller oksogrupper eller med halogenatomer, acid, a lower cycloalkane carboxylic acid which may be unsubstituted or substituted with one or more hydroxy, lower alkoxy, carboxy, lower alkoxycarbonyl, lower alkyl, lower alkanoyl or oxo groups or with halogen atoms,
et benzoyl eller naftoylradikal eventuelt substituert med hydroksy, laverealkoksy, laverealkanoyloksy, karboksy, laverealkoksykarbonyl, nitro eller aminogrupper eller med halogenatomer, a benzoyl or naphthoyl radical optionally substituted with hydroxy, lower alkoxy, lower alkanoyloxy, carboxy, lower alkoxycarbonyl, nitro or amino groups or with halogen atoms,
et radikal av en feny1-laverealkanoin eller naftyl-lavere-alkanoinsyre som kan være usubstituert eller substituert i den aromatiske kjernen med en eller flere hydroksy, laverealkoksy, karboksy, laverealkoksykarbonyl, laverealkanoyl, laverealkanoyloksy, nitro, amino eller mono- eller di-laverealkylaminogrupper eller med halogenatomer; a radical of a phenyl-lower alkanoic or naphthyl-lower alkanoic acid which may be unsubstituted or substituted in the aromatic nucleus with one or more hydroxy, lower alkoxy, carboxy, lower alkoxycarbonyl, lower alkanoyl, lower alkanoyloxy, nitro, amino or mono- or di-lower alkylamino groups or with halogen atoms;
et radikal av en umettet eller mettet aza-, tia-, oksa-, tiaza-, oksazar eller diaza-cyklisk syre som kan være kondensert til et fenylradikal; a radical of an unsaturated or saturated aza-, thia-, oxa-, thiaza-, oxazaro or diaza-cyclic acid which may be condensed to a phenyl radical;
et laverealkoksykarbonylradikal, et fenoksykarbonylradikal, et karbamoylradikal, eventuelt mono- eller di-substituert med laverealkylradikaler eller ved fenyl eller benzylradikaler eventuelt substituert i fenylkjerneh med en eller flere hydroksy eller laverealkoksygrupper eller med halogenatomer; a lower alkoxycarbonyl radical, a phenoxycarbonyl radical, a carbamoyl radical, optionally mono- or di-substituted with lower alkyl radicals or by phenyl or benzyl radicals optionally substituted in the phenyl nucleus with one or more hydroxy or lower alkoxy groups or with halogen atoms;
et radikal av en laverealkylsulfonsyre eller fenylsulfon-syre eventuelt substituert med en eller flere laverealkyl eller laverealkoksygrupper eller med halogenatomer, eller et radikal av en fosforsyre som kan være usubstituert eller forestret ved et eller to laverealkylradikaler eller ved et a radical of a lower alkylsulfonic acid or phenylsulfonic acid optionally substituted with one or more lower alkyl or lower alkoxy groups or with halogen atoms, or a radical of a phosphoric acid which may be unsubstituted or esterified by one or two lower alkyl radicals or by a
eller to eventuelt substituerte- fenylradikaler,or two optionally substituted phenyl radicals,
eller salter av slike forbindelser.or salts of such compounds.
Foreliggende oppfinnelse angår spesielt forbindelser med formel I, hvor R er The present invention relates in particular to compounds of formula I, where R is
et laverealkylradikal som kan være usubstituert eller substituert med en, to eller flere hydroksy, laverealkoksy, laverealkanoyloksy, karboksy, cyano, laverealkanoyl, amino, mono- e.ller di-laverealkylamino, laverealkylenamino eller oksa- eller aza-alkylenaminogrupper eller med klor eller fluoratomer; a lower alkyl radical which may be unsubstituted or substituted with one, two or more hydroxy, lower alkoxy, lower alkanoyloxy, carboxy, cyano, lower alkanoyl, amino, mono- or di-lower alkylamino, lower alkyleneamino or oxa- or aza-alkyleneamino groups or with chlorine or fluorine atoms ;
et cykloalifatisk radikal inneholdende 5 eller 6 ringkarbonatomer, og hvor radikalet kan være usubstituert eller substituert med hydroksy-laverealkyl, laverealkoksy, karboksy, laverealkoksykarbonyl, amino eller mono- eller di-laverealkylaminogrupper; a cycloaliphatic radical containing 5 or 6 ring carbon atoms, and where the radical may be unsubstituted or substituted with hydroxy-lower alkyl, lower alkoxy, carboxy, lower alkoxycarbonyl, amino or mono- or di-lower alkyl amino groups;
et cykloalifatisk-C-L_^alkylradikal, hvor ringen kan inneholde 5 eller 6 karbonatomer og kan være substituert med minst ett alkylradikal med fra 1 til 4 karbonatomer;. a cycloaliphatic-C-L_^ alkyl radical, where the ring may contain 5 or 6 carbon atoms and may be substituted by at least one alkyl radical with from 1 to 4 carbon atoms;.
et fenylradikal som kan være usubstituert eller mono-, di-eller tri-substituert ved hydroksy, C1_i(alkoksy, karboksy, nitro, amino eller mono- eller di-(C^^alkyl)aminogrupper eller ved klor eller fluoratomer; a phenyl radical which may be unsubstituted or mono-, di- or tri-substituted by hydroxy, C 1-1 (alkoxy, carboxy, nitro, amino or mono- or di-(C 1-4 alkyl)amino groups or by chlorine or fluorine atoms;
et benzyl, fenyletyl eller fenylpropylradikal som kan være usubstituert eller mono-, di- eller tri-substituert i fenylkjernen med hydroksy, C-L_^alkoksy, karboksy, (C alkoksy)karbonyl, nitro, amino, mono- eller di-(C^_^alkyl)-amino, eller C^^alkylgrupper eller ved klor eller fluoratomer; a benzyl, phenylethyl, or phenylpropyl radical which may be unsubstituted or mono-, di-, or tri-substituted in the phenyl ring with hydroxy, C-1-4 alkoxy, carboxy, (C 1-4 alkoxy)carbonyl, nitro, amino, mono- or di-(C ^_^alkyl)-amino, or C^^alkyl groups or by chlorine or fluorine atoms;
et tetrahydropyranyl, pyridyl, kinolinyl eller pyrimidyl-radikal eventuelt substituert med en eller flere nitro, amino eller hydroksygrupper;<*>a tetrahydropyranyl, pyridyl, quinolinyl or pyrimidyl radical optionally substituted with one or more nitro, amino or hydroxy groups;<*>
et alkankarboksylsyreradikal med fra 3 til 18 karbonatomer, og som kan være usubstituert eller substituert med en.eller flere hydroksy, karboksy, (C-L_^alkoksy) karbonyl, C1_^a<l>kyl, amino eller mono- eller di-(C-^^alkyl)aminogrupper eller ved klor eller fluoratomer; an alkane carboxylic acid radical with from 3 to 18 carbon atoms, and which may be unsubstituted or substituted with one or more hydroxy, carboxy, (C-L-Alkoxy) carbonyl, C1-^alkyl, amino or mono- or di-( (C 1 -3 alkyl)amino groups or by chlorine or fluorine atoms;
et cykloalkankarboksylsyreradikal med fra 3 til 6 ringkarbonatomer som kan være usubstituert eller substituert med en eller flere hydroksy, karboksy, laverealkoksykarbonyl, amino eller mono- eller di-.(C-^_^alkyl)aminogrupper eller ved klor eller fluoratomer; a cycloalkanecarboxylic acid radical with from 3 to 6 ring carbon atoms which may be unsubstituted or substituted by one or more hydroxy, carboxy, lower alkoxycarbonyl, amino or mono- or di-.(C-^_^alkyl) amino groups or by chlorine or fluorine atoms;
et cykloalkanalkanoinsyreradikal, hvor den alifatiske kjeden kan ha fra 1 til 4 karbonatomer og ringen kan ha fra 3 til 6.ringkarbonatomer; a cycloalkanealkanoic acid radical, where the aliphatic chain may have from 1 to 4 carbon atoms and the ring may have from 3 to 6 ring carbon atoms;
et benzoylradikal som kan være usubstituert eller mono-, di-eller tri-substituert med hydroksy, C^_i)-alkoksy, karboksy, (C-L_iJalkoksy )karbonyl, C1_i|-alkanoyl, C-^-alkanoyloksy, nitro, amino eller mono- eller di-(C1_^alkyl)aminogrupper eller med fluor eller kloratomer; a benzoyl radical which may be unsubstituted or mono-, di- or tri-substituted by hydroxy, C 1 -C 1 )-alkoxy, carboxy, (C 1 -C 1 -C 1 -C 1 ) carbonyl, C 1 -C 1 -alkanoyl, C 1 -C 2 -alkanoyloxy, nitro, amino or mono- or di-(C 1-6 alkyl) amino groups or with fluorine or chlorine atoms;
et fenylalkanoinsyreradikal hvor den alifatiske kjeden kan inneholde fra 1 til 4 karbonatomer og hvor fenylradikalet kan være substituert som angitt ovenfor for benzoylgruppen; a phenylalkanoic acid radical where the aliphatic chain may contain from 1 to 4 carbon atoms and where the phenyl radical may be substituted as indicated above for the benzoyl group;
et radikal av en nikotin- eller isonikotinsyre; a radical of a nicotinic or isonicotinic acid;
et (C-^^alkoksy) karbonylradikal; a (C 1 -C 6 ) carbonyl radical;
et karbamoylradikal eventuelt mono- eller di-substituert ved C-j^alkylgrupper eller ved fenylgrupper usubstituert eller substituert med hydroksy, metoksy eller etoksygrupper eller ved hjelp av klor eller fluoratomer; eller et fosforsyreradikal som er usubstituert eller mono- eller a carbamoyl radical optionally mono- or di-substituted by C-1-4 alkyl groups or by phenyl groups unsubstituted or substituted by hydroxy, methoxy or ethoxy groups or by means of chlorine or fluorine atoms; or a phosphoric acid radical which is unsubstituted or mono- or
di-metyl, etyl eller fenylsubstituert,dimethyl, ethyl or phenyl substituted,
samt salter av slike forbindelser.as well as salts of such compounds.
Foreliggende oppfinnelse angår spesielt forbindelser med formel I, hvor R er The present invention relates in particular to compounds of formula I, where R is
et laverealkylradikal som er usubstituert eller substituert med-en eller to hydroksy, C ^a-lkoksy, karboksy, C-^^alkanoyloksy, amino, mono- eller di-(C-^^alkyl)amino eller cyanogrupper; a lower alkyl radical which is unsubstituted or substituted with one or two hydroxy, C 1-6 hydroxy, carboxy, C 1-6 alkanoyloxy, amino, mono- or di-(C 1-6 alkyl)amino or cyano groups;
et cykloalifatisk radikal med 5 eller 6 ringkarbonatomer som er usubstituert eller substituert med en eller to hydroksy, C1_^alkoksy, karboksy, C1_i)alkanoyloksy, amino eller di-laverealkylaminogrupper; a cycloaliphatic radical of 5 or 6 ring carbon atoms which is unsubstituted or substituted with one or two hydroxy, C 1-4 alkoxy, carboxy, C 1-1 )alkanoyloxy, amino or di-lower alkylamino groups;
et cykloalkanalkylradikal hvor alkyIdelen har fra 1 til 4 karbonatomer og hvor ringen inneholder 5 eller 6 karbonatomer; a cycloalkanealkyl radical where the alkyl part has from 1 to 4 carbon atoms and where the ring contains 5 or 6 carbon atoms;
et fenylradikal som er usubstituert eller mono-, di- eller tri-substituert ved hydroksy, metoksy, etoksy, propoksy, amino eller nitrogrupper; a phenyl radical which is unsubstituted or mono-, di- or tri-substituted by hydroxy, methoxy, ethoxy, propoxy, amino or nitro groups;
et benzyl, fenyletyl eller fenylpropylradikal som er usubstituert eller mono- eller di-substituert i fenylkjernen med en eller to hydroksy, metoksy, etoksy, propoksy, karboksy, (C-^_ ^alkoksy) karbonyl, nitro, amino eller mono- eller di-(C-^_^alk<y>l)aminogrupper eller ved klor eller fluoratomer; a benzyl, phenylethyl or phenylpropyl radical which is unsubstituted or mono- or di-substituted in the phenyl ring with one or two hydroxy, methoxy, ethoxy, propoxy, carboxy, (C-^_ ^ alkoxy) carbonyl, nitro, amino or mono- or di -(C-^_^alk<y>l)amino groups or by chlorine or fluorine atoms;
et tetrahydropyranylradikal; a tetrahydropyranyl radical;
et pyridylradikal som er usubstituert eller substituert med .med en nitro, amino eller hydroksygruppe; a pyridyl radical which is unsubstituted or substituted with a nitro, amino or hydroxy group;
et alkankarboksylsyreradikal med fra 3 til 18 karbonatomer og som kan være usubstituert eller substituert med en eller flere hydroksy, karboksy, (C^_galkoksy)karbonyl, C^_^alka- an alkanecarboxylic acid radical with from 3 to 18 carbon atoms and which may be unsubstituted or substituted with one or more hydroxy, carboxy, (C^_galkoxy)carbonyl, C^_^alka-
noyljamino eller mono- eller di-(C^_^alkyl)aminogrupper eller med klor eller fluoratomer; noylamino or mono- or di-(C^_^alkyl)amino groups or with chlorine or fluorine atoms;
et cykloalkankarboksylsyreradikal med 5 eller 6 ringkarbonatomer, og hvor radikalet skal være usubstituert eller substituert med en, to eller tre hydroksy, karboksy, (C1_i(alkoksy)karbonyl, amino eller mono- eller di-(C^_^-. alkyl)aminogrupper eller med klor eller fluoratomer; a cycloalkanecarboxylic acid radical with 5 or 6 ring carbon atoms, and where the radical must be unsubstituted or substituted with one, two or three hydroxy, carboxy, (C1_i(alkoxy)carbonyl, amino or mono- or di-(C^_^-. alkyl)amino groups or with chlorine or fluorine atoms;
et cykloalkanalkanoinsyreradikal hvor alkylkjeden kan inneholde fra 2 til 4 karbonatomer og hvor cykloalkandelen kan inneholde 5 eller 6 ringkarbonatomer; a cycloalkane alkanoic acid radical where the alkyl chain may contain from 2 to 4 carbon atoms and where the cycloalkane moiety may contain 5 or 6 ring carbon atoms;
et benzoylradikal som er usubstituert eller mono-, di- eller tri-substituert med hydroksy, C-^_i)alkoksy, karboksy, (C^_^-alkoksy)karbonyl, C-^alkanoyl, C1_I|alkanoyloksy, nitro, amino eller mono- eller di-(^alkyl)aminogrupper eller ved klor eller fluoratomer; a benzoyl radical which is unsubstituted or mono-, di- or tri-substituted by hydroxy, C 1 -C 1 ) alkoxy, carboxy, (C 2 -C 2 ) alkoxy) carbonyl, C 3 -C 4 alkanoyl, C 1 -C 1 -alkanoyloxy, nitro, amino or mono- or di-(^alkyl)amino groups or by chlorine or fluorine atoms;
et fenylalkanoinsyreradikal hvor den alifatiske kjeden har fra 1 til 4 karbonatomer og hvor fenylkjernen er usubstituert eller substituert med en" eller to hydroksy, C^_^-alkoksy, amino, karboksy, (C-^_1)alkoksy)karbonyl, C^_^-alkanoyl, ^alkanoyloksygrupper eller med klor eller fluoratomer; a phenylalkanoic acid radical in which the aliphatic chain has from 1 to 4 carbon atoms and in which the phenyl nucleus is unsubstituted or substituted by one or two hydroxy, C^_^-alkoxy, amino, carboxy, (C-^_1)alkoxy)carbonyl, C^_ 3-alkanoyl, 3-alkanoyloxy groups or with chlorine or fluorine atoms;
et nikotin eller isonikotinsyreradikal; a nicotine or isonicotinic acid radical;
et (^alkoksy)karbonylradikal; a (N-Alkoxy)carbonyl radical;
et karbamoylradikal eventuelt mono-substituert med en C-j^alkyl eller fenylradikal; a carbamoyl radical optionally mono-substituted with a C 1-6 alkyl or phenyl radical;
eller et usubstituert fosforsyreradikal eller et dimetyl-, dietyl- eller monohydroksyfenylfosforsyreradikal. or an unsubstituted phosphoric acid radical or a dimethyl, diethyl or monohydroxyphenyl phosphoric acid radical.
Oppfinnelsen angår spesielt de nye forbindelser med formel I som er beskrevet i eksemplene. The invention relates in particular to the new compounds of formula I which are described in the examples.
De nye forbindelser kan fremstilles ved fremgangsmåter som i seg selv er kjente. De kan således fremstilles ved at man i forbindelser med formel II hvor R-^0 representerer en beskyttet hydroksygruppe som lett lar seg hydrolysere eller hydrogenere, spalter OR^-gruppene til hydroksygrupper, og hvis ønskelig, modifiserer et radikal R i en resulterende forbindelse ved reduksjon og/eller, hvis det er ønskelig, omdanne et resulterende salt til den frie forbindelsen eller til et annet salt og/eller, hvis det er ønskelig, omdanner en resulterende forbindelse hvis denne har en saltdannende gruppe til et salt. The new compounds can be prepared by methods which are known per se. They can thus be prepared by, in compounds of formula II where R-^0 represents a protected hydroxy group which can easily be hydrolyzed or hydrogenated, the OR^ groups are split into hydroxy groups, and if desired, a radical R in a resulting compound is modified by reduction and/or, if desired, converting a resulting salt into the free compound or into another salt and/or, if desired, converting a resulting compound if it has a salt-forming group into a salt.
I forbindelser med formel II kan således radikalet R^være et mono-, di^eller poly-substituert laverealkylradikal, et laverealkenylradikal, et aralifatisk radikal som kan være usubstituert eller mono-, di- eller tri-substituert i In compounds of formula II, the radical R can thus be a mono-, di- or poly-substituted lower alkyl radical, a lower alkenyl radical, an araliphatic radical which can be unsubstituted or mono-, di- or tri-substituted in
■den aromatiske kjernen, et radikal av en alifatisk, aromatisk eller aralifatisk karboksylsyre, et radikal av en karbonsyre forestrét med et iaverealkylradikal, eller et radikal hvor, med oksygenatomet' bundet til R^, som kan danne eller ikke danne et cyklisk acetal. ■ the aromatic nucleus, a radical of an aliphatic, aromatic or araliphatic carboxylic acid, a radical of a carboxylic acid esterified with an iaverealkyl radical, or a radical where, with the oxygen atom' bonded to R^, which may or may not form a cyclic acetal.
Når er et Iaverealkylradikal, kan dette inneholde fra 1 til 4 karbonatomer og er spesielt et metyl- eller etylradikal. Disse grupper kan være substituert med laverealkoksygrupper, fortrinnsvis en metoksy- eller etoksygruppe eller laverealkoksyetoksygrupper, spesielt en metoksyetoksy-gruppe. When is a lower alkyl radical, this can contain from 1 to 4 carbon atoms and is in particular a methyl or ethyl radical. These groups can be substituted with lower alkoxy groups, preferably a methoxy or ethoxy group or lower alkoxyethoxy groups, especially a methoxyethoxy group.
Når er et laverealkenylradikal, så bør dette inneholde fra 2 til 5 karbonatomer og spesielt kan nevnes allyl, metallyl, buten-2-yl eller penten-2-yl. When is a lower alkenyl radical, this should contain from 2 to 5 carbon atoms and in particular allyl, metallyl, buten-2-yl or penten-2-yl can be mentioned.
Når substituenten FL er et aralifatisk radikal, da spesielt et benzylradikal, så kan dette være substituert på. forskjellige måter, f.eks. med en eller flere C^_^alkylradikaler, fortrinnsvis metyl, etyl, isopropyl og tert.butyl-grupper, med ett eller flere halogenatomer, fortrinnsvis klor, brom eller fluor, med en eller flere alkoksygrupper såsom metoksy eller etoksy, eller med en cyanogruppe. Disse forskjellige substituenter kan samtidig eller ikke oppta orto-og para-stillingene, fortrinnsvis para-stillingen. Når substituenten i radikalet. R^ er av annen orden, f.eks. en nitro-gruppe, så er det foretrukket at denne bør sitte i meta-stillingen. When the substituent FL is an araliphatic radical, especially a benzyl radical, this can be substituted on. different ways, e.g. with one or more C^_^alkyl radicals, preferably methyl, ethyl, isopropyl and tert.butyl groups, with one or more halogen atoms, preferably chlorine, bromine or fluorine, with one or more alkoxy groups such as methoxy or ethoxy, or with a cyano group . These different substituents may or may not simultaneously occupy the ortho and para positions, preferably the para position. When the substituent in the radical. R^ is of a different order, e.g. a nitro group, then it is preferred that this should sit in the meta position.
Når R er et alifatisk akylradikal, så bør den alifatiske delen være en C ^alkylgruppe, fortrinnsvis en metyl- eller etylgruppe eventuelt substituert med en alkoksy-gruppe, såsom en metoksygruppe. Hvis R er et aromatisk eller aralifatisk akylradikal, så kan aryldelen være et fenylradikal substituert på forskjellige måter, og det alifatiske radikal kan være et C1_2alkylradikal. When R is an aliphatic alkyl radical, the aliphatic part should be a C 1-4 alkyl group, preferably a methyl or ethyl group optionally substituted with an alkoxy group, such as a methoxy group. If R is an aromatic or araliphatic alkyl radical, then the aryl moiety may be a phenyl radical substituted in various ways, and the aliphatic radical may be a C 1-2 alkyl radical.
Når R-^ er et alkoksykarbonylradikal, så kan alkyldelen i seg selv være substituert med et arylradikal, When R-^ is an alkoxycarbonyl radical, then the alkyl part itself can be substituted with an aryl radical,
som i seg selv kan være substituert på forskjellige måter eller med halogenatomer. which may themselves be substituted in various ways or with halogen atoms.
Når danner et acetal med oksygenatomet bundet til R-^j så kan dette være lineært eller cyklisk, f.eks. pyra-nylgruppen for R . When forming an acetal with the oxygen atom bound to R-^j, this can be linear or cyclic, e.g. the pyranyl group for R .
Av de radikaler med formel R^som kan nevnesOf the radicals with formula R^ which can be mentioned
er f.eks. allyl, metylallyl, etylallyl, buten-2-yl, penten-2-yl, metoksymetyl, etoksymetyl, metoksyetoksymety1, acetonyl, propionylmetyl, cinnamyl, fenacyl, benzyl, 2-metylbenzy1, 4-metylbenzyl, 4-tert.-butylbenzyl, 4-brombenzyl, 4-fluor-benzyl, 4-klorbenzyl, 4-metoksybenzyl, 4-etoksybenzyl, 3-nitrobenzyl, 3,5-dinitrobenzy1, 4-cyanobenzyl, 4-klor- eller brom- eller fenylfenacyl eller metoksykarbonyl, etoksykarbonyl, 2,2,2-trikloretoksykarbonyl eller fenoksykarbonyl. is e.g. allyl, methylallyl, ethylallyl, buten-2-yl, penten-2-yl, methoxymethyl, ethoxymethyl, methoxyethoxymethyl, acetonyl, propionylmethyl, cinnamyl, phenacyl, benzyl, 2-methylbenzy1, 4-methylbenzyl, 4-tert.-butylbenzyl, 4 -bromobenzyl, 4-fluorobenzyl, 4-chlorobenzyl, 4-methoxybenzyl, 4-ethoxybenzyl, 3-nitrobenzyl, 3,5-dinitrobenzyl, 4-cyanobenzyl, 4-chloro- or bromo- or phenylphenacyl or methoxycarbonyl, ethoxycarbonyl, 2 ,2,2-trichloroethoxycarbonyl or phenoxycarbonyl.
Gruppene OR^kan spaltes ved hydrolyse eller ved hydrogenering. The groups OR^ can be cleaved by hydrolysis or by hydrogenation.
Forbindelsene kan hydrolyseres under påvirkning av syrer, men det er alltid en viss risiko i dette tilfellet for at flavaninstrukturen kan bli forandret, og følgelig vil utbyttet bli betydelig redusert. Av egnede syrer er det foretrukket å bruke p-toluensulfonsyre, f.eks. ved å utføre reaksjonen i alkohol, da spesielt i metanol. Alt etter type av substituenter som skal hydrolyseres, kan reaksjonen skje i løpet av et par timer til flere dager, og kan skje ved romtemperatur eller kan akselereres ved oppvarming, eventuelt ved koking under tilbakeløp, dog under den risiko at man da får delvis dekomponering av de forønskede produkter. The compounds can be hydrolysed under the influence of acids, but there is always a certain risk in this case that the flavanin structure may be changed, and consequently the yield will be significantly reduced. Of suitable acids, it is preferred to use p-toluenesulfonic acid, e.g. by carrying out the reaction in alcohol, then especially in methanol. Depending on the type of substituents to be hydrolysed, the reaction can take place within a few hours to several days, and can take place at room temperature or can be accelerated by heating, possibly by boiling under reflux, however with the risk of partial decomposition of the desired products.
Det er også mulig å spalte OR^-gruppene ved katalytisk hydrogenering ved hjelp av molekylært hydrogen eller ved overføring av hydrogen in situ ved hjelp av en hydrogendonor såsom cykloheksen. Hvis forbindelsen som skal hydrogeneres, har en saltdannende gruppe i -substituenten■r 3-stillingen, så kan man bruke den frie formen eller et salt av denne gruppen. It is also possible to cleave the OR^ groups by catalytic hydrogenation using molecular hydrogen or by transferring hydrogen in situ using a hydrogen donor such as cyclohexene. If the compound to be hydrogenated has a salt-forming group in the 3-position of the -substituent, then the free form or a salt of this group can be used.
Reaksjonen bør skje i nærvær avet oppløsnings-middel såsom vann, metanol, etanol, isopropanol, tert.-butyl-alkohol, etylacetat, dioksan eller tetrahydrofuran. Hydrogenering kan utføres ved romtemperatur og under normalt trykk, men kan også skje ved forhøyede temperaturer og/eller under forhøyet trykk som reduserer varigheten av reaksjonen. Reak-sjonsbetingelsene og type av katalysator velges fortrinnsvis slik at man unngår en oppbrytning av den flavaniske heterocykliske kjernen og slik at man på den ene siden ikke angriper den aromatiske kjernen og på den annen side de forønskede substituenter R. Som egnet katalysator kan man bruke finfordelt palladium eller palladium på aktivert karbon, og reaksjonen utføres fortrinnsvis ved romtemperatur og under normalt trykk. The reaction should take place in the presence of a solvent such as water, methanol, ethanol, isopropanol, tert-butyl alcohol, ethyl acetate, dioxane or tetrahydrofuran. Hydrogenation can be carried out at room temperature and under normal pressure, but can also take place at elevated temperatures and/or under elevated pressure, which reduces the duration of the reaction. The reaction conditions and type of catalyst are preferably chosen so that a breakdown of the flavanic heterocyclic core is avoided and so that on the one hand the aromatic core and on the other hand the desired substituents R are not attacked. As a suitable catalyst you can use finely divided palladium or palladium on activated carbon, and the reaction is preferably carried out at room temperature and under normal pressure.
Hydrogenerbare grupper i radikalet R kan på samme tid hydrogeneres, da spesielt hvis man bruker ekstremt reaktive katalysatorer, såsom palladium på karbon. Det er imidlertid mulig å la gruppene R forbli intakte ved å redusere aktiviteten på disse katalysatorer. Hydrogenable groups in the radical R can be hydrogenated at the same time, especially if you use extremely reactive catalysts, such as palladium on carbon. However, it is possible to leave the groups R to remain intact by reducing the activity of these catalysts.
Forbindelser som har et radikal inneholdende en saltdannende gruppe, f.eks. i form av fri karboksygrupper, Compounds having a radical containing a salt-forming group, e.g. in the form of free carboxyl groups,
kan ifølge de reaksjonsbetingelser man velger, oppnås i den frie formen eller i form av salter, og slike former er gjen-sidig overførbare i hverandre. Salter av forbindelser inne--holdende en fri karboksygruppe kan f.eks. være metallsaltet, can, according to the reaction conditions chosen, be obtained in the free form or in the form of salts, and such forms are mutually transferable to one another. Salts of compounds containing a free carboxy group can e.g. be the metal salt,
da spesielt alkalimetallsalter, f.eks. natrium eller kaliumsalter, foruten alk.ali-j ordmetallsalter, f. eks. magnesium eller kalsiumsalter, eller salter av ammonium, f.eks. de med ammoniakk og organiske baser såsom tri-laverealkylaminer, then especially alkali metal salts, e.g. sodium or potassium salts, besides alk.ali-j ord metal salts, e.g. magnesium or calcium salts, or salts of ammonium, e.g. those with ammonia and organic bases such as tri-lower alkylamines,
f.eks. trimetylamin eller trietylamin, da spesielt ikke-toksiske, farmasøytisk akseptable salter.av den ovennevnte type. De kan f.eks. fremstilles ved å behandle de frie forbindelser med metallhydroksyder eller . karbonater eller med ammoniakk eller aminer, så vel som med- passende ioneutbyttere og organometal-liske forbindelser. e.g. trimethylamine or triethylamine, then especially non-toxic, pharmaceutically acceptable salts of the above-mentioned type. They can e.g. are produced by treating the free compounds with metal hydroxides or . carbonates or with ammonia or amines, as well as with suitable ion exchangers and organometallic compounds.
Forbindelser som innbefatter basiske grupper kan også oppnås i form av syreaddisjonssalter, da spesielt i form av ikke-toksiske farmasøytisk akseptable salter f.eks. med mineralsyrer såsom saltsyre, hydrobromsyre, svovelsyre eller fosforsyre, eller med organiske karboksyliske eller sulfoniske syrer såsom alifatiske, cykloalifatiske, cykloalifatiske-alifatiske, aromatiske, aralifatiske, heterocykliske, heterocykliske-alifatiske syrer, f.eks. eddiksyre, propionsyre, ravsyre, glycolinsyre, melkesyre, malinsyre, tartarsyre, sitronsyre, askorbinsyre, maleinsyre, fenyleddiksyre, benzosyre, 4-aminobenzosyre,.antranilinsyre, 4-hydroksybenzosyre, sali-, cylsyre, aminosalicylsyre, emboninsyre eller nikotinsyre, Compounds which include basic groups can also be obtained in the form of acid addition salts, as especially in the form of non-toxic pharmaceutically acceptable salts, e.g. with mineral acids such as hydrochloric acid, hydrobromic acid, sulfuric acid or phosphoric acid, or with organic carboxylic or sulphonic acids such as aliphatic, cycloaliphatic, cycloaliphatic-aliphatic, aromatic, araliphatic, heterocyclic, heterocyclic-aliphatic acids, e.g. acetic acid, propionic acid, succinic acid, glycolic acid, lactic acid, malic acid, tartaric acid, citric acid, ascorbic acid, maleic acid, phenylacetic acid, benzoic acid, 4-aminobenzoic acid, anthranilic acid, 4-hydroxybenzoic acid, salicylic, cylic acid, aminosalicylic acid, embonic acid or nicotinic acid,
så vel som met;ansulfon-, etansulfon-, 2-hydroksyetansulfon-, etylensulfon-, fenylsulfon-, p-metylfenylsulfon-, naftalensulfon-, sulfanilin- eller cykloheksylsulfaminsyrer. ' Salter av disse syrer kan f. eks. fremstilles ved å behandle de fi?ie forbindelser inneholdende basiske grupper me.d syrer eller med egnede anionutbyttere. as well as methanesulfonic, ethanesulfonic, 2-hydroxyethanesulfonic, ethylenesulfonic, phenylsulfonic, p-methylphenylsulfonic, naphthalenesulfonic, sulfaniline or cyclohexylsulfamic acids. ' Salts of these acids can e.g. are produced by treating the five compounds containing basic groups with acids or with suitable anion exchangers.
De nye forbindelser inneholdende basiske grupper kan omdannes til sine kvaternære ammoniumforbindelser ved behandling med alkyleringsmidler såsom laverealkylhalogenider, f.eks. metyljodid eller laverealkylsulfater eller benzylsul-fater såsom .dimetylsulfater. The new compounds containing basic groups can be converted to their quaternary ammonium compounds by treatment with alkylating agents such as lower alkyl halides, e.g. methyl iodide or lower alkyl sulfates or benzyl sulfates such as dimethyl sulfates.
Noen av utgangsforbindelsene fqr den foreliggende fremgangsmåte er kjente, men de fleste er nye. De kan fremstilles ved en fremgangsmåte som i seg selv er kjent eller mer spesielt ved en ny og fordelaktig fremgangsmåte. Således kan (+)-cyanidan-3-ol eller et av dets salter omsettes med en reaktiv ester av en alkohol med formelen Some of the starting compounds for the present method are known, but most are new. They can be produced by a method which is known in itself or more particularly by a new and advantageous method. Thus (+)-cyanidan-3-ol or one of its salts can be reacted with a reactive ester of an alcohol of the formula
hvor R^har samme betydning som angitt ovenfor, og hvor radikalet R innføres i hydroksygruppen i .3-stillingen ved foretring eller forestring. where R^ has the same meaning as stated above, and where the radical R is introduced into the hydroxy group in the .3-position by etherification or esterification.
En reaktiv ester er spesielt en ester med enA reactive ester is particularly an ester with a
sterk uorganisk syre, da spesielt en hydrohalogensyre, såsom saltsyre eller hydrobromsyre eller en organisk sulfonsyre, fortrinnsvis en laverealkansulfonsyre, f.eks. metan- eller etansulfonsyre, eller en benzensulfonsyre, eventuelt substituert i benzenkjernen med metyl, klor eller brom, f.eks. p-toluensulfonsyre eller p-brombenzensulfonsyre. strong inorganic acid, then especially a hydrohalic acid, such as hydrochloric acid or hydrobromic acid or an organic sulphonic acid, preferably a lower alkanesulphonic acid, e.g. methane or ethanesulfonic acid, or a benzenesulfonic acid, optionally substituted in the benzene ring with methyl, chlorine or bromine, e.g. p-toluenesulfonic acid or p-bromobenzenesulfonic acid.
Ved denne fremgangsmåten kan man fremstille derivater av (+)-cyanidan-3-ol og de 4-fenoliske hydroksygruppene. vil da være substituerte. Av disse tetra-etre har allerede (+)-3',4',5,7-0-tetrabenzyl-cyanidan-3-ol vært fremstilt ifølge en fremgangsmåte som har vært strengt begrenset til laboratoriet (K. Weinges og D. Seiler, Liebigs Ann. Chem. With this method, derivatives of (+)-cyanidan-3-ol and the 4-phenolic hydroxy groups can be produced. will then be substituted. From these tetraethers, (+)-3',4',5,7-0-tetrabenzyl-cyanidan-3-ol has already been prepared according to a method that has been strictly limited to the laboratory (K. Weinges and D. Seiler , Liebig's Ann. Chem.
7 14 193-204 (1968)) som anbefaler at man behandler (+)-cyani-dan~3-ol i oppløsning med aceton med benzylklorid i nærvær av kaliumjodid og kaliumkarbonat, og hvor det hele utføres 7 14 193-204 (1968)) who recommends treating (+)-cyani-dan~3-ol in solution with acetone with benzyl chloride in the presence of potassium iodide and potassium carbonate, and where the whole is carried out
under nitrogen og koking under tilbakeløp i flere timer. Dette er den vanlige fremgangsmåte for å få utført en benzylering, under nitrogen and boiling under reflux for several hours. This is the usual procedure for carrying out a benzylation,
og etter separasjon og utkrystallisering fra etanol, resulterer det i en blanding av (+)-3',4',5,7-0-tetrabenzyl-8-benzyl-cyanidan-3-61 og (+)-3<1>,4',5,7-0-tetrabenzyl-cyanidan-3- ol. Den sistnevnte forbindelsen kan så isoleres ved kolonne-kromatografi i et utbytte på 1 til 2 % noe som er ekstremt lavt, og gjør at denne fremgangsmåten for å fremstille (+)-3', 4',5,7-0-tetrabenzyl-cyanidan-3_ol fullstendig uakseptabelt for kommersielle formål. and after separation and crystallization from ethanol, results in a mixture of (+)-3',4',5,7-0-tetrabenzyl-8-benzyl-cyanidan-3-61 and (+)-3<1> ,4',5,7-0-tetrabenzyl-cyanidan-3-ol. The latter compound can then be isolated by column chromatography in a yield of 1 to 2%, which is extremely low, and makes this method for preparing (+)-3', 4',5,7-0-tetrabenzyl- cyanidan-3_ol completely unacceptable for commercial purposes.
Hvis imidlertid benzylklorid erstattes med etIf, however, benzyl chloride is replaced by a
annet halogenid valgt fra den gruppen av radikaler R, som er nevnt ovenfor, så blir denne fremgangsmåten helt akseptabel, spesielt med substituerte'eller usubstituerte fenakylklorider eller bromider såsom fenakylklorid eller fenakylbromid eller 4- bromfenaky1 eller bromid eller 4-fenylfenakylklorid eller bromid. Etter f raf iltrering av'■ det uoppløselige kåliumkarbo-natet og. fordampning av aceton, så kan man bare oppløse residuet for utkrystallisering i et passende oppløsningsmiddel, f.eks. en blanding av aceton og metanol. Man får et godt utbytte av den tilsvarende O-tetra-eter. other halide selected from the group of radicals R mentioned above, then this method becomes completely acceptable, especially with substituted or unsubstituted phenacyl chlorides or bromides such as phenacyl chloride or phenacyl bromide or 4-bromophenacyl or bromide or 4-phenylphenacyl chloride or bromide. After filtering off the insoluble potassium carbonate and. evaporation of acetone, then one can only dissolve the residue for crystallization in a suitable solvent, e.g. a mixture of acetone and methanol. A good yield of the corresponding O-tetraether is obtained.
I tillegg til dette har man funnet en ny fremgangsmåte, som inngår i foreliggende oppfinnelse, og ved hjelp av hvilken mån kan' fremstille mellomproduktene i meget godt utbytte. Fremgangsmåten erkarakterisert vedat nevnte (+)-cyanid-3-ol omsettes i et aprotisk organisk oppløsningsmiddel med høy dielektrisk konstant, med et alkalisk hydrid eller et alkalisk karbonat, hvorved'det tetra-alkaliske saltet av (+.)-cyanidan-3-ol omsettes med en reaktiv ester av en alkohol med formelen idet man bruker et forhold mellom (+)-cyanidan-3-ol til nevnte, alkaliske hydrid til den reaktive ester på 1 : ca. 4,25 : ca. 4,5, eller et forhold mellom (+)-cyanidan-3-ol til 'alkalisk karbonat til reaktiv ester på 1 : ca. 8 : ca. 6. In addition to this, a new method has been found, which forms part of the present invention, and by means of which the intermediate products can be produced in very good yield. The method is characterized in that said (+)-cyanid-3-ol is reacted in an aprotic organic solvent with a high dielectric constant, with an alkaline hydride or an alkaline carbonate, whereby the tetra-alkaline salt of (+.)-cyanidan-3- ol is reacted with a reactive ester of an alcohol with the formula using a ratio of (+)-cyanidan-3-ol to said alkaline hydride to the reactive ester of 1: approx. 4.25 : approx. 4.5, or a ratio of (+)-cyanidan-3-ol to 'alkaline carbonate to reactive ester of 1 : approx. 8: approx. 6.
Det alkaliske hydrid er mer spesielt natriumhydrid som brukes i form av en dispersjon i olje. Det alkaliske karbonatet er fortrinnsvis kaliumkarbonat. The alkaline hydride is more specifically sodium hydride which is used in the form of a dispersion in oil. The alkaline carbonate is preferably potassium carbonate.
Aprotiske oppløsningsmidler med høy dielektrisk konstant er fortrinnsvis amider, såsom dimetylformamid, men kan også være sulfoksyder såsom f.eks. dimetylsulfoksyd. Imidlertid er dimetylformamid det foretrukne oppløsningsmiddel, for det første av økonomiske grunner, og dessuten for at det kan innvinnes ved enkel destillasjon under normalt trykk, foruten at det er enklere å .bruke enn dimetylsulf oksyd. I tillegg til dette er det viktig at reaksjonsmediet bør være så vannfritt som mulig. Hvis man derfor tørker dimetylformamidet på en molekylær sil, og så tørker oppløsningen av (+)-cyanidan-3-ol i dimetylformamid på samme måten, så hemmer man dannelsen av sekundære produkter i større grad uten at tørk-ingen svekker dannelsen av de forønskede produkter.' Aprotic solvents with a high dielectric constant are preferably amides, such as dimethylformamide, but can also be sulfoxides such as e.g. dimethyl sulfoxide. However, dimethylformamide is the preferred solvent, firstly for economic reasons, and also because it can be recovered by simple distillation under normal pressure, besides being easier to use than dimethylsulphoxide. In addition to this, it is important that the reaction medium should be as water-free as possible. If you therefore dry the dimethylformamide on a molecular sieve, and then dry the solution of (+)-cyanidan-3-ol in dimethylformamide in the same way, the formation of secondary products is inhibited to a greater extent without the drying weakening the formation of the desired products.'
Reaksjonen kan finne sted i nærvær av kvarter- . nære ammoniumsalter såsom tetra-n-butylammoniumbisulfat som brukes i et forhold på 0,1 til 0,5 mol pr. mol av nevnte (+)-cyanidan-3-ol, eller i en krdneeter, fortrinnsvis l8-krone-6, som' brukes i et forhold på 0,5 mol pr. mol av (+)-cyanidan-3-ol. The reaction can take place in the presence of quarter- . close ammonium salts such as tetra-n-butylammonium bisulphate which are used in a ratio of 0.1 to 0.5 mol per mol of said (+)-cyanidan-3-ol, or in a carbon ether, preferably l8-crown-6, which is used in a ratio of 0.5 mol per moles of (+)-cyanidan-3-ol.
Reaksjonen utføres ved temperaturer mellom -25°C og +50°C. Det er velkjent at dimetylformamid starter å dekom-ponere så lavt.som ved romtemperatur, men ikke når det er i kontakt med basiske stoffer, og denne dekomponering unngås så langt som mulig ved„å utføre reaksjonen i dette oppløsnings-midlet ved temperaturer mellom -25°C og +25°C, mer spesielt mellom -5°C og ca. 0°C. Det er ingen fare for dekomponering når man bruker dimetylsulfoksyd, og reaksjonen kan da utføres ved temperaturer lavere enn 50°C, fortrinnsvis mellom +15°C og +30°C, f.eks. ved romtemperatur. The reaction is carried out at temperatures between -25°C and +50°C. It is well known that dimethylformamide begins to decompose as low as room temperature, but not when it is in contact with basic substances, and this decomposition is avoided as far as possible by carrying out the reaction in this solvent at temperatures between - 25°C and +25°C, more particularly between -5°C and approx. 0°C. There is no danger of decomposition when using dimethylsulfoxide, and the reaction can then be carried out at temperatures lower than 50°C, preferably between +15°C and +30°C, e.g. at room temperature.
Ifølge foreliggende oppfinnelse må man etter dannelsen av alkalisaltet av (+)-cyanidan-3-ol fordi dette saltet ikke er stabilt i dimetylformamid/natriumhydridmediumet selv ved lav temperatur, umiddelbart tilføre foretrings- eller forestringsmidlet. Hvis dette ikke gjøres, vil utbyttet av reaksjonen bli redusert og man får komplikasjoner ved rensingen av de forønskede produkter. Etter at man har tilsatt foretrings- og forestringsmidlet er temperaturen lav og bør holdes i en viss periode hvoretter man lar den langsomt stige, f.eks. til romtemperatur. På dette trinn vil reaksjonen være avsluttet, og reaksjonsvæsken kan holdes i mer enn 15 timer i denne tilstand uten at dette■forandrer selve rensingen eller svekker kvaliteten på det forønskede produkt. Det er også viktig å sikre tilstrekkelig blanding av mediet under reaksjonen. According to the present invention, after the formation of the alkali salt of (+)-cyanidan-3-ol, because this salt is not stable in the dimethylformamide/sodium hydride medium even at low temperature, the etherifying or esterifying agent must be immediately added. If this is not done, the yield of the reaction will be reduced and there will be complications in the purification of the desired products. After the etherification and esterification agent has been added, the temperature is low and should be kept for a certain period, after which it is allowed to rise slowly, e.g. to room temperature. At this stage, the reaction will be finished, and the reaction liquid can be kept for more than 15 hours in this state without changing the purification itself or impairing the quality of the desired product. It is also important to ensure adequate mixing of the medium during the reaction.
Utviklingen- av reaksjonen kan undersøkes ved hjelp av tynnsjiktskromatografi på silisiumdioksydgel, idet man bruker kloroform eller diklormetan som den bevegelige fase. The development of the reaction can be examined by means of thin-layer chromatography on silicon dioxide gel, using chloroform or dichloromethane as the mobile phase.
Etter å ha eliminert oppløsningsmidlet ved destillasjon, kan residuet oppløses i et passende oppløsningsmiddel som kan brukes for utkrystallisering av mellomproduktet. Det foreslåtte oppløsningsmiddel for utkrystalliseringen av de forønskede produkter er trikloretylen som er meget godt egnet. Dog kan man bruke andre oppløsningsmidler, såsom karbontetraklorid, toluen og eventuelt etylacetat, etanbl, isopropanol eller blandinger av disse, f.eks. karbontetraklorid/n-heksan eller aceton/metanol. Imidlertid er etyleter og n-heksan mindre godt egnet, og det samme gjelder aceton, pyridin, kloroform, dimetylformamid, dimetylsulfoksyd, tetrahydrofuran og diklormetan idet de forønskede produkter alle er oppløse-lige i nevnte oppløsningsmidler ved romtemperatur. After eliminating the solvent by distillation, the residue can be dissolved in a suitable solvent which can be used for crystallization of the intermediate. The proposed solvent for the crystallization of the desired products is trichlorethylene, which is very suitable. However, other solvents can be used, such as carbon tetrachloride, toluene and possibly ethyl acetate, ethanol, isopropanol or mixtures of these, e.g. carbon tetrachloride/n-hexane or acetone/methanol. However, ethyl ether and n-hexane are less suitable, and the same applies to acetone, pyridine, chloroform, dimethylformamide, dimethylsulfoxide, tetrahydrofuran and dichloromethane, the desired products being all soluble in said solvents at room temperature.
Radikalet R innføres ved fremgangsmåten som i seg selv er kjente i de fremstilte mellomprodukter. Således kan f.eks. et halogenderivat med formelen The radical R is introduced by the method which is known in itself in the intermediate products produced. Thus, e.g. a halogen derivative with the formula
brukes ved reaksjonen. Denne utføres i nærvær av en base, f.eks. alkali, såsom natrium eller kaliumhydroksyd, sølvoksyd, natriumamid eller natrium eller kaliumhydrid. Foretringen kan utføres i nærvær av et ikke-reaktivt oppløsningsmiddel såsom dioksan, tetrahydrofuran eller toluen, eller eventuelt i blandinger av disse oppløsningsmidler med hverandre eller used in the reaction. This is performed in the presence of a base, e.g. alkali, such as sodium or potassium hydroxide, silver oxide, sodium amide or sodium or potassium hydride. The etherification can be carried out in the presence of a non-reactive solvent such as dioxane, tetrahydrofuran or toluene, or optionally in mixtures of these solvents with each other or
med vann. Reaksjonen finner sted ved romtemperatur og kan akselereres ved oppvarming, eventuelt til kokepunktet for det brukte oppløsningsmidlet. Varigheten av reaksjonen er mellom et par minutter og flere døgn, men et par timer vil vanligvis være tilstrekkelig. Når basen er soda eller pottaske i -vandig oppløsning og mellomproduktet er i et vann-ublandbart with water. The reaction takes place at room temperature and can be accelerated by heating, possibly to the boiling point of the solvent used. The duration of the reaction is between a few minutes and several days, but a few hours will usually be sufficient. When the base is soda ash or pot ash in -aqueous solution and the intermediate product is in a water-immiscible
oppløsningsmiddel, så kan man bruke en faseoverføringskata-lysator, såsom tetrabutylammoniumbisulfat. solvent, then a phase transfer catalyst, such as tetrabutylammonium bisulphate, can be used.
Hvis R er et hydroksyalkyl eller et aminoalkyl-radikal, så er det også mulig å fremstille derivater med formel II ved å kondensere et epoksyd eller et aziridin med mellomproduktene i en syre eller i et basisk medium. If R is a hydroxyalkyl or an aminoalkyl radical, then it is also possible to prepare derivatives of formula II by condensing an epoxide or an aziridine with the intermediate products in an acid or in a basic medium.
Hvis R er et aromatisk radikal kan derivatene -med formel II. fremstilles ved at man reagerer et aromatisk halogenid med mellomproduktene. Denne reaksjonen kan utføres i et inert oppløsningsmiddel, f.eks. tetrahydrofuran eventuelt ved romtemperatur, i nærvær av en base, såsom et tertiært amin, f.eks. trimetyl- eller trietyl-amin, eller i nærvær av et fluorid, såsom kaliumfluorid eller kvaternært ammoniumfluorid i nærvær eller fravær av en kroneeter, såsom l8-krone-6. Et. alkoholat av mellomproduktene reagerer f.eks. med et halogenid av en heterocyklisk forbindelse. Det er også mulig å bruke en aromatisk diester av fosforsyre i nærvær av katalytiske mengder av en sulfonsyre, f.eks. p-toluen-sulfonsyre. If R is an aromatic radical, the derivatives -with formula II. is produced by reacting an aromatic halide with the intermediate products. This reaction can be carried out in an inert solvent, e.g. tetrahydrofuran optionally at room temperature, in the presence of a base, such as a tertiary amine, e.g. trimethyl- or triethyl-amine, or in the presence of a fluoride, such as potassium fluoride or quaternary ammonium fluoride in the presence or absence of a crown ether, such as l8-crown-6. One. alcoholate of the intermediate products react e.g. with a halide of a heterocyclic compound. It is also possible to use an aromatic diester of phosphoric acid in the presence of catalytic amounts of a sulphonic acid, e.g. p-toluenesulfonic acid.
Mellomprodukter med formel II hvor R er hydrogen, kan tilsettes olefiner inneholdende som substituenter elektron-tiltrekkende grupper såsom cyano, nitro, keton eller ester-gruppe'r i nærvær av en base, og reagensene kan.f.eks. være oppløst i et inert vann-ublandbart oppløsningsmiddel, og Intermediates of formula II where R is hydrogen can be added to olefins containing as substituents electron-withdrawing groups such as cyano, nitro, ketone or ester groups in the presence of a base, and the reagents can, e.g. be dissolved in an inert water-immiscible solvent, and
■ basen kan' være 50% vandig natriumkarbonatoppløsning, og som f aseoverf øringskatalys.ator kan man f. eks. bruke benzyltri-metylammoniumhydroksyd. ■ the base can be a 50% aqueous sodium carbonate solution, and as a phase transfer catalyst one can e.g. use benzyltrimethylammonium hydroxide.
Et derivat av en syre-med formelenA derivative of an acid-with the formula
såsom et syrehalogenid, akylanhydrid eller akylcyanid som kan dannes in situ, blir fortrinnsvis brukt for innføringen av' radikalet R i mellomproduktene. Et basisk oppløsningsmiddel such as an acid halide, alkyl anhydride or alkyl cyanide which can be formed in situ, is preferably used for the introduction of the radical R into the intermediates. A basic solvent
såsom pyridin kan brukes i nærvær eller fravær av et tertiært alifatisk amin, såsom trietylamin og/eller pyridin, eller en blanding av oppløsningsmidler hvorav minst ett er basisk, eller et inert eller basisk oppløsningsmiddel, og fortrinnsvis en alkalisk katalysator. Denne reaksjonen gjelder også for N-substituerte isocyanater. such as pyridine can be used in the presence or absence of a tertiary aliphatic amine, such as triethylamine and/or pyridine, or a mixture of solvents of which at least one is basic, or an inert or basic solvent, and preferably an alkaline catalyst. This reaction also applies to N-substituted isocyanates.
Estrene av en mineralsyre eller en sulfonsyre med mellomproduktene kan fremstilles ved å reagere sistnevnte med et halogenid av nevnte syre, eller med .en mineral polysyre som er egnet for forestring og hvor en eller to hydroksygrupper henholdsvis er substituert eller blokkert, hvoretter de be-, skyttende grupper kan elimineres ved hydrolyse eller hydrogenering, separat eller sammen med radikalene R, som beskytter de aromatiske hydroksygruppene på nevnte (+)-cyanidan-3-ol. Disse estre av mineralsyrer kan også fremstilles mer direkte ved hjelp av anhydridene. The esters of a mineral acid or a sulphonic acid with the intermediate products can be prepared by reacting the latter with a halide of said acid, or with a mineral polyacid which is suitable for esterification and where one or two hydroxy groups are respectively substituted or blocked, after which they be-, protecting groups can be eliminated by hydrolysis or hydrogenation, separately or together with the radicals R, which protect the aromatic hydroxy groups on said (+)-cyanidan-3-ol. These esters of mineral acids can also be prepared more directly using the anhydrides.
Som et resultat av det nære forholdet mellom de nye forbindelser i fri form og i form av deres salter, så er det i det ovennevnte og i det etterfølgende underforstått at de frie forbindelser også innbefatter saltene, og referanser til saltene innbefatter også de frie forbindelser. As a result of the close relationship between the new compounds in free form and in the form of their salts, it is understood in the above and in what follows that the free compounds also include the salts, and references to the salts also include the free compounds.
Substituentene R kan være kiralé.r og de nye forbindelser kan således være i form av rene stereoisomerer eller i form av blandinger av stereoisomerer. De sistnevnte kan på basis av fysiske-kjemiske forskjeller mellom bestanddelene i blandingen oppløses på kjent måte i rene stereoisomerer, f.eks. ved hjelp av kromatografi, f.eks. ved tynnsjiktskromatografi eller ved en annen egnet prosess. De mest aktive av stereoisomerene blir fortrinnsvis isolert. The substituents R can be chiral and the new compounds can thus be in the form of pure stereoisomers or in the form of mixtures of stereoisomers. The latter can, on the basis of physical-chemical differences between the components in the mixture, be dissolved in a known manner into pure stereoisomers, e.g. by means of chromatography, e.g. by thin-layer chromatography or by another suitable process. The most active of the stereoisomers are preferably isolated.
De ovennevnte fremgangsmåter kan utføres ved hjelp av velkjenttmetodikk, og kan utføres i fravær av eller i nærvær av fortynningsmidler eller oppløsningsmidler, og hvis nødvendig under avkjøling eller oppvarming, under for-høyet trykk og/eller i inert gassformet atmosfære, såsom i nitrogenatmosfære. The above methods can be carried out using well-known methodology, and can be carried out in the absence of or in the presence of diluents or solvents, and if necessary under cooling or heating, under elevated pressure and/or in an inert gaseous atmosphere, such as in a nitrogen atmosphere.
Oppfinnelsen angår også fremgangsmåter for gjennomføring av prosessen hvor en forbindelse fremstilt som et mellomprodukt .på ethvert trinn av prosessen, blir brukt som utgangsmateriale og de gjenværende trinn av nevnte prosess ut- føres, eller .sistnevnte bli-r avbrutt på et av sine trinn, eller hvor utgangsforbindelsen blir dannet under reaksjons-betingelsene eller brukes i form av et. reaktivt derivat. I slike tilfeller bør man fortrinnsvis bruke utgangsforbindelser som resulterer i forbindelser som er spesielt verdifulle. The invention also relates to methods for carrying out the process where a compound produced as an intermediate product at any step of the process is used as starting material and the remaining steps of said process are carried out, or the latter is interrupted at one of its steps, or where the starting compound is formed under the reaction conditions or is used in the form of a. reactive derivative. In such cases, one should preferably use starting compounds that result in compounds that are particularly valuable.
De farmakologisk akseptable forbindelser ifølge foreliggende.oppfinnelse kan f.eks. brukes for fremstilling av farmasøytiske preparater som inneholder en effektiv mengde The pharmacologically acceptable compounds according to the present invention can e.g. used for the manufacture of pharmaceutical preparations containing an effective amount
av det aktive stoff i blanding med faste eller flytende, mineralske eller organiske bærestoffer eller fortynningsmidler av den type som brukes i farmasien og som er egnet for enteral eller parenteral tilførsel. Preparatene brukes fortrinnsvis i form av tabletter eller gelatinkapsler og inneholder det aktive stoff sammen med fortynningsmidler som laktose, dekstrose,' of the active substance in a mixture with solid or liquid, mineral or organic carriers or diluents of the type used in pharmacy and which are suitable for enteral or parenteral administration. The preparations are preferably used in the form of tablets or gelatin capsules and contain the active substance together with diluents such as lactose, dextrose,
sukrose, mannitol, sorbitol, cellulose og/eller glycin, og/eller smøremidler som silisiumdioksyd, talkum, stearinsyre eller salter av disse, såsom magnesiumstearat eller kalsium-stearat og/eller polyetylenglykol, og tablettene kan dessuten inneholde bindemidler såsom magnesiumsilikat, et aluminium-silikat, stivelse såsom mais stive Ise, hvetestivelse, risstivelse eller arrow-rot, gelatin, gummi tragakant,' metylcellulose, natriumkarboksymetylcellulose og/eller polyvinylpyrrolidon, og hvis det er ønskelig, tørkemidler såsom stivelse, galaktan, algininsyre eller et salt av disse såsom natriumalginat og/ eller brusende blandinger eller adsorpsjonsmidler, fargestof-fer, smakskorrigerende tilsetninger og/eller søtningsmidler. De injiserbare preparater er fortrinnsvis vandige isotone oppløsninger eller suspensjoner, og suppositoriene er mer spesielt emulsjoner eller suspensjoner i olje. De farmasøy-tiske preparatene kan steriliseres og/eller inneholde hjelpe-stoffer såsom konserveringsmidler, stabiliseringsmidler, fuktemidler og/eller emulgeringsmidler, oppløslighetsgjørende midler, salter for å regulere det osmotiske trykk og/eller buffere. De foreliggende farmasøytiske preparater kan hvis det er ønskelig, innholde også andre farmakologiske verdifulle stoffer som fremstilles på en i seg selv kjent måte, f.eks. ved at man utfører vanlig blanding, granulering eller fremstiller dragerte preparater, og disse kan inneholde fra 0,1 til 75 mer spesielt fra ca. 1 til ca. 50 % av det sucrose, mannitol, sorbitol, cellulose and/or glycine, and/or lubricants such as silicon dioxide, talc, stearic acid or salts thereof, such as magnesium stearate or calcium stearate and/or polyethylene glycol, and the tablets may also contain binders such as magnesium silicate, an aluminum silicate, starch such as corn starch, wheat starch, rice starch or arrowroot, gelatin, gum tragacanth, methylcellulose, sodium carboxymethylcellulose and/or polyvinylpyrrolidone, and if desired, drying agents such as starch, galactan, alginic acid or a salt thereof such as sodium alginate and/or effervescent mixtures or adsorbents, dyes, taste-correcting additives and/or sweeteners. The injectable preparations are preferably aqueous isotonic solutions or suspensions, and the suppositories are more particularly emulsions or suspensions in oil. The pharmaceutical preparations can be sterilized and/or contain auxiliary substances such as preservatives, stabilizers, wetting agents and/or emulsifiers, solubilizing agents, salts to regulate the osmotic pressure and/or buffers. The present pharmaceutical preparations can, if desired, also contain other pharmacologically valuable substances which are produced in a manner known per se, e.g. by carrying out ordinary mixing, granulation or preparing coated preparations, and these can contain from 0.1 to 75 more especially from approx. 1 to approx. 50% of it
aktive stoff.active substance.
Forbindelser ifølge foreliggende oppfinnelse kan tilføres i doser fra 1 til 1000 mg, fortrinnsvis fra 1 til 500 mg pr. enhetsdose. Compounds according to the present invention can be administered in doses from 1 to 1000 mg, preferably from 1 to 500 mg per unit dose.
Oppfinnelsen angår også de nye mellomprodukter med. formel II hvor OR^ og OR har samme betydning som angitt ovenfor, bortsett fra forbindelsen hvor alle radikalene R^ The invention also relates to the new intermediate products. formula II where OR^ and OR have the same meanings as stated above, except for the compound in which all the radicals R^
er benzyl og R er hydrogen eller metyl.is benzyl and R is hydrogen or methyl.
Oppfinnelsen angår videre nye utgangsforbindelser med formel II, hvor OR^ har samme betydning som angitt ovenfor og OR er en fri hydroksygruppe. The invention further relates to new starting compounds of formula II, where OR^ has the same meaning as stated above and OR is a free hydroxy group.
De følgende eksempler illustrerer oppfinnelsen. Alle temperaturer er angitt i °C. The following examples illustrate the invention. All temperatures are given in °C.
Eksempel 1Example 1
I en 3 liters rundkolbe- plasserte man en suspensjon av 12 g palladiumklorid (PdCl2) i l800 ml metanol og utførte deretter en hydrogenering^ i 2 timer ved romtemperatur, og man brukte 2400 ml hydrogen. Metanolen ble helt av, og palladiumkatalysatoren ble vasket fire ganger med 800 ml frisk metanol som eliminerer den saltsyre som var dannet, så vel som spor av oppløselig PdClg som ikke var omsatt.- Metanolen ble så erstattet med etylacetat og vasket tre ganger med 500 ml av dette oppløsningsmiddel.- Etter site vasking ble tyhnsjikt av etylacetat plassert over katalysatoren for å hindre spontan antenning av dette ved kontakt med luft. A suspension of 12 g of palladium chloride (PdCl2) in 1800 ml of methanol was placed in a 3 liter round-bottomed flask and a hydrogenation was then carried out for 2 hours at room temperature, and 2400 ml of hydrogen was used. The methanol was poured off, and the palladium catalyst was washed four times with 800 ml of fresh methanol, which eliminates the hydrochloric acid that had formed, as well as traces of soluble PdClg that had not reacted. The methanol was then replaced with ethyl acetate and washed three times with 500 ml of this solvent.- After site washing, a thin layer of ethyl acetate was placed over the catalyst to prevent spontaneous ignition of this on contact with air.
En oppløsning av 40 g-( + ) 3 ' , 4 ' , 5, 7-0-tetra-benzyl-3-0-metyl-cyanidan-3-ol i l600 ml etylacetat ble tilsatt denne nye fremstilte suspensjon av palladium-svart, A solution of 40 g-( + ) 3 ' , 4 ' , 5, 7-0-tetra-benzyl-3-0-methyl-cyanidan-3-ol in 1600 ml of ethyl acetate was added to this newly prepared suspension of palladium black ,
og blandingen ble hydrogenert i 3 timer og hydrogenforbruket var 6600 ml. Nevnte katalysator ble så fjernet ved filtrering, og filtratet fordampet til tørrhet.under et vakuum ved 40°C. Residuet ble oppløst i 2000 .ml vann, og vannet fordampet under et svakt vakuum ved 40°C inntil man fikk et volum på ca. 100 ml. Dette fjerner azeotropisk etylacetatet og det toluen som er dannet ved fjerning av benzylgruppene, blir gjentatt tre ganger inntil man fikk et sluttvolum på 100 ml som ble tørket ved lyofilisering. Utbyttet er kvantitativt og består av 18,5 g med (+) 3-0-metyl-cyanidan-3-ol. Smeltepunkt: 118-120°C. W29+2,76 i EtOH (c = 0,5). and the mixture was hydrogenated for 3 hours and the hydrogen consumption was 6600 ml. Said catalyst was then removed by filtration, and the filtrate evaporated to dryness under a vacuum at 40°C. The residue was dissolved in 2000 ml of water, and the water evaporated under a weak vacuum at 40°C until a volume of approx. 100 ml. This azeotropically removes the ethyl acetate and the toluene formed by the removal of the benzyl groups, is repeated three times until a final volume of 100 ml was obtained which was dried by lyophilization. The yield is quantitative and consists of 18.5 g of (+) 3-0-methyl-cyanidan-3-ol. Melting point: 118-120°C. W29+2.76 in EtOH (c = 0.5).
Eksempel 2Example 2
En suspensjon av 6,0 g palladiumklorid i 900 ml metanol ble hydrogenert i en 2000 ml kolbe i lg time ved romtemperatur, og 1100 ml hydrogen ble brukt. Etter avhelling av metanolen ble blandingen vasket tre ganger med 200 ml metanol og så tre ganger med 200 ml etylacetat. A suspension of 6.0 g of palladium chloride in 900 ml of methanol was hydrogenated in a 2000 ml flask for 1 hour at room temperature, and 1100 ml of hydrogen was used. After pouring off the methanol, the mixture was washed three times with 200 ml of methanol and then three times with 200 ml of ethyl acetate.
En oppløsning av 21,2 g (+) 3',4',5,7-0-tetra-benzyl-3-0-butyl-cyanidan-3-ol i 900 ml etylacetat ble så tilsatt, og blandingen ble hydrogenert i 5 timer ved romtemperatur, og hydrogenforbruket var 3250 ml. Palladiumet ble fjernet ved filtrering, og filtratet fordampet ved et middels vakuum ved 40°C. Residuet ble oppløst i 500 ml vann og så fordampet'til et, volum på 50 ml.' Dette ble gjentatt fire ganger for å fjerne azeotropisk etylacetatet og det toluen som ble dannet under hydrogeneringen. Etter siste fordamp-ningstrinn ble residuet tørket under 10 mm Hg ved 60°C til konstant vekt. Utbyttet av (+) 3_0-butyl-cyanidan-3-ol var kvantitativt og utgjorde 10,4 g. "Smeltepunkt: 103-104°C. A solution of 21.2 g of (+) 3',4',5,7-0-tetra-benzyl-3-0-butyl-cyanidan-3-ol in 900 ml of ethyl acetate was then added, and the mixture was hydrogenated in 5 hours at room temperature, and the hydrogen consumption was 3250 ml. The palladium was removed by filtration and the filtrate evaporated under a medium vacuum at 40°C. The residue was dissolved in 500 ml of water and then evaporated to a volume of 50 ml. This was repeated four times to azeotropically remove the ethyl acetate and the toluene formed during the hydrogenation. After the last evaporation step, the residue was dried under 10 mm Hg at 60°C to constant weight. The yield of (+) 3_0-butyl-cyanidan-3-ol was quantitative and amounted to 10.4 g. "Melting point: 103-104°C.
Eksempel 3'Example 3'
Man brukte fremgangsmåten som i eksempel 2, bortsett fra at man brukte 21,6 g (+) 3',4',5,7-0-tetra-benzyl-3-0-butyryl-cyanidan-3-ol. The method was used as in example 2, except that 21.6 g of (+) 3',4',5,7-0-tetra-benzyl-3-0-butyryl-cyanidan-3-ol were used.
Etter at residuet' var tørket til konstant vekt som i eksempel 2, ble det oppløst i en blanding av 5500 ml vann og 1100 ml etanol ved romtempratur og så filtrert, hvoretter filtratet ble konsentrert i et middels vakuum til 40°C til et volum på 2500 ml, og resultatet var en pastalignende olje. Oppløsningen ble helt av og hensatt ved 4°C i 3 døgn, og det hvite bunnfallet som var dannet ble frafiltrert, vasket med kaldt vann og tørket under 10 mm Hg over P2°5ved 50°C til konstant vekt. Utbyttet av (+) 3~0-butyryl-cyanidan-3-ol er 7,3 g, dvs. 67,6 Smeltepunkt: 112-113°C. After the residue' had been dried to constant weight as in example 2, it was dissolved in a mixture of 5500 ml of water and 1100 ml of ethanol at room temperature and then filtered, after which the filtrate was concentrated in a medium vacuum at 40°C to a volume of 2500 ml, and the result was a paste-like oil. The solution was poured off and left at 4°C for 3 days, and the white precipitate that had formed was filtered off, washed with cold water and dried under 10 mm Hg over P2°5 at 50°C to constant weight. The yield of (+) 3~0-butyryl-cyanidan-3-ol is 7.3 g, i.e. 67.6 Melting point: 112-113°C.
Eksempel 4Example 4
Fremgangsmåten var som i eksempel 2, bortsett fra at man brukte 22,5 g (+) 3'34',5,7-0-tetrabenzyl-3-0-(3,3_dimetylbutanoyl)-cyanidan-3-ol. Utbyttet var (+) 3-0-(3,3-dimetylbutanoy1)-cyanidan-3-ol er kvantitativt, og utgjorde 11,6 g. Smeltepunkt: Il8-120<Q>C. The procedure was as in example 2, except that 22.5 g of (+) 3'34',5,7-0-tetrabenzyl-3-0-(3,3_dimethylbutanoyl)-cyanidan-3-ol were used. The yield was (+) 3-0-(3,3-dimethylbutanoyl)-cyanidan-3-ol is quantitative, and amounted to 11.6 g. Melting point: Il8-120<Q>C.
Eksempel 5Example 5
Fremgangsmåten var som i eksempel 2, bortsettThe procedure was as in example 2, except
fra at man brukte 22 g (+) 3',4',5,7-0-tetrabenzyl-3-0-(3-karboksypropionyl)-cyanidan-3-ol.. from using 22 g of (+) 3',4',5,7-0-tetrabenzyl-3-0-(3-carboxypropionyl)-cyanidan-3-ol..
Etter at etylacetatet og toluenet var fjernet azeotropisk med vann, ble residuet oppløst i 1000 ml vann, fordampet til det ble svakt uklart (ca. 500 ml), filtrert, hvoretter filtratet ble lyofilisert til konstant vekt. Utbyttet av (+) 3-0-(3-karboksypropionyl)-cyanidan-3-ol er praktisk talt kvantitativt og utgjorde ca. 11,7 g. After the ethyl acetate and toluene were azeotropically removed with water, the residue was dissolved in 1000 mL of water, evaporated until slightly cloudy (ca. 500 mL), filtered, after which the filtrate was lyophilized to constant weight. The yield of (+) 3-0-(3-carboxypropionyl)-cyanidan-3-ol is practically quantitative and amounted to approx. 11.7 g.
Smeltepunkt': 102-106°C.Melting point': 102-106°C.
Eksempel 6Example 6
Fremgangsmåten er som i eksempel 1, bortsettThe procedure is as in example 1, except
fra at man brukte 50 g ( + ) 3 ' , 4 ' , 5, 7-0-tetrabenzy I-.3-0-dekanoy1-cyanidan-3-01. from the fact that 50 g of ( + ) 3 ' , 4 ' , 5, 7-0-tetrabenzy I-.3-0-decanoyl-cyanidan-3-01 were used.
Etter at etylacetaten var fordampet, ble residuet . tørket i vakuum ved 40°C og oppløst i 300 ml etanol, og opp-løsningen ble fordampet til 50 ml,. hvoretter' man tilsatte 250 ml etanol og 250 ml vann. Oppløsningen ble fordampet After the ethyl acetate was evaporated, the residue was . dried in vacuum at 40°C and dissolved in 300 ml of ethanol, and the solution was evaporated to 50 ml. after which 250 ml of ethanol and 250 ml of water were added. The solution was evaporated
til 50 ml, og man tilsatte 500 .ml vann, hvoretter oppløs-ningsmidlet ble drevet av under et svakt vakuum ved. 40°C. Residuet ble tørket til konstant vekt under høyvakuum over to 50 ml, and 500 ml of water was added, after which the solvent was driven off under a weak vacuum by 40°C. The residue was dried to constant weight under high vacuum above
P20,-. Utbyttet av ( + ) 3-0-dekanoyl-cyanidan-3-ol er 26 g,P20. The yield of ( + ) 3-0-decanoyl-cyanidan-3-ol is 26 g,
dvs. 94,3 Smeltepunkt: 71-74°C.i.e. 94.3 Melting point: 71-74°C.
Eksempel 7Example 7
26,6g'(+) 3',4',5,7-0-tetrabenzyl-3-0-palmi-toyl-cyanidan-3-ol ble oppløst i 900 ml etylacetat (oppløs- 26.6g'(+) 3',4',5,7-0-tetrabenzyl-3-0-palmi-toyl-cyanidan-3-ol was dissolved in 900 ml of ethyl acetate (solvent
ning ble akselerert ved oppvarming) i en 2000 ml rundkolbe.ning was accelerated by heating) in a 2000 ml round bottom flask.
l6,0 g 10 % palladium på aktivert karbon ble tilsatt, og blandingen ble hydrogenert. Palladiumet og det aktiverte karbon ble fjernet ved filtrering, og filtratet fordampet til tørrhet. Residuet ble tatt opp i en masse som ble oppløst i 400 ml varm metanol. 1500 ml vann ble tilsatt metanoloppløs-ningen under røring, og denne ble fortsatt, over natten ved romtemperatur og så i 48 timer på et isbad. Det dannede bunnfall ble frafiltrert og tørket under høyvakuum over ^ 2^ 5 16.0 g of 10% palladium on activated carbon was added and the mixture was hydrogenated. The palladium and activated carbon were removed by filtration and the filtrate evaporated to dryness. The residue was taken up in a mass which was dissolved in 400 ml of hot methanol. 1500 ml of water was added to the methanol solution with stirring, and this was continued overnight at room temperature and then for 48 hours in an ice bath. The precipitate formed was filtered off and dried under high vacuum over ^2^5
ved romtemperatur. Utbyttet av (+) 3_0-palmitoyl-cyanidan-3-ol er 12,4 g, dvs. 78,2 %. Smeltepunkt: 67-69°C. at room temperature. The yield of (+) 3_O-palmitoyl-cyanidan-3-ol is 12.4 g, i.e. 78.2%. Melting point: 67-69°C.
Eksempel 8Example 8
Fremgangsmåten var som i eksempel 2, og palladium-svart ble fremstilt ved hydrogenering av en suspensjon av 18 g palladiumklorid i 900 ml etylacetat, hvoretter 40 g av en oppløsning av (+) 3',4',5,7-0-tetrabenzyl-3-0-tetrahydro-ftalyl-cyanidan-3-ol i 1800 ml etylacetat ble hydrogenert som beskrevet i eksempel 1. Etter at det organiske oppløsnings-midlet (etylacetat og toluen) var fjernet azeotropisk med vann, ble residuet tørket til konstant vekt ved romtemperatur under et høyvakuum over P2°5'Utbyttet av (+) 3-0-(2-karboksy-cykloheksankarbonyl)-cyanidan-3-ol er 22,2 g, dvs. kvantitativt. Smeltepunkt: 138-l40°C. The procedure was as in Example 2, and palladium black was prepared by hydrogenating a suspension of 18 g of palladium chloride in 900 ml of ethyl acetate, after which 40 g of a solution of (+) 3',4',5,7-0-tetrabenzyl -3-O-tetrahydro-phthalyl-cyanidan-3-ol in 1800 ml of ethyl acetate was hydrogenated as described in Example 1. After the organic solvent (ethyl acetate and toluene) had been removed azeotropically with water, the residue was dried to constant weight at room temperature under a high vacuum above P2°5' The yield of (+) 3-0-(2-carboxy-cyclohexanecarbonyl)-cyanidan-3-ol is 22.2 g, i.e. quantitative. Melting point: 138-140°C.
Eksempel 9Example 9
En suspensjon av 30 g palladiumklorid i 4,5 liter metanol ble hydrogenert i en 10 liters rundkolbe. Reaksjonen varer i en time og forbruker 4,92 liter hydrogen. Katalysatoren ble vasket, først fire ganger med 1 liter metanol.og så fire ganger med 1 liter etylacetat. En oppløsning av 113 g ( + ) 3' ,4',5,7-0-tetrabenzyl-3-0-benzoyl-cyanidan-3-ol i 4 A suspension of 30 g of palladium chloride in 4.5 liters of methanol was hydrogenated in a 10 liter round bottom flask. The reaction lasts for an hour and consumes 4.92 liters of hydrogen. The catalyst was washed, first four times with 1 liter of methanol and then four times with 1 liter of ethyl acetate. A solution of 113 g of ( + ) 3' ,4',5,7-0-tetrabenzyl-3-0-benzoyl-cyanidan-3-ol in 4
liter etylacetat ble tilsatt katalysatoren impregnert med etylacetat, og blandingen hydrogenert i ca. lg time. Pd-kata-lysatoren•ble frafiltrert, vasket på filteret med 250 ml etylacetat, og all etylacetaten ble slått sammen og destillert under et svakt vakuum ved 40°C. Residuet ble oppløst i 5 liter vann, og den oppnådde suspensjonen rørt i 30 minutter ved romtemperatur hvoretter vannet ble drevet av under et middels vakuum ved 40°C til et volum på ca. 500 ml. Dette ble gjentatt to ganger, og suspensjonen ble til slutt fordampet til tørrhet. Residuet ble tørket til konstant vekt over silisiumdioksydgel over høyvakuum. Utbyttet av (+) 3-0-benzoyl-cyanidan-3-ol er kvantitativt og utgjorde 59. g. Smeltepunkt: 132-135°C (amorft produkt). liter of ethyl acetate was added to the catalyst impregnated with ethyl acetate, and the mixture hydrogenated for approx. lg hour. The Pd catalyst was filtered off, the filter was washed with 250 ml of ethyl acetate, and all the ethyl acetate was combined and distilled under a weak vacuum at 40°C. The residue was dissolved in 5 liters of water, and the resulting suspension stirred for 30 minutes at room temperature, after which the water was driven off under a medium vacuum at 40°C to a volume of approx. 500 ml. This was repeated twice and the suspension was finally evaporated to dryness. The residue was dried to constant weight over silica gel under high vacuum. The yield of (+) 3-0-benzoyl-cyanidan-3-ol is quantitative and amounted to 59 g. Melting point: 132-135°C (amorphous product).
Eksempel 10 Example 10
Fremgangsmåten var som i eksempel 9, bortsettThe procedure was as in example 9, except
fra at man brukte 115,8 g ( + ) .3 ',4',5,7-0-tetrabenzyl-3-0-(4-fluorbenzoyl)-cyanidan-3-ol. Utbyttet er 6l,5 g av (+) 3-0-(4-fluorbenzoyl)-cyanidan-3-ol, dvs. 99,5 %. Smeltepunkt: 131-133°C. from using 115.8 g of ( + ) .3',4',5,7-0-tetrabenzyl-3-0-(4-fluorobenzoyl)-cyanidan-3-ol. The yield is 61.5 g of (+) 3-O-(4-fluorobenzoyl)-cyanidan-3-ol, i.e. 99.5%. Melting point: 131-133°C.
Eksempel 11Example 11
Som i eksempel 9 ble palladium-svart fremstilt fra en suspensjon av 40 g palladiumklorid i 4,5 liter metanol, og metanolen ble erstattet med etylacetat, hvoretter man tilsatte en oppløsning av 130 g (+) 3',4',-5,7-0-tetrabenzyl-3-0-(3,4-dibenzyloksybenzoyl)-cyanidan-3-ol i 5,5 liter etylacetat, og blandingen ble hydrogenert. Etter at etylacetat og toluen' var fjernet azeotropisk med vann, ble residuet oppløst i 500 ml vann og oppløsningen lyofilisert til konstant vekt. Utbyttet av (+) 3_0-protokatekyl-cyanidan-3-ol er kvantitativt og utgjør 57,5 g- Smeltepunkt: l66-l68°C. As in Example 9, palladium black was prepared from a suspension of 40 g of palladium chloride in 4.5 liters of methanol, and the methanol was replaced by ethyl acetate, after which a solution of 130 g of (+) 3',4',-5, 7-O-tetrabenzyl-3-O-(3,4-dibenzyloxybenzoyl)-cyanidan-3-ol in 5.5 liters of ethyl acetate, and the mixture was hydrogenated. After ethyl acetate and toluene were removed azeotropically with water, the residue was dissolved in 500 ml of water and the solution lyophilized to constant weight. The yield of (+) 3_0-protocatechyl-cyanidan-3-ol is quantitative and amounts to 57.5 g. Melting point: 166-168°C.
Eksempel 12Example 12
Fremgangsmåten er som i eksempel 2, bortsett fra at man brukte 24,5 g (+) 3',4',5,7"0-tetrabenzyl-3-0-(acetyl-salicylyl)-cyanidan-3-ol. Utbyttet av (+) 3-0-(acetylsali-cylyl)-cyanidan-3-ol er kvantitativt og utgjør 13,5 g. The procedure is as in example 2, except that 24.5 g of (+) 3',4',5,7"0-tetrabenzyl-3-0-(acetyl-salicylyl)-cyanidan-3-ol were used. The yield of (+) 3-O-(acetylsalicyyl)-cyanidan-3-ol is quantitative and amounts to 13.5 g.
Smeltepunkt: ll8-119°C. uMelting point: ll8-119°C. u
Eksempel 13Example 13
Fremgangsmåten er som i eksempel 1: Palladium-svart ble fremstilt fra 24 g palladiumklorid i 3,6 liter metanol, hvoretter man hydrogenerte 64 g (+.X 3' , 4 ' , 5, 7_0-tetrabenzyl-3-0-(2-karboksybenzoyl)-cyanidan-3-ol i 3,5 liter etylacetat. Etter frafiltrering av katalysatoren og fordampning av etylacetatet og toluenet, ble residuet oppløst The procedure is as in example 1: Palladium black was prepared from 24 g of palladium chloride in 3.6 liters of methanol, after which 64 g (+.X 3' , 4 ' , 5, 7_0-tetrabenzyl-3-0-(2 -carboxybenzoyl)-cyanidan-3-ol in 3.5 liters of ethyl acetate. After filtering off the catalyst and evaporating the ethyl acetate and toluene, the residue was dissolved
i 2 liter etanol og oppløsningen fordampet til ca. 100 ml. Dette ble gjentatt to ganger, hvoretter residuet ble tørket under høyvakuum ved 40°C til konstant vekt. Utbyttet av (+) 3-0-(2-karboksybenzoy1)-cyanidan-3-ol er kvantitativt og utgjør 35 g. Smeltepunkt: 139-l42°C. in 2 liters of ethanol and the solution evaporated to approx. 100 ml. This was repeated twice, after which the residue was dried under high vacuum at 40°C to constant weight. The yield of (+) 3-O-(2-carboxybenzoyl)-cyanidan-3-ol is quantitative and amounts to 35 g. Melting point: 139-142°C.
E ksempel 1, 4Example 1, 4
Palladium-svart ble fremstilt som i eksempel 1, hvoretter metanolen ble erstattet med etylacetat og man hydrogenerte 30,8 g (+) 3',4',5,7-0-tetrabenzyl-3-0-(N-fenylkarba-moyl)-cyanidan-3-ol i l600 ml etylacetat. Etter frafiltrering av katalysatoren ble etylacetatet fordampet til et volum på ca. 50 ml, og man tilsatte 250 ml vann og justerte pH til 6 ved hjelp av en vandig oppløsning av IN NaOH. Fordampning til tørrhet i vakuum ble utført ved 40°C, hvoretter man tilsatte Palladium black was prepared as in Example 1, after which the methanol was replaced by ethyl acetate and 30.8 g of (+) 3',4',5,7-0-tetrabenzyl-3-0-(N-phenylcarbamoyl) was hydrogenated )-cyanidan-3-ol in 1600 ml of ethyl acetate. After filtering off the catalyst, the ethyl acetate was evaporated to a volume of approx. 50 ml, and 250 ml of water was added and the pH was adjusted to 6 using an aqueous solution of 1N NaOH. Evaporation to dryness in vacuo was carried out at 40°C, after which addition was made
500 ml vann og fordampet tre ganger, til slutt ble residuet opp-løst i 1 liter etanol som ble avdestillert, og det hele ble gjentatt. Produktet ble så oppløst i en blanding av 300 ml. etanol og 300 .ml vann, fordampet og så oppløst i 500 ml vann og fordampet til 100 ml. Det dannede bunnfall ble frafiltrert og tørket til konstant vekt ved 40°C i vakuum. Utbyttet av (+) 3-0-(N-fenylkarbamoyl)-cyanidan~3^ol er 15,0 g, dvs. 500 ml of water and evaporated three times, finally the residue was dissolved in 1 liter of ethanol which was distilled off, and the whole thing was repeated. The product was then dissolved in a mixture of 300 ml. ethanol and 300 ml of water, evaporated and then dissolved in 500 ml of water and evaporated to 100 ml. The precipitate formed was filtered off and dried to constant weight at 40°C in vacuum. The yield of (+) 3-O-(N-phenylcarbamoyl)-cyanidan~3^ol is 15.0 g, i.e.
91,6 %. Smeltepunkt: l89-200°C.91.6%. Melting point: l89-200°C.
E ksempel 15Example 15
Fremgangsmåten er som i eksempel 2 bortsett fra at man brukte 18,2 g (+) 3',4',5,7-0-tetrabenzyl-3-0-metan-sulfonyl-cyanidan-3-ol og utførte hydrogenering i 600 ml etylacetat. Oppløsningsmidlene ble avdestillert ved romtemperatur, og residuet tørket ved samme.under høyvakuum. Det ble så opp-løst i 500 ml etanol ved romtemperatur, og destillert til ca. 50 ml under høyvakuum ved 0°C. Det ble gjentatt to ganger og produktet ble tørket ved 35°C i 15 minutter i vakuum og The procedure is the same as in example 2 except that 18.2 g of (+) 3',4',5,7-0-tetrabenzyl-3-0-methane-sulfonyl-cyanidan-3-ol were used and hydrogenation was carried out in 600 ml of ethyl acetate. The solvents were distilled off at room temperature, and the residue dried at the same time under high vacuum. It was then dissolved in 500 ml of ethanol at room temperature, and distilled to approx. 50 ml under high vacuum at 0°C. It was repeated twice and the product was dried at 35°C for 15 minutes in vacuum and
■ residuet tørket til konstant vekt under høyvakuum ved romtemperatur. Utbyttet av (+) 3-0-metansulfonyl-cyanidan-3-ol er kvantitativt og utgjør 9,2 g. Stoffet dekomponerer langsomt selv ved romtemperatur, og det ble lagret i .flere døgn i en fryser ved -30°C. ■ the residue dried to constant weight under high vacuum at room temperature. The yield of (+) 3-0-methanesulfonyl-cyanidan-3-ol is quantitative and amounts to 9.2 g. The substance decomposes slowly even at room temperature, and it was stored for several days in a freezer at -30°C.
Eksempel 16Example 16
.Som i eksempel 7 ble en oppløsning av 40 g (+) 3'-4 ',5,7-0-tetrabenzyl-3-0-(4-metylbenzensulfony1)-cyanidan-3-ol i 1,8 liter etylacetat hydrogenert i en 3000 ml rundkolbe over 20 g 10% palladium på aktivert karbon. Hydrogeneringen tar 2\ time. Palladiumen og karbonet ble frafiltrert og filtratet fordampet til tørrhet i vakuum ved romtemperatur, hvoretter man tilsatte 1,7 liter etanol og utfører en destillasjon .ved 0°C under høyvakuum. Da volumet var ca. 100 ml, tilsatte man 800 ml etanol og destillerte ved 0°C under høyvakuum. Residuet ble så oppvarmet til 35°C i 15 minutter under•høyvakuum og holdt på romtemperatur under nevnte vakuum inntil man fikk konstant vekt. Utbyttet av (+) 3-0-(4-metylbenzensulfpnyl)-cyanidan-3-ol er kvantitativt og utgjør 22 g. As in example 7, a solution of 40 g of (+) 3'-4',5,7-0-tetrabenzyl-3-0-(4-methylbenzenesulfonyl)-cyanidan-3-ol in 1.8 liters of ethyl acetate was hydrogenated in a 3000 ml round bottom flask over 20 g of 10% palladium on activated carbon. The hydrogenation takes 2\ hours. The palladium and carbon were filtered off and the filtrate evaporated to dryness in vacuum at room temperature, after which 1.7 liters of ethanol were added and a distillation was carried out at 0°C under high vacuum. When the volume was approx. 100 ml, 800 ml of ethanol was added and distilled at 0°C under high vacuum. The residue was then heated to 35°C for 15 minutes under high vacuum and kept at room temperature under said vacuum until a constant weight was obtained. The yield of (+) 3-O-(4-methylbenzenesulfonyl)-cyanidan-3-ol is quantitative and amounts to 22 g.
Produktet ble lagret i en dypfryser ved -30°CThe product was stored in a deep freezer at -30°C
for å unngå dekomponering.to avoid decomposition.
Eksempel 17Example 17
•En suspensjon av 29 g palladiumklorid i 2,9 liter metanol ble hydrogenert i en 10 liters rundkolbe. Metanolen tilsatt saltsyre ble helt av, og pålladium-svart 'ble først vasket tre ganger med 300 ml metanol og så tre ganger med 300 ml etylacetat. En oppløsning av 54,5 g (+)-3',4',5,770-tetrabenzyl-3-0-(2-cyanoetyl)-cyanidan-3-ol i 2,9 liter etylacetat ble så tilsatt, og det hele ble hydrogenert. Etter fjerning av katalysatoren ved filtrering, ble oppløsningsmidlet fordampet i et middels vakuum og residuet oppløst i 1,5 liter vann, og blandingen fordampet på en roterende fordamper (Rotavapor) ved 40°C under et middels vakuum til 500 ml. Dette ble gjentatt ytterligere to ganger, og den siste fraksjon på 500 ml ble lyofilisert til konstant vekt. Nevnte (+) 3-0-(2-cyanoetyl)-cyanidan-3-ol ble oppnådd i.et utbytte på 25 g, dvs. 94 %. •A suspension of 29 g of palladium chloride in 2.9 liters of methanol was hydrogenated in a 10 liter round bottom flask. The methanol with added hydrochloric acid was poured off, and the palladium black was first washed three times with 300 ml of methanol and then three times with 300 ml of ethyl acetate. A solution of 54.5 g of (+)-3',4',5,770-tetrabenzyl-3-0-(2-cyanoethyl)-cyanidan-3-ol in 2.9 liters of ethyl acetate was then added, and the whole was hydrogenated. After removal of the catalyst by filtration, the solvent was evaporated in a medium vacuum and the residue dissolved in 1.5 liters of water, and the mixture evaporated on a rotary evaporator (Rotavapor) at 40°C under a medium vacuum to 500 ml. This was repeated twice more and the final fraction of 500 ml was lyophilized to constant weight. Said (+) 3-O-(2-cyanoethyl)-cyanidan-3-ol was obtained in a yield of 25 g, i.e. 94%.
Eksempel 18Example 18
56 g (+> 3',4',5,7-0-tetrabenzyl-3-0-(2-cyano-etyl)-cyanidan-3-ol, 4 liter absolutt etanol og 100 ml kloroform ble plassert i en 10 liters rundkolbe. Under utelukkelse 56 g (+> 3',4',5,7-0-tetrabenzyl-3-0-(2-cyano-ethyl)-cyanidan-3-ol, 4 liters of absolute ethanol and 100 ml of chloroform were placed in a 10 liter round flask Under exclusion
av luft ble blandingen oppvarmet til 60°C ir\ntil man får en fullstendig oppløsning, og den ble så avkjølt til romtemperatur og argon boblet gjennom den. Under argon tilsatte man 25 g 10% palladium på aktivert karbon og utførte en hydrogenering. 12 liter hydrogen ble brukt. Hydrogenet ble så erstattet med nitrogen, katalysatoren frafiltrert og filtratet fordampet til tørrhet i et middels vakuum. Residuet ble blandet med 1 liter etylacetat, og den resulterende suspensjonen rørt i 30 minutter ved 40°C. Oppløsningsmidlet ble så fordampet til ca. 200 ml, det hele avkjølt' til 0°C,. of air, the mixture was heated to 60°C until complete dissolution was obtained, then cooled to room temperature and argon bubbled through it. Under argon, 25 g of 10% palladium on activated carbon was added and a hydrogenation was carried out. 12 liters of hydrogen were used. The hydrogen was then replaced with nitrogen, the catalyst filtered off and the filtrate evaporated to dryness in a medium vacuum. The residue was mixed with 1 liter of ethyl acetate, and the resulting suspension stirred for 30 minutes at 40°C. The solvent was then evaporated to approx. 200 ml, the whole cooled to 0°C.
filtrert og bunnfallet vasket med etylacetat. Behandlingen med etylacetat ble gjentatt to ganger. Til slutt ble bunnfallet vasket to ganger med etylacetat, så to ganger med metylenklorid og så tørket under høyvakuum i 24 timer ved romtemperatur. Produktet ble oppløst i 2 liter vann, og oppløsningen ble fordampet til 200 ml ved destillasjon under et middels trykk, hvorpå man tilsatte 1,8 liter vann og fordampet på samme måten til 200 ml. Den endelige oppløsning ble lyofilisert til konstant vekt. Klorhydratet av (+) 3-0- filtered and the precipitate washed with ethyl acetate. The treatment with ethyl acetate was repeated twice. Finally, the precipitate was washed twice with ethyl acetate, then twice with methylene chloride and then dried under high vacuum for 24 hours at room temperature. The product was dissolved in 2 liters of water, and the solution was evaporated to 200 ml by distillation under medium pressure, after which 1.8 liters of water were added and evaporated in the same way to 200 ml. The final solution was lyophilized to constant weight. The hydrochloride of (+) 3-0-
(3-aminopropyl)-cyanidan-3-ol ble oppnådd i et utbytte på 21 g, dvs. 68,4 %. Smeltepunkt (med dekomponering): 195°C. (3-Aminopropyl)-cyanidan-3-ol was obtained in a yield of 21 g, i.e. 68.4%. Melting point (with decomposition): 195°C.
Eksempel 19Example 19
En ca. 55 % dispersjon av 5,0 g natriumhydridAn approx. 55% dispersion of 5.0 g sodium hydride
i olje ble tilsatt en 500 ml rundkolbe utstyrt med kjøler og lukket med kalsiumkloridrør, en dråpetrakt med trykkutjevner, in oil was added to a 500 ml round bottom flask equipped with a condenser and closed with a calcium chloride tube, a dropping funnel with a pressure equaliser,
en dyse for tilførsel av nitrogen, et termometer og en røre-mekanisme. En sterk nitrogenstrøm ble gjennom i 5 minutter a nozzle for supplying nitrogen, a thermometer and a stirring mechanism. A strong stream of nitrogen was passed through for 5 minutes
og så redusert slik at 60 ml vannfri tetrahydrofuran ble til-ført dråpe.vis gjennom dråpetrakten. Blandingen ble oppvarmet til ca. 40°C ved hjelp av et ytre oljebad og under røring'ble and then reduced so that 60 ml of anhydrous tetrahydrofuran was added dropwise through the dropping funnel. The mixture was heated to approx. 40°C using an external oil bath and with stirring
7,5 ml (17 g) nylig destillert metyljodid tilsatt dråpevis. Deretter tilsatte man dråpevis 52,0 g (+) 3 ' , 4 ',5,7-0-tetra-benzyl-cyanidan^3-ol i 170 ml vannfri tetrahydrofuran i løpet av en time. Blandingen ble rørt i 1\ time og holdt på 40°C. 7.5 ml (17 g) of freshly distilled methyl iodide added dropwise. 52.0 g of (+) 3',4',5,7-0-tetra-benzyl-cyanidan-3-ol in 170 ml of anhydrous tetrahydrofuran was then added dropwise over the course of one hour. The mixture was stirred for 1 hour and kept at 40°C.
Den ble så avkjølt til romtemperatur, 200 ml vann ble tilsattIt was then cooled to room temperature, 200 ml of water was added
og blandingen rørt i 15 minutter.„ Reaksjonsblandingen ble så filtrert og filtratet plassert i en skylletrakt inneholdende 200 ml toluen og 200 ml vann. Den organiske fasen ble utskilt og vasket med 50 ml .vann og den vandige' fase eks-trahert to ganger med 400 ml metylenklorid. De organiske fraksjoner ble slått sammen, tørket over magnesiumsulfat og fordampet under et middels vakuum ved 40°C Residuet ble tørket over natten ved 15 mm Hg ved 45°C og veide 51 g- and the mixture stirred for 15 minutes. The reaction mixture was then filtered and the filtrate placed in a rinsing funnel containing 200 ml of toluene and 200 ml of water. The organic phase was separated and washed with 50 ml of water and the aqueous phase extracted twice with 400 ml of methylene chloride. The organic fractions were combined, dried over magnesium sulfate and evaporated under a medium vacuum at 40°C. The residue was dried overnight at 15 mm Hg at 45°C and weighed 51 g-
Det tørre residuum ble oppløst ved 100°C i 510 ml metoksyetanol, filtrert varmt, og filtratet ble avkjølt langsomt under røring. Etter 8 timer ble det dannede bunnfall frafiltrert, vasket med 30 ml kald metoksyetanol og tørket i vakuum ved 50°C over natten. Utbyttet av (+) 3',4',5,7-0-tetrabenzyl-3_0-metyl-cyanidan-3_ol er 45,5 g, dvs. 85,5 The dry residue was dissolved at 100°C in 510 ml of methoxyethanol, filtered hot, and the filtrate was cooled slowly with stirring. After 8 hours, the precipitate formed was filtered off, washed with 30 ml of cold methoxyethanol and dried in vacuum at 50°C overnight. The yield of (+) 3',4',5,7-0-tetrabenzyl-3_0-methyl-cyanidan-3_ol is 45.5 g, i.e. 85.5
■Smeltepunkt: 124-125°C.■Melting point: 124-125°C.
Eksempel 20Example 20
1,5 liter av en 50% vandig oppløsning av NaOH,1.5 liters of a 50% aqueous solution of NaOH,
en oppløsning av 52 g (+) 3',4',5,7-0-tetrabenzy1-cyanidan-,3-ol i 1,5 liter butylklorid og 6,8 g tetrabutylammonium-hydrogensulfat ble tilsatt en 6 liters rundkolbe utstyrt med mekanisk rører og kjøler. Blandingen ble oppvarmet til 50°C a solution of 52 g of (+) 3',4',5,7-0-tetrabenzy1-cyanidan-,3-ol in 1.5 liters of butyl chloride and 6.8 g of tetrabutylammonium hydrogen sulfate was added to a 6 liter round bottom flask equipped with mechanical stirrer and cooler. The mixture was heated to 50°C
og holdt på denne temperatur i 2 timer og 45 minutter under and held at this temperature for 2 hours and 45 minutes below
kraftig røring. Etter avkjøling til romtemperatur ble to faser'utskilt, og den organiske fase vasket tre ganger med 300 ml vann og tørket over magnesiumsulfat._ Etter filtrering ble butylkloridet avdestillert og innvunnet. Residuet ble omkrystallisert to ganger i 3,2 liter absolutt etanol. Etter tørking'ble ( + ) 3',4',5,7-0-tetrabenzyl-3-0-butyl-cyanidan-3-ol oppnådd i et utbytte på 40,0'g, dvs. 70,8%. vigorous stirring. After cooling to room temperature, two phases were separated, and the organic phase was washed three times with 300 ml of water and dried over magnesium sulfate. After filtration, the butyl chloride was distilled off and recovered. The residue was recrystallized twice in 3.2 liters of absolute ethanol. After drying, (+) 3',4',5,7-0-tetrabenzyl-3-0-butyl-cyanidan-3-ol was obtained in a yield of 40.0'g, i.e. 70.8%.
Smeltepunkt: 55-56°C.Melting point: 55-56°C.
Eksempel 21Example 21
En oppløsning av 52 g (+) 3',4',5,7-0-tetra-benzyl-cyanidan-3-ol i 360 ml vannfri pyridin ble tilsatt en 500 ml 4-halset rundkolbe utstyrt med dråpetrakt med trykk-utligner, en kjøler, lukket med kalsiumkloridrør, en dyse for tilførsel av nitrogen og en magnetisk rører.' 17 g butyryl-klorid ble så tilsatt under nitrogen og kraftig røring. Blandingen ble reagert ved romtemperatur under røring i 5s time og så helt over i 500 ml vann inneholdende is. Blandingen ble rørt i en time og det oljeaktige. lag utskilt. Dette ble blandet først med 500 ml av en vandig oppløsning av IN NaHCO-j og så to ganger med 500 ml vann. Det faste produkt A solution of 52 g of (+) 3',4',5,7-0-tetra-benzyl-cyanidan-3-ol in 360 ml of anhydrous pyridine was added to a 500 ml 4-necked round bottom flask equipped with a dropping funnel with a pressure equalizer , a cooler, closed with calcium chloride tubes, a nozzle for supplying nitrogen and a magnetic stirrer.' 17 g of butyryl chloride was then added under nitrogen and vigorous stirring. The mixture was reacted at room temperature with stirring for 5 hours and then completely poured into 500 ml of water containing ice. The mixture was stirred for one hour and the oily. layer separated. This was mixed first with 500 ml of an aqueous solution of 1N NaHCO-j and then twice with 500 ml of water. The fixed product
ble frafiltrert, vasket med vann og tørket i vakuum. Omkrystallisering ble utført fra 3 liter etanol og 400 ml aceton. Etter tørking fikk man (+) 3',4',5,7-0-tetrabenzyl-3~0-butyryl-cyanidan-3-ol i et utbytte på 52,4 g, dvs. 91 %• Smeltepunkt: 92-93°C. was filtered off, washed with water and dried in vacuo. Recrystallization was carried out from 3 liters of ethanol and 400 ml of acetone. After drying (+) 3',4',5,7-0-tetrabenzyl-3~0-butyryl-cyanidan-3-ol was obtained in a yield of 52.4 g, i.e. 91%• Melting point: 92- 93°C.
Eksempel 22Example 22
Fremgangsmåten er som i eksempel 21, men man brukte 21,5 g 3,3_dimetylbutanoylklorid. Reaksjonstiden er en time. Etter vasking med vann fikk man 56 g råprodukt, dette ble oppløst i 400 ml aceton og 3 liter etanol som ble tilsatt dråpevis og så ble oppløsningen hensatt for' utkrystallisering i 6 døgn. Man fikk (+) 3',4',5,7-0-tetrabenzy1-3_0-(3,3-dimetylbutanpyl)-cyanidan-3-ol i et utbytte på 50,6 g, dvs. 84,6 %. Smeltepunkt: 58°C. The procedure is as in example 21, but 21.5 g of 3,3-dimethylbutanoyl chloride was used. The reaction time is one hour. After washing with water, 56 g of crude product was obtained, this was dissolved in 400 ml of acetone and 3 liters of ethanol which was added dropwise and the solution was then set aside for crystallization for 6 days. (+) 3',4',5,7-0-tetrabenzyl-3_0-(3,3-dimethylbutanyl)-cyanidan-3-ol was obtained in a yield of 50.6 g, i.e. 84.6%. Melting point: 58°C.
■ Eksempel 23■ Example 23
52 g (>) 3',4',5,7-0-tetrabenzyl-cyanidan-3-ol, 400 .'ml trietylamin, 80 ml pyridin og 16 g ravsyreanhydrid ble tilført en 1 liters rundkolbe utstyrt med kjøler, lukket med kalsiumkloridrør. Blandingen ble kokt under tilbakeløp i en time, hvoretter oppløsningsmidlet ble fjernet under middels 52 g (>) 3',4',5,7-0-tetrabenzyl-cyanidan-3-ol, 400 ml of triethylamine, 80 ml of pyridine and 16 g of succinic anhydride were added to a 1 liter round bottom flask equipped with a condenser, closed with calcium chloride tube. The mixture was refluxed for one hour, after which the solvent was removed under medium
vakuum ved 40°C. Residuet ble vasket to ganger med 300 ml vann, surgjort til pH 3 med HC1, så to ganger med destillert vann. Omkrystallisering ble utført to ganger med 3 liter, etanol. Man fikk (+) 3',4',5,7-0-tetrabenzy1-3-0-(3-karboksy-propionyl)-cyanidan-3-ol i et utbytte på 47,3 g, dvs. 8l,8 %. Smeltepunkt: 95"96°C. vacuum at 40°C. The residue was washed twice with 300 ml of water, acidified to pH 3 with HCl, then twice with distilled water. Recrystallization was carried out twice with 3 liters of ethanol. (+) 3',4',5,7-0-tetrabenzyl-3-0-(3-carboxy-propionyl)-cyanidan-3-ol was obtained in a yield of 47.3 g, i.e. 8l.8 %. Melting point: 95-96°C.
Eksempel 24Example 24
Fremgangsmåten er som i eksempel 21 bortsettThe procedure is the same as in example 21 except
fra at man brukte en 1 liters rundkolbe og 104 g (+) 3',4',5-7-0-tetrabenzyl-cyanidan-3-ol i 720 ml pyridin i nærvær av 6l g kaprinklorid. Blandingen ble holdt på 50°C i 11 time under røring og så helt over i 3 liter av is og vann og blandet i en time. Bunnfallet ble frafiltrert, vasket først to ganger med 1 liter vandig oppløsning av IN NaHCO-^og så from using a 1 liter round bottom flask and 104 g of (+) 3',4',5-7-0-tetrabenzyl-cyanidan-3-ol in 720 ml of pyridine in the presence of 6l g of capric chloride. The mixture was kept at 50°C for 11 hours with stirring and then poured into 3 liters of ice and water and mixed for one hour. The precipitate was filtered off, first washed twice with 1 liter of aqueous solution of 1N NaHCO-^ and then
to ganger med 1 liter vann og tørket i vakuum ved romtempera-.• tur over P2°5*Tilslutt ble blandingen omkrystallisert i twice with 1 liter of water and dried in vacuum at room temperature above P2°5*Finally, the mixture was recrystallized in
1,4 liter metoksyetanol. Man fikk (+) 3',4',5,7-0-tetra-benzyl-.3-0-dekanoyl-cyanidan-.3-ol i et utbytte på 121,7 g, dvs. 94,5 Smeltepunkt:- 88-89°C. 1.4 liters of methoxyethanol. (+) 3',4',5,7-0-tetra-benzyl-.3-0-decanoyl-cyanidan-.3-ol was obtained in a yield of 121.7 g, i.e. 94.5 Melting point: - 88-89°C.
E ksempel 23Example 23
Fremgangsmåten er som i eksempel .21 idet man brukte 44 g palmitoylklorid og holdt reaksjonsmediet-på 90°C The procedure is as in example 21, using 44 g of palmitoyl chloride and keeping the reaction medium at 90°C
i 2 timer. Det resulterende (+) 3',4',5,7-0-tetrabénzy1-3-0-palmitoyl-cyanidan-3_ol ble renset ved oppløsning under varme i 80 ml aceton, hvoretter 3 liter' etanol ble tilsatt dråpevis til oppløsningen. Utbyttet av det forønskede stoff var 68,4 g, dvs. 96,2%..Smeltepunkt: 57-59°C. for 2 hours. The resulting (+) 3',4',5,7-0-tetrabenzyl-3-0-palmitoyl-cyanidan-3-ol was purified by dissolving under heat in 80 ml of acetone, after which 3 liters of ethanol was added dropwise to the solution. The yield of the desired substance was 68.4 g, i.e. 96.2%. Melting point: 57-59°C.
Eksempel 26Example 26
Fremgangsmåten er som i eksempel 23, men man brukte 24,5 g tetrahydroftalsyreanhydrid. Reaksjonsblandingen ble kokt under tilbakeløp i 45 minutter,- og oppløsningsmidlet fjernet ved destillasjon, under et middels vakuum ved 40°C. Residuet ble oppløst i 600 ml metylenklorid og ekstrahert to ganger med 500 ml 2N HC1 og to ganger med 500 ml destillert vann. Oppløsningen av metylenklorid ble tørket over MgSO^ The procedure is as in example 23, but 24.5 g of tetrahydrophthalic anhydride was used. The reaction mixture was refluxed for 45 minutes and the solvent removed by distillation under a medium vacuum at 40°C. The residue was dissolved in 600 ml of methylene chloride and extracted twice with 500 ml of 2N HCl and twice with 500 ml of distilled water. The methylene chloride solution was dried over MgSO 4
. og oppløsningsmidlet avdampet. Residuet ble omkrystallisert. and the solvent evaporated. The residue was recrystallized
i en blanding av karbontetraklorid og petroleter. Man fikk (+) 3',4',5,7-0-tetrabenzyl-3-0-tetrahydroftalyl-cyanidan3-ol i et utbytte på 55,2 g, dvs. 86 %. Smeltepunkt: 67-68°C. in a mixture of carbon tetrachloride and petroleum ether. (+) 3',4',5,7-0-tetrabenzyl-3-0-tetrahydrophthalyl-cyanidan-3-ol was obtained in a yield of 55.2 g, i.e. 86%. Melting point: 67-68°C.
Eksempel 27Example 27
Fremgangsmåten er som i eksempel 21, bortsett fra at man brukte 22,5 g benzqylklorid, og blandingen ble holdt på 80°C i 6 timer. Det utskilte produkt ble etter vasking med NaHCO^og vann omkrystallisert i en blanding av 7 liter etanol og 1,25 liter aceton. (+) 3',4',5,7-0-tetra-benzyl-3_0-benzoyl-cyanidan-3-ol ble oppnådd i et utbytte på 50,1 g, dvs. 83 %. Smeltepunkt: 115-ll6°C. The procedure is as in Example 21, except that 22.5 g of benzyl chloride was used, and the mixture was kept at 80°C for 6 hours. The separated product was, after washing with NaHCO 3 and water, recrystallized in a mixture of 7 liters of ethanol and 1.25 liters of acetone. (+) 3',4',5,7-0-tetra-benzyl-3_0-benzoyl-cyanidan-3-ol was obtained in a yield of 50.1 g, i.e. 83%. Melting point: 115-116°C.
Eksempel 28Example 28
Fremgangsmåten er som i eksempel 21, bortsett fra at 25,4 g 4-fluorbenzoylklorid ble brukt, og blandingen holdt på romtemperatur i 7 timer. Det ferdige produkt ble 'oppløst i 3,5 liter aceton under oppvarming og utfelt ved å tilsette 800 ml vann. Ved avkjøling fikk man utfelt (+)3'_ 4',5,7_0-tetrabenzyl-3_0-(4-fluorbenzoyl)-cyanidan-3-ol i The procedure is as in Example 21, except that 25.4 g of 4-fluorobenzoyl chloride was used, and the mixture was kept at room temperature for 7 hours. The finished product was dissolved in 3.5 liters of acetone under heating and precipitated by adding 800 ml of water. Upon cooling, (+)3'_4',5,7_0-tetrabenzyl-3_0-(4-fluorobenzoyl)-cyanidan-3-ol was precipitated in
"et utbytte på 52,2 g, dvs.- 84,4 %. Smeltepunkt: 154°C. "a yield of 52.2 g, i.e. - 84.4%. Melting point: 154°C.
Eksempel 29Example 29
Fremgangsmåte som i eksempel 21", bortsett fraProcedure as in Example 21", except
at man brukte en oppløsning av 56,6 g 3,4-dibenzyloksybenzoyl-klorid i 130 ml pyridin. Blandingen ble rørt ved romtemperatur i 2 timer og 45 minutter. Det endelige produkt ble omkrystallisert to ganger fra aceton. (+) 3',4',5,7_0-tetraben-syl-3-0-(3,4-dibenzyloksybenzoyl)-cyanidan-3-ol ble oppnådd that a solution of 56.6 g of 3,4-dibenzyloxybenzoyl chloride in 130 ml of pyridine was used. The mixture was stirred at room temperature for 2 hours and 45 minutes. The final product was recrystallized twice from acetone. (+) 3',4',5,7_0-tetraben-syl-3-0-(3,4-dibenzyloxybenzoyl)-cyanidan-3-ol was obtained
i et utbytte på 56,5 g, dvs. 73 Smeltepunkt: l62-l63°C. in a yield of 56.5 g, i.e. 73 Melting point: 162-163°C.
Eksempel 3' 0Example 3' 0
Fremgangsmåten er som i eksempel 21, bortsett fra at man tilsatte en oppløsning av 32 g acetylsalicylyl-klorid i 180 ml pyridin og blandingen ble rørt i 2 timer ved The procedure is as in example 21, except that a solution of 32 g of acetylsalicylic chloride in 180 ml of pyridine was added and the mixture was stirred for 2 hours at
65°C. Etter vasking med NaHCOy og vann ble råproduktet omkrystallisert først fra 8 liter etanol og så fra en blanding av 5 liter etanol og 1,2 liter aceton. Utbyttet av (+) 3',4'-5,7-0-tetrabenzyI-3-0-(acetylsalicylyl)-cyanidan-3-ol er 44,8 g, dvs. 69 %. Smeltepunkt: 136-137°C. 65°C. After washing with NaHCOy and water, the crude product was recrystallized first from 8 liters of ethanol and then from a mixture of 5 liters of ethanol and 1.2 liters of acetone. The yield of (+) 3',4'-5,7-0-tetrabenzyl-3-0-(acetylsalicylicyl)-cyanidan-3-ol is 44.8 g, i.e. 69%. Melting point: 136-137°C.
Eksempel - 31Example - 31
260 g (+) 3',4',5,7-0-tetrabenzyl-cyanidan-3-ol, 89 g ftalsyreanhydrid, 3 liter trietylamin og 1 liter pyridin 260 g (+) 3',4',5,7-0-tetrabenzyl-cyanidan-3-ol, 89 g phthalic anhydride, 3 liters triethylamine and 1 liter pyridine
ble tilsatt en 4-halset 6 liters rundkolbe utstyrt med mekanisk rører, en kjøler lukket med kalsiumkloridrører, en dyse for tilførsel av nitrogen samt et termometer. Under nitrogen ble blandingen kokt under tilbakeløp (92°C) i 9 timer og så avkjølt.til romtemperatur og filtrert. Blandingen ble fordampet til . tørrhet i et middels vakuum ved 40°C i en roterende fordamper (Rotavapor),'og det oljeaktige residuum ble oppløst i 500 ml metylenklorid og ekstrahert to ganger med 500 ml vandig 2N HC1 og så to ganger med 500 ml vann. Den organiske oppløsning ble tørket over magnesiumsulfat, filtrert og fordampet til tørrhet. Råproduktet ble omkrystallisert fra 2,5 liter toluen og 1,6 liter ligroin. Det utkrystalliserte was added to a 4-necked 6 liter round-bottomed flask equipped with a mechanical stirrer, a condenser closed with calcium chloride stirrers, a nozzle for the supply of nitrogen and a thermometer. Under nitrogen, the mixture was refluxed (92°C) for 9 hours and then cooled to room temperature and filtered. The mixture was evaporated to . dryness in a medium vacuum at 40°C in a rotary evaporator (Rotavapor), and the oily residue was dissolved in 500 ml of methylene chloride and extracted twice with 500 ml of aqueous 2N HCl and then twice with 500 ml of water. The organic solution was dried over magnesium sulfate, filtered and evaporated to dryness. The crude product was recrystallized from 2.5 liters of toluene and 1.6 liters of naphtha. It crystallized
produkt ble tørket til konstant vekt under høyvakuum ved romtemperatur. Utbyttet av (+) 3',4',5,7-0-tetrabenzyl-3-0-(2-karboksybenzoyl)-cyanidan-3_ol er 221,6 g, dvs.. 69,4 %. Smeltepunkt: 127-129°C. product was dried to constant weight under high vacuum at room temperature. The yield of (+) 3',4',5,7-0-tetrabenzyl-3-0-(2-carboxybenzoyl)-cyanidan-3-ol is 221.6 g, i.e. 69.4%. Melting point: 127-129°C.
Eksempel 32Example 32
Fremgangsmåte som i eksempel 21 bortsett fra at man brukte en 1 liters rundkolbe og 65 g (+) 3',4',5,7-0-tetrabenzyl-cyanidan-3-ol i 800 ml pyridin.'Blandingen ble holdt på 100°C under nitrogen og man tilsatte 17,1 ml (18,7 g) N-fenylisocyanat dråpevis..Blandingen ble hensatt i en time ved 100°C, avkjølt til romtemperatur, filtrert og tilsatt 6 liter vann under kraftig røring. Det hvite bunnfallet ble vasket med 6 liter vann. og tørket under et middels vakuum ved 60°C i 2 døgn. Det ble omkrystallisert fra 8 liter aceton som ga 60,7 g,' og etter konsentrasjon til ca. 2 liter fikk man ytterligere 16,2 g. Utbyttet av (+) 3',4',5,7-0-tetra- Procedure as in example 21 except that a 1 liter round bottom flask and 65 g of (+) 3',4',5,7-0-tetrabenzyl-cyanidan-3-ol in 800 ml of pyridine were used. The mixture was kept at 100 °C under nitrogen and 17.1 ml (18.7 g) of N-phenylisocyanate were added dropwise. The mixture was left for one hour at 100°C, cooled to room temperature, filtered and 6 liters of water added with vigorous stirring. The white precipitate was washed with 6 liters of water. and dried under a medium vacuum at 60°C for 2 days. It was recrystallized from 8 liters of acetone, which gave 60.7 g, and after concentration to approx. 2 liters gave a further 16.2 g. The yield of (+) 3',4',5,7-0-tetra-
benzyl-3-0-(N-fenylkarbamoyl)-cyanidan-3-ol er således 76,9 g, dvs. 100 %. Smeltepunkt.: 204°C. benzyl-3-0-(N-phenylcarbamoyl)-cyanidan-3-ol is thus 76.9 g, i.e. 100%. Melting point.: 204°C.
Eksempel 53Example 53
En oppløsning av 65 g (+) 3',4',5,7-0-tetra-benzyl-cyanidan-3-pl i 500 ml pyridin og 25 .ml trietylamin ble tilsatt en 3-halset 750 ml rundkolbe utstyrt med magnetisk rører, et kalsiumkloridrør, en skilletrakt samt en dyse for tilførsel av nitrogen. En strøm av nitrogen ble ført igjennom kolben, og blandingen avkjølt til -15°C og så dråpevis i løpet, av .30 minutter tilsatt 23 g metansulfonylklorid.. Reaksjonsblandingen ble rørt i 30 minutter ved -15°C, og så helt over i 2,5 liter isvann. Bunnfallet ble frafiltrert og blandet med 1 liter vann og så filtrert og tørket i vakuum over ^2^5"Produktet ble omkrystallisert fra 2 liter n-butanol, filtrert og vasket med 250 ml metanol og så igjen med 500 ml metanol. Stoffet ble tørket i vakuum over ^ 2^ 5 ved romtemperatur. Utbyttet av (+)3',4',5,7-0-tetrabenzyl-3-0-metan-sulfonyl-cyanidan-3-ol er 60,5 g, dvs. 83 %• Smeltepunkt: l-38-139°C. A solution of 65 g of (+) 3',4',5,7-0-tetra-benzyl-cyanidan-3-pl in 500 ml of pyridine and 25 ml of triethylamine was added to a 3-necked 750 ml round bottom flask fitted with a magnetic tubes, a calcium chloride tube, a separating funnel and a nozzle for supplying nitrogen. A stream of nitrogen was passed through the flask, and the mixture cooled to -15°C and then 23 g of methanesulfonyl chloride was added dropwise over 30 minutes. The reaction mixture was stirred for 30 minutes at -15°C, and then completely poured into 2.5 liters of ice water. The precipitate was filtered off and mixed with 1 liter of water and then filtered and dried in vacuum over ^2^5" The product was recrystallized from 2 liters of n-butanol, filtered and washed with 250 ml of methanol and then again with 500 ml of methanol. The substance was dried in vacuum over ^ 2^ 5 at room temperature The yield of (+)3',4',5,7-0-tetrabenzyl-3-0-methane-sulfonyl-cyanidan-3-ol is 60.5 g, i.e. 83%• Melting point: l-38-139°C.
Eksempel 34Example 34
158 g (+) 3 ' , 4 ' ,5,7-0-tetrabenzyl-cyanidan-3-ol og 250 ml pyridin ble tilsatt en 4-halset 500 ml rundkolbe utstyrt med kjøler lukket med et kalsiumkloridrør, en dyse for tilførsel av nitrogen, et dyppetermometer og en magnetisk rører. Blandingen ble oppvarmet til 90°C og ( + ) 3'-,4'-5,7_0-tetrabenzyl-cyanidan-3-ol ble tilsatt oppløsningen. 158 g of (+) 3 ' , 4 ' ,5,7-0-tetrabenzyl-cyanidan-3-ol and 250 ml of pyridine were added to a 4-necked 500 ml round bottom flask equipped with a condenser closed with a calcium chloride tube, a nozzle for supplying nitrogen, an immersion thermometer and a magnetic stirrer. The mixture was heated to 90°C and (+) 3'-,4'-5,7_0-tetrabenzyl-cyanidan-3-ol was added to the solution.
67 g 4-metylbenzensulfonylklorid ble så tilsatt under oppvarming, og oppløsningen holdt på 90°C under nitrogen og røring i 4 timer. Blandingen ble så avkjølt til -30°C i 67 g of 4-methylbenzenesulfonyl chloride were then added while heating, and the solution was kept at 90°C under nitrogen and stirring for 4 hours. The mixture was then cooled to -30°C i
2\ time og man fikk et bunnfall. 1,5 liter vann ble tilsatt, og blandingen ble blandet og frafiltrert og .^vasket med en vandig IN NaHCO^ og så med vann inntil filtratet ble nøy-tralt. De utfelte stoff ble omkrystallisert fra 5 liter kloroform og 20 liter isopropanol. Utbyttet av ('+) 3',4'-5,7-0-tetrabenzyI-3-0-(4-metylbenzensulfony1)-cyanidan-3-ol er 162,9 g, dvs. 84,3 Smeltepunkt: 173-174°C. 2\ hour and a precipitate was obtained. 1.5 liters of water was added and the mixture was mixed and filtered off and washed with an aqueous 1N NaHCO3 and then with water until the filtrate became neutral. The precipitated substance was recrystallized from 5 liters of chloroform and 20 liters of isopropanol. The yield of ('+) 3',4'-5,7-0-tetrabenzyI-3-0-(4-methylbenzenesulfonyl)-cyanidan-3-ol is 162.9 g, i.e. 84.3 Melting point: 173- 174°C.
Eksempel 35Example 35
'En oppløsning av 300 g (+) 3',4',5,7-0-tetra-benzyl-cyanidan-3-ol i 3 liter toluen ble først tilsatt, så 'A solution of 300 g (+) 3',4',5,7-0-tetra-benzyl-cyanidan-3-ol in 3 liters of toluene was first added, then
ble 4,5 liter av en 50 % vandig oppløsning av NaOH og så tilslutt l6 g Triton B ble under røring tilsatt en 20 liters rundkolbe utstyrt med skilletrakt og en mekanisk rører. became 4.5 liters of a 50% aqueous solution of NaOH and then finally 16 g of Triton B were added while stirring to a 20 liter round flask equipped with a separatory funnel and a mechanical stirrer.
Under røring ble 82 g akrylonitril tilsatt; dråpevis"i løpet av 45 minutter. Blandingen ble kraftig rørt i 2 timer ved romtemperatur, 30 g akrylonitril ble tilsatt og røring fortsatt over natten. En tredj.e del 100 g akrylonitril ble så tilsatt reaksjonsblandingen.■ Røring ble fortsatt i ytterligere 2 timer, hvoretter toluenfasen ble isolert og vasket tre ganger med 1 liter 0,1N saltsyre og så med 2 liter vann. Toluenfasen ble tørket over magnesiumsulfat og toluenen fordampet. Residuet ble oppløst i 1,8 liter aceton, og aceton-oppløsningen helt under røring over i 5,4 liter kokende etanol. Ved avkjøling fikk man utfelt (+) 3',4',5,7-0-tetrabenzyl-3-0-(2-cyanoetyl)-cyanidan-3-ol. Den ble filtrert og tørket. Utbytte: 318 g, dvs. 98 %. Smeltepunkt: 100-101°C. With stirring, 82 g of acrylonitrile were added; dropwise" over the course of 45 minutes. The mixture was vigorously stirred for 2 hours at room temperature, 30 g of acrylonitrile was added and stirring continued overnight. A third of 100 g of acrylonitrile was then added to the reaction mixture. Stirring was continued for a further 2 hours , after which the toluene phase was isolated and washed three times with 1 liter of 0.1N hydrochloric acid and then with 2 liters of water. The toluene phase was dried over magnesium sulfate and the toluene evaporated. The residue was dissolved in 1.8 liters of acetone, and the acetone solution completely while stirring over in 5.4 liters of boiling ethanol. Upon cooling, (+) 3',4',5,7-0-tetrabenzyl-3-0-(2-cyanoethyl)-cyanidan-3-ol was precipitated. It was filtered and dried Yield: 318 g, i.e. 98% Melting point: 100-101°C.
Eksempel 36Example 36
En 3-halset 500 ml rundkolbe ble utstyrt med en dyse for tilførsel av nitrogen, en dråpetrakt med trykkutjevner, et kalsiumkloridrør og en magnetisk rører. 52 g 3',4',5,7-0-tetråbenzyl-cyanidan-3-ol, 260 ml vannfri dioksan ■ og 130 mg p— toluensulfonsyre ble tilsatt kolben. 26 ml (24 g) dihydropyran ble tilsatt dråpevis under røring. Røringen ble fortsatt ved romtemperatur i 2\ time, hvoretter blandingen ble filtrert og filtratet fordampet til tørrhet under et middels vakuum. Residuet ble oppløst i 500 ml kloroform, og oppløsningen ble vasket to ganger med 300'ml vandig IN NaHCO^, deretter med 300 ml destillert vann. Kloroformoppløsningen ble tørket over magnesiumsulfat, filtrert og fordampet. Residuet ble tørket under høyvakuum ved romtemperatur. Nevnte (+) 3',4',5,7_0-tetrabenzyl-3~0-tetrahydropyranyl-cyanidan-3-ol ble oppnådd i form av en blanding av de to diastereoisomereformer i et utbytte på 56 g, dvs. 95,3 %. A 3-necked 500 ml round bottom flask was equipped with a nozzle for the supply of nitrogen, a dropping funnel with a pressure equaliser, a calcium chloride tube and a magnetic stirrer. 52 g of 3',4',5,7-0-tetrabenzyl-cyanidan-3-ol, 260 ml of anhydrous dioxane and 130 mg of p-toluenesulfonic acid were added to the flask. 26 ml (24 g) of dihydropyran was added dropwise with stirring. Stirring was continued at room temperature for 2 hours, after which the mixture was filtered and the filtrate evaporated to dryness under a medium vacuum. The residue was dissolved in 500 ml of chloroform, and the solution was washed twice with 300 ml of aqueous 1N NaHCO 3 , then with 300 ml of distilled water. The chloroform solution was dried over magnesium sulfate, filtered and evaporated. The residue was dried under high vacuum at room temperature. Said (+) 3',4',5,7_0-tetrabenzyl-3~0-tetrahydropyranyl-cyanidan-3-ol was obtained in the form of a mixture of the two diastereoisomeric forms in a yield of 56 g, i.e. 95.3 %.
Produktet er i form av en kåket masse, så detThe product is in the form of a caked mass, so that
er ikke mulig å bestemme smeltepunktet.is not possible to determine the melting point.
Eksempel 37Example 37
Det ble fremstilt en suspensjon i 1 liter nylig destillert dimetylformamid av 92,8 g av en 55 % dispersjon av natriumhydrid i olje (51 g NaH) under nitrogen. Suspensjonen ble avkjølt til mellom -5°C og 0°C ved hjelp av et ytre kjølebad. A suspension was prepared in 1 liter of freshly distilled dimethylformamide of 92.8 g of a 55% dispersion of sodium hydride in oil (51 g NaH) under nitrogen. The suspension was cooled to between -5°C and 0°C using an external cooling bath.
En oppløsning av 145 g (+)-cyanidan-3-0I iA solution of 145 g of (+)-cyanidan-3-OH in
2 liter nylig destillert dimetylformamid ble tilsatt på en slik måte at suspensjonen holdt seg mellom -5 og 0°C (til-setningstid ca. en time). Hydrogen ble utviklet og fjernet 2 liters of freshly distilled dimethylformamide were added at a in such a way that the suspension remained between -5 and 0°C (addition time approx. one hour). Hydrogen was evolved and removed
med nitrogensirkulasjon.with nitrogen circulation.
'Da tilførselen av (+)-cyanidan-3-ol var avsluttet, ble reaksjonen hensatt ved lav temperatur i 15 minutter og utviklingen av hydrogengass stoppet da praktisk talt opp. I løpet av lg time tilsatte man så 267,5 ml, dvs. 385 g benzylbromid på en slik måte at temperaturen holdt seg i nevnte område. Denne temperatur ble videre holdt der i 30 minutter, hvoretter man langsomt lot den heve til romtemperatur. When the addition of (+)-cyanidan-3-ol was finished, the reaction was left at low temperature for 15 minutes and the evolution of hydrogen gas then practically stopped. In the course of 1 hour, 267.5 ml, i.e. 385 g of benzyl bromide were then added in such a way that the temperature remained in the aforementioned range. This temperature was further held there for 30 minutes, after which it was slowly allowed to rise to room temperature.
Dimetylformamidet ble innvunnet ved destillasjon i vakuum ved 60°C, og det oljeaktige residuum ble oppløst i 3 liter trikloretylen. Den organiske oppløsning' ble vasket tre ganger med 3 liter destillert vann og så filtrert for å fjerne urenheter i suspensjonen. The dimethylformamide was recovered by distillation in vacuum at 60°C, and the oily residue was dissolved in 3 liters of trichloroethylene. The organic solution was washed three times with 3 liters of distilled water and then filtered to remove impurities in the suspension.
Ved konsentrasjon og avkjøling.til 5°C flere ganger, fikk man 159 g praktisk talt rent (+) 3',4',5,7-0-.tetrabenzyl-cyanidan-3-ol som ble utkrystallisert. Utbytte: By concentration and cooling to 5°C several times, 159 g of practically pure (+) 3',4',5,7-0-tetrabenzyl-cyanidan-3-ol was obtained, which was crystallized. Dividend:
51 %..Produktet•er i form av hvite nåler.51%..The product•is in the form of white needles.
Smeltepunkt: l44-l45°C.Melting point: l44-l45°C.
Eksempel 58Example 58
Fremgangsmåten ble utført.som beskrevet i eksempel 37, bortsett fra at dimetylformamidet var tørket på en molekylær sil (4 Å,'2 mm) og at oppløsningen av (+)-cyanidan-3-ol i dimetylformamid var tørket på lignende måte. Mån fikk (+) 3',4',5,7-0-tetrabenzy1-cyanidan-3-ol i et utbytte på 55 %. The procedure was carried out as described in Example 37, except that the dimethylformamide was dried on a molecular sieve (4 Å, 2 mm) and that the solution of (+)-cyanidan-3-ol in dimethylformamide was dried in a similar manner. Mån obtained (+) 3',4',5,7-0-tetrabenzyl-cyanidan-3-ol in a yield of 55%.
Eksempel 39Example 39
Fremgangsmåten var som i eksempel 37, men benzyl-bromidet ble erstattet med 2,25 mol benzylklorid. Etter at réaksjonsmediet var hevet til romtemperatur, ble denne temperatur opprettholdt i 10 timer under røring før man avdestil-lerte dimetylformamidet. Utbyttet av (+) 3',4',5,7-0-tetrabenzyl-cyanidan-3-ol er 57 %• The procedure was as in Example 37, but the benzyl bromide was replaced with 2.25 mol of benzyl chloride. After the reaction medium had been raised to room temperature, this temperature was maintained for 10 hours with stirring before the dimethylformamide was distilled off. The yield of (+) 3',4',5,7-0-tetrabenzyl-cyanidan-3-ol is 57%•
Eksempel 40Example 40
En oppløsning av 1,45 g (+)-cyanidan-3-ol i 20 ml nylig destillert dimetylsulfoksyd ble langsomt under røring og ved romtemperatur tilsatt en suspensjon i 10 ml nylig destillert dimetylsulfoksyd, holdt under nitrogen, bestående av 0,93 g av en 55 % dispersjon av natriumhydrid i olje (0,51 g NaH). Hydrogen ble utviklet og fjernet ved nitrogensirkulasjon. Etter røring i en time ved romtemperatur var hydrogenutviklingen stoppet opp, og natriumsaltet av (+)-cyanidan-3-ol var delvis' avsatt på veggen i kolben. 2,68 ml (3,85 g) benzylbromid ble så tilsatt dråpevis, og man fikk en svak eksotermisk reaksjon. 30 minutter senere blir blandingen klar og blir så rørt i en time ved romtemperatur. Oppløsningen ble så dråpevis under røring helt over i 300 ml kald 10 % vandig oppløsning av natriumklorid. Det dannede bunnfall ble frafiltrert, tørket i vakuum ved 80°C og så omkrystallisert fra 40 ml karbontetraklorid. Man fikk 196 g (+) 3'j4',5,7_0-tetrabenzyl-cyanidan-3_ol, dvs. et utbytte på 60,3 A solution of 1.45 g of (+)-cyanidan-3-ol in 20 ml of freshly distilled dimethyl sulfoxide was added slowly with stirring at room temperature to a suspension in 10 ml of freshly distilled dimethyl sulfoxide, kept under nitrogen, consisting of 0.93 g of a 55% dispersion of sodium hydride in oil (0.51 g NaH). Hydrogen was evolved and removed by nitrogen circulation. After stirring for one hour at room temperature, the evolution of hydrogen had stopped, and the sodium salt of (+)-cyanidan-3-ol had partially deposited on the wall of the flask. 2.68 ml (3.85 g) of benzyl bromide was then added dropwise, and a slight exothermic reaction was obtained. 30 minutes later the mixture becomes clear and is then stirred for one hour at room temperature. The solution was then poured dropwise, while stirring, into 300 ml of cold 10% aqueous solution of sodium chloride. The precipitate formed was filtered off, dried in vacuum at 80°C and then recrystallized from 40 ml of carbon tetrachloride. 196 g of (+) 3'j4',5,7_0-tetrabenzyl-cyanidan-3_ol were obtained, i.e. a yield of 60.3
Eksempel 4lExample 4l
Fremgangsmåten som i eksempel 37, bortsett fra at man brukte 4l6 g ct-brom-o-xy len i stedet for benzylbromid. Residuet ble etter fjerning av dimetylformamidet oppløst i kloroform. Oppløsningen ble vasket med destillert vann, filtrert og fordampet. Residuet ble ,omkrystallisert fra en blanding av benzen og petroleter (6:3 volum/volum). Man fikk (+) 3'j4',537-0-tetra-(2-metylbenzyl)-cyanidan-3-ol i et utbytte på 51 %. Smeltepunkt: 88-90°C. The procedure as in Example 37, except that 416 g of ct-bromo-o-xylene were used instead of benzyl bromide. After removal of the dimethylformamide, the residue was dissolved in chloroform. The solution was washed with distilled water, filtered and evaporated. The residue was recrystallized from a mixture of benzene and petroleum ether (6:3 volume/volume). (+) 3'j4',537-0-tetra-(2-methylbenzyl)-cyanidan-3-ol was obtained in a yield of 51%. Melting point: 88-90°C.
Eksempel 42Example 42
Fremgangsmåte som.i eksempel'37 bortsett fraProcedure as in example'37 except
at man brukte 4l6 g oe-brom-p-xylen i stedet for benzylbromid. Residuet etter fjerning av dimetylformamidet ble oppløst i kloroform. Oppløsningen ble vasket med vann, filtrert og fordampet og så omkrystallisert fra karbontetraklorid. Man fikk (+) 3',4',5,7-0-tetra-(4-metylbertzyl)-cyanidan-3-ol i et utbytte på 40 %. Smeltepunkt: 66-70°C. that 4l6 g of oe-bromo-p-xylene was used instead of benzyl bromide. The residue after removal of the dimethylformamide was dissolved in chloroform. The solution was washed with water, filtered and evaporated and then recrystallized from carbon tetrachloride. (+) 3',4',5,7-0-tetra-(4-methylbertzyl)-cyanidan-3-ol was obtained in a yield of 40%. Melting point: 66-70°C.
Eksempel 43Example 43
Fremgangsmåte som i eksempel 37 bortsett fraProcedure as in Example 37 except
at man brukte 562 g 2-brombenzylbromid i stedet for benzylbromid.. Residuet ble etter fjerning' av dimetylf ormamidet oppløst i kloroform. Oppløsningen ble vasket med vann, filtrert og fordampet og så omkrystallisert fra en blanding av kloroform og karbontetraklorid (40:55 v/v).. Utbyttet av (+) 3',4',5,7-0-tetra-(2-brombenzyl)-cyanidan-3-ol var 74 %. Smeltepunkt: 155-157°C. that 562 g of 2-bromobenzyl bromide was used instead of benzyl bromide. After removal of the dimethylformamide, the residue was dissolved in chloroform. The solution was washed with water, filtered and evaporated and then recrystallized from a mixture of chloroform and carbon tetrachloride (40:55 v/v).. The yield of (+) 3',4',5,7-0-tetra-(2 -bromobenzyl)-cyanidan-3-ol was 74%. Melting point: 155-157°C.
Eksempel 44 Example 44
Fremgangsmåten var som i eksempel 37 bortsettThe procedure was as in example 37 except
fra at man brukte l8l g metylklormetyleter i stedet for benzylbromid. Residuet som man fikk etter fjerning av dimetylformamidet ble oppløst i kloroform, vasket tre ganger med vann og så fordampet. Omkrystallisering ble først ut- from using 18l g of methyl chloromethyl ether instead of benzyl bromide. The residue obtained after removal of the dimethylformamide was dissolved in chloroform, washed three times with water and then evaporated. Recrystallization was first ex-
ført fra n-heksan og så fra en blanding av metanol og vann (1:1 v/v). Man fikk (+) 3',4',5,7-0-tetra(metoksymetyl)-cyanidan-3-ol i et utbytte på 40 %. conducted from n-hexane and then from a mixture of methanol and water (1:1 v/v). (+) 3',4',5,7-0-tetra(methoxymethyl)-cyanidan-3-ol was obtained in a yield of 40%.
Smeltepunkt: 92-93°C.Melting point: 92-93°C.
Eksempel 45 Example 45
Fremgangsmåten er som i eksempel 37 bortsettThe procedure is the same as in example 37 except
fra at man brukte 272 g av allylbromid i stedet for benzyl-■bromid. Den endelige oppløsningen av dimetylf ormamid- ble helt over en blanding av vann og knust is, og det hvite bunnfallet ble utskilt ved sentrifugering og oppløst i kloroform. Kloroformoppløsningen ble vasket tre ganger med vann og så fordampet. Residuet ble omkrystallisert fra n-heksan. Utbyttet av (+) 3',4',5,7-0-tetra-allyl-cyanidan-3-ol er 28 %. Smeltepunkt: 78,5 - 80°C. from the fact that 272 g of allyl bromide was used instead of benzyl bromide. The final solution of dimethylformamide was poured over a mixture of water and crushed ice, and the white precipitate was separated by centrifugation and dissolved in chloroform. The chloroform solution was washed three times with water and then evaporated. The residue was recrystallized from n-hexane. The yield of (+) 3',4',5,7-0-tetra-allyl-cyanidan-3-ol is 28%. Melting point: 78.5 - 80°C.
Eksempel 46Example 46
Fremgangsmåten er som i eksempel 37 bortsettThe procedure is the same as in example 37 except
fra at man brukte 244 g etylklorformat i stedet for benzylbromid. Destillasjonsresiduet av dimetylformamidoppløsningen ble oppløst i kloroform og denne ble vasket flere ganger med vann og så fordampet. Residuet ble oppløst i en blanding av metanol og vann (15:5, volum/volum), og urenhetene ble ut- from using 244 g of ethyl chloroformate instead of benzyl bromide. The distillation residue of the dimethylformamide solution was dissolved in chloroform and this was washed several times with water and then evaporated. The residue was dissolved in a mixture of methanol and water (15:5, volume/volume), and the impurities were
felt. Etter henstand i flere døgn i kulden ble den overlig-gende væske avdestillert og (+) 3',4',5,7~0-tetra(etoksykarbonyl)-cyanidan-3_ol ble innvunnet i et utbytte på 52 %. Smeltepunkt: ca. 65°C. field. After standing for several days in the cold, the overlying liquid was distilled off and (+) 3',4',5,7~0-tetra(ethoxycarbonyl)-cyanidan-3_ol was recovered in a yield of 52%. Melting point: approx. 65°C.
Eksempel 47Example 47
1,45 g (+)-cyanidan-3_ol ble oppløst i 50 ml vannfri aceton, hvoretter man tilsatte 6,91 g vånnfritt kaliumkarbonat, og blandingen ble kokt under tilbakeløp under nitrogen. En oppløsning av 6,26. g p-bromfenakylbromid i 30 ml vannfri aceton ble så tilsatt og koking under tilbake-løp ble fortsatt under røring i 3 timer. Etter avkjøling ble 1.45 g of (+)-cyanidan-3-ol was dissolved in 50 ml of anhydrous acetone, after which 6.91 g of anhydrous potassium carbonate was added, and the mixture was refluxed under nitrogen. A resolution of 6.26. g of p-bromophenacyl bromide in 30 ml of anhydrous acetone was then added and refluxing was continued with stirring for 3 hours. After cooling was
saltene frafiltrert, og oppløsningen fordampet til tørrhet og residuet oppløst i 50 ml kloroform. Kloroformoppløsningen ble vasket tre ganger med 50 ml vann og kloroformen avdrevet, hvorved man fikk 6,23 g av et gult pulveraktig residuum. Dette the salts filtered off, and the solution evaporated to dryness and the residue dissolved in 50 ml of chloroform. The chloroform solution was washed three times with 50 ml of water and the chloroform evaporated, whereby 6.23 g of a yellow powdery residue was obtained. This
ble oppløst i ca. 1000 ml eter. Den uoppløselige delen så was dissolved in approx. 1000 ml of ether. The insoluble part so
vel som noen krystaller som var dannet ved avkjøling ble frafiltrert. Eteroppløsningen ble så konsentrert til 150 ml,' og dette ga 2,9'g av ( + ) 3 ' , 4 ' , 5, 7-0-tetra- (4-bromf enakyl) - cyanidan-3-ol, dvs. et utbytte på 53,8%. Produktet kan om-krystalli.seres fra etanol. Smeltepunkt: 127-129°C. as well as some crystals that had formed on cooling were filtered off. The ether solution was then concentrated to 150 ml, and this gave 2.9 g of (+ ) 3' , 4' , 5, 7-0-tetra-(4-bromoenacyl)-cyanidan-3-ol, i.e. a dividend of 53.8%. The product can be recrystallized from ethanol. Melting point: 127-129°C.
Eksempel 48Example 48
En 3-halset 500 ml rundkolbe-ble utstyrt med en kjøler lukket med et kalsiumkloridrør, en dyse for tilførsel av nitrogen som også muliggjør påsetting av et vakuum, en skilletrakt med trykkutjevner samt en magnetrører. En strøm av nitrogen ble ført gjennom, hvoretter man tilsatte 5,4 g av en 55 % suspensjon av NaH i olje. Denne ble vasket to ganger me.d 50 ml vannfri heksan for å fjerne oljen, og nevnte NaH ble tørket i vakuum. Deretter tilsatte man en oppløsning av 32,5 g (+)' 3 ' ,41,5,7-0-tetrabenzyl-cyanidan-3-ol i 200 ml .vannfri THF. Blandingen ble kokt under tilbakeløp. i 2 timer og så avkjølt på et isbad. Deretter tilsatte man en oppløs-ning av 9 g metoksymetylklorid i 40 ml vannfri'THF dråpevis i løpet av 45 minutter. Blandingen ble deretter rørt over et isbad i 2\ time, og oppløsningen suget gjennom et glass-filter under nitrogen og så filtrert gjennom Cellite. Filtratet ble fordampet til tørrhet ved romtemperatur i en roterende fordamper (Rotavapor). Residuet ble omkrystallisert to ganger fra en blanding av 200 ml aceton og 500 ml propan-2-ol. Utbytte: 25,1 g (72,3 %) av (+) 3',4',5,7-0-tetra-benzy1-3-0-metoksymetyl-cyanidan-3-ol. A 3-necked 500 ml round-bottomed flask was equipped with a condenser closed with a calcium chloride tube, a nozzle for the supply of nitrogen which also enables the application of a vacuum, a separatory funnel with a pressure equalizer and a magnetic stirrer. A stream of nitrogen was passed through, after which 5.4 g of a 55% suspension of NaH in oil was added. This was washed twice with 50 ml of anhydrous hexane to remove the oil, and said NaH was dried in vacuo. A solution of 32.5 g of (+)'3',41,5,7-0-tetrabenzyl-cyanidan-3-ol in 200 ml of anhydrous THF was then added. The mixture was boiled under reflux. for 2 hours and then cooled in an ice bath. A solution of 9 g of methoxymethyl chloride in 40 ml of anhydrous THF was then added dropwise over the course of 45 minutes. The mixture was then stirred over an ice bath for 2 hours, and the solution sucked through a glass filter under nitrogen and then filtered through Cellite. The filtrate was evaporated to dryness at room temperature in a rotary evaporator (Rotavapor). The residue was recrystallized twice from a mixture of 200 ml of acetone and 500 ml of propan-2-ol. Yield: 25.1 g (72.3%) of (+) 3',4',5,7-0-tetra-benzy1-3-0-methoxymethyl-cyanidan-3-ol.
Smeltepunkt: 108-110°C.Melting point: 108-110°C.
Eksempel 49Example 49
En suspensjon av 7,15 g palladiumklorid i 2,4 liter metanol ble hydrogenert i en 5 liters rundkolbe. Hoved-mengden av metanolen ble avhelt, og palladiumet vasket fire ganger med 4 liter metanol og fire ganger med 200 ml etylacetat. Etter siste avhellingen ble palladiumen hensatt under et tynt lag av etylacetat. En oppløsning av 20 g A suspension of 7.15 g of palladium chloride in 2.4 liters of methanol was hydrogenated in a 5 liter round bottom flask. The main amount of the methanol was poured off, and the palladium was washed four times with 4 liters of methanol and four times with 200 ml of ethyl acetate. After the last decanting, the palladium was deposited under a thin layer of ethyl acetate. A solution of 20 g
(+ ) 3 ' , 4 ' , 5, 7_0-tetrabenzyl-3-0-metoksymetyl-cyanidan--3-ol i 2,<1>! liter etylacetat ble så tilsatt, og hydrogeneringen forbruker 3,6 liter hydrogen-og varer i 5 timer. Katalysatoren ble frafiltrert og vasket to ganger med 200 ml etylacetat. De samlede etylacetatoppløsninger ble fordampet til tørrhet, 700 ml etanol ble tilsatt residuet og blandingen fordampet til ca. 100 ml og det hele gjentatt en gang,, deretter to ganger med 700 ml vann. Residuet ble tørket til konstant vekt i vakuum ved romtemperatur. Utbyttet av (+) 3-0-metoksymetyl-cyanidan-3-ol er kvantitativt. Smeltepunkt: 106-109°C. (+ ) 3 ' , 4 ' , 5, 7_0-tetrabenzyl-3-0-methoxymethyl-cyanidan--3-ol in 2,<1>! liters of ethyl acetate were then added, and the hydrogenation consumes 3.6 liters of hydrogen and lasts for 5 hours. The catalyst was filtered off and washed twice with 200 ml of ethyl acetate. The combined ethyl acetate solutions were evaporated to dryness, 700 ml of ethanol was added to the residue and the mixture evaporated to approx. 100 ml and the whole thing repeated once, then twice with 700 ml of water. The residue was dried to constant weight in vacuo at room temperature. The yield of (+) 3-0-methoxymethyl-cyanidan-3-ol is quantitative. Melting point: 106-109°C.
Eksempel 50Example 50
42,5 g (37,9 ml) bortrifluorideterat i 50 ml diglym nylig destillert over natrium ble tilført- en 3-halset rundkolbe A, utstyrt med en dyse for tilførsel av nitrogen, en dråpetrakt samt et evakueringsrør. En oppløsning av 7,65 g natriumborhydrid i 250 ml diglym ble så plassert i dråpetrakten. 42.5 g (37.9 ml) of boron trifluoride etherate in 50 ml of diglyme recently distilled over sodium was added to a 3-necked round-bottomed flask A, equipped with a nozzle for the supply of nitrogen, a dropping funnel and an evacuation tube. A solution of 7.65 g of sodium borohydride in 250 ml of diglyme was then placed in the dropping funnel.
En annen rundkolbe B med fire halser ble utstyrt med en dråpetrakt, et nedadrettet filterrør forbundet med evakueringsdysen på kolbe A, en uavhengig dyse for tilførsel av nitrogen samt en kjøler, hvis øvre ende var forbundet med en vaskekolbe inneholdende aceton ved hjelp av et U-rør inneholdende blå silisiumdioksydgel. En oppløsning av 28 g (+) 3 ',4 ',5,7-0-tetrabenzyl-3-0-(2-cyanoetyl)-cyanidan-3~ol i 500 ml vannfritt THF nylig destillert over natrium ble så plassert i sistnevnte kolbe B. De to kolbene A og B ble utstyrt med en magnetrører, og innholdet i kolbe A ble- kraftig rørt mens- innholdet i kolbe B ble forsiktig rørt. En strøm av tørr nitrogen ble ført gjennom som vasker i suksesjon kolbe A, kolbe B, kjøleren i kolbe B, U-røret og vaskekolben og derfra ut i avtrekket. Oppløsningen av natriumborhydrid ble dråpevis tilsatt kolbe A i løpet av 15time, og'ved kontakt med bortrifluoridet.eratet får man fremstilt borhydrid BjHg som føres med nitrogenstrømmen og over i kolbe B hvor det reduserer 2-cyanoetylgruppen til 3-aminopropyl. Blandingen ble hensatt for reaksjon i 5§time etter at tilførselen av matriumborhydrid var fullstendig. 100 ml absolutt etanol ble så tilsatt gjennom dråpetrakten i kolbe B, det utvikles gasser, men utviklingen- stopper etter et par minutter. Reak sjonsblandingen i kolbe B ble så destillert i vakuum i en roterende 'fordamper (Rotavapor) ved en temperatur under 30°C. Residuet ble oppløst i 200 ml kokende butan-2-ol og hensatt over natten ved 4°C, hvorved det dannes en olje. Butan-2-olen ble avhelt, og denne behandling'med butan-2-ol • ble gjentatt fire ganger. Another round-bottomed flask B with four necks was fitted with a dropping funnel, a downward-directed filter tube connected to the evacuation nozzle of flask A, an independent nozzle for the supply of nitrogen, and a condenser, the upper end of which was connected to a washing flask containing acetone by means of a U- tube containing blue silica gel. A solution of 28 g of (+) 3',4',5,7-0-tetrabenzyl-3-0-(2-cyanoethyl)-cyanidan-3~ol in 500 ml of anhydrous THF freshly distilled over sodium was then placed in the latter flask B. The two flasks A and B were equipped with a magnetic stirrer, and the contents of flask A were vigorously stirred while the contents of flask B were gently stirred. A stream of dry nitrogen was passed through washing in succession flask A, flask B, the cooler in flask B, the U-tube and the washing flask and thence out into the hood. The solution of sodium borohydride was added dropwise to flask A over the course of 15 hours, and on contact with the boron trifluoride, borohydride BjHg is produced, which is carried with the nitrogen stream into flask B where it reduces the 2-cyanoethyl group to 3-aminopropyl. The mixture was allowed to react for 5 hours after the addition of matric borohydride was complete. 100 ml of absolute ethanol was then added through the dropping funnel in flask B, gases are evolved, but the evolution stops after a couple of minutes. The reaction mixture in flask B was then distilled in vacuum in a rotary evaporator (Rotavapor) at a temperature below 30°C. The residue was dissolved in 200 ml of boiling butan-2-ol and left overnight at 4°C, whereby an oil is formed. The butan-2-ol was poured off, and this treatment with butan-2-ol • was repeated four times.
De samlede butanolekstrakter ble fordampet iThe combined butanol extracts were evaporated in
en roterende fordamper, og residuet tørket under høyvakuum over Po2 0r b i 24 timer til konstant vekt. Utbyttet av (+) 3'-4',5,7_0-tetrabenzyl-3-0-(3-aminopropyl)-cyanidan-3-ol er 12,9 g,'dvs. 45,6 %. Smeltepunkt: 93-95°C. a rotary evaporator, and the residue dried under high vacuum over Po2 0r b for 24 hours to constant weight. The yield of (+) 3'-4',5,7_0-tetrabenzyl-3-0-(3-aminopropyl)-cyanidan-3-ol is 12.9 g, i.e. 45.6%. Melting point: 93-95°C.
Eksempel 51Example 51
En suspensjon i 700 ml nylig destillert dimetylformamid av 65,5 g av en 55 % dispersjon av natriumhydrid i olje (36 g NaH) ble fremstilt under nitrogen og under kraftig røring. Suspensjonen ble avkjølt til mellom -5 og 0°C ved hjelp av et kjølebad. En'oppløsning av 650 g ( + ) 3',4',5,7-0-tetrabenzyl-cyanidan-3-ol i 3800 ml nylig destillert dimetylformamid ble langsomt tilsatt den avkjølte suspensjonen på en slik måte at temperaturen holdt seg innenfor nevnte område. 15 minutter etter tilførselen ble 178,5 ml,.;dvs. 257 g benzylbromid tilsatt i løpet av 45 minutter slik at temperaturen holdt seg under 0°C. Denne temperatur ble så holdt i ca. 30 minutter, og ble så hevet til romtemperatur under røring. Dimetylf ormamidet ble fjernet'' ved destillasjon under et middels vakuum ved 60°C i en roterende fordamper, og residuet ble så oppløst i 3 liter kloroform ved romtemperatur, vasket tre ganger med 2 liter destillert vann, filtrert og så fordampet. Residuet ble oppløst i 1750 ml varm benzen og petroleter A suspension in 700 ml of freshly distilled dimethylformamide of 65.5 g of a 55% dispersion of sodium hydride in oil (36 g NaH) was prepared under nitrogen and with vigorous stirring. The suspension was cooled to between -5 and 0°C using a cooling bath. A solution of 650 g of ( + ) 3',4',5,7-0-tetrabenzyl-cyanidan-3-ol in 3800 ml of freshly distilled dimethylformamide was slowly added to the cooled suspension in such a way that the temperature remained within said area. 15 minutes after the supply, 178.5 ml,.;i.e. 257 g of benzyl bromide added during 45 minutes so that the temperature remained below 0°C. This temperature was then maintained for approx. 30 minutes, and was then raised to room temperature with stirring. The dimethylformamide was removed by distillation under a medium vacuum at 60°C in a rotary evaporator, and the residue was then dissolved in 3 liters of chloroform at room temperature, washed three times with 2 liters of distilled water, filtered and then evaporated. The residue was dissolved in 1750 ml of hot benzene and petroleum ether
(BP 30-45°C) ble langsomt tilsatt under oppvarming og røring inntil blandingen blir turbid (ca. 1 liter petroleter er nød-vendig) . Praktisk talt rent ( + ) 3, 3 ' , 4 ' , 5 ,7-0-pentabenzyl-cyanidan-3-0I ble oppnådd ved avkjøling i et utbytte på 710 g, (BP 30-45°C) was slowly added while heating and stirring until the mixture becomes turbid (approx. 1 liter of petroleum ether is necessary). Practically pure (+) 3,3',4',5,7-0-pentabenzyl-cyanidan-3-0I was obtained by cooling in a yield of 710 g,
.dvs. 96. 56 - Smeltepunkt: 119-121°C..ie 96. 56 - Melting point: 119-121°C.
Eksempel 52Example 52
0,96 g av en 55 % dispersjon av natriumhydrid i olje (0,53 g NaH) ble tilsatt en 3-halset 50 ml rundkolbe utstyrt med en 25 ml dråpetrakt med trykkutjevner, et nitrogen- 0.96 g of a 55% dispersion of sodium hydride in oil (0.53 g NaH) was added to a 3-necked 50 ml round-bottomed flask fitted with a 25 ml dropping funnel with pressure equaliser, a nitrogen-
tilførselsrør og en kjøler lukket med et kalsiumkloridrør, og det hele tørket under oppvarming i en strøm av nitrogen. Under avkjøling, mens man opprettholdt en svak nitrogenstrøm, ble 10 ml nylig destillert dimetylsulfoksyd tilsatt, og blandingen ble rørt ved romtemperatur ved hjelp av en magnetisk rører. En oppløsning av 1,45 g (+) cyanidan-3-ol i 15 ml nylig destillert dimetylsulfoksyd ble så dråpevis tilsatt fra dråpetrakten under røring ved romtemperatur. Hydrogen ble utviklet. feed tube and a condenser closed with a calcium chloride tube, and the whole dried under heating in a stream of nitrogen. While cooling, while maintaining a gentle stream of nitrogen, 10 mL of freshly distilled dimethylsulfoxide was added and the mixture was stirred at room temperature using a magnetic stirrer. A solution of 1.45 g (+) cyanidan-3-ol in 15 ml of freshly distilled dimethylsulfoxide was then added dropwise from the dropping funnel with stirring at room temperature. Hydrogen was developed.
30 minutter etter tilsetningen av oppløsningen, tilsatte man 30 minutes after the addition of the solution, was added
en oppløsning av 2,74 ml (2,99 g) metoksyetoksymetylklorid i a solution of 2.74 mL (2.99 g) of methoxyethoxymethyl chloride i
10 ml nylig destillert dimetylsulfoksyd, noe som skjer ved 10 ml of freshly distilled dimethylsulfoxide, which occurs at
hjelp av dråpetrakten. 30 minutter etter dette blir hele oppløsningen helt over 150 ml vann mettet med natriumklorid og pH justeres til'7- Man får et brunaktig-svart kåket bunnfall, og dette ble ekstrahert tre ganger med 100 ml toluen. Toluenoppløsningen ble vasket tre ganger med 50 ml vann, hvoretter toluenen ble fordampet. Man fikk 2,88 g av et oljeaktig brunrødt residuum..Oljen ble ekstrahert ti ganger med 100 ml n-heksan under koking med tilbakeløp. De samlede n-heksanoppløsninger gir etter avkjøling 1,53 g (+) 3',4',5,7-■ O-tetra(metoksyetoksymetyl)-cyanidan-3"-ol i form av en gul-aktig olje. Dekomponering ved 150°C/0,02 mnrHg.. using the dropper. 30 minutes after this, the entire solution is completely saturated with sodium chloride over 150 ml of water and the pH is adjusted to 7. A brownish-black caked precipitate is obtained, and this was extracted three times with 100 ml of toluene. The toluene solution was washed three times with 50 ml of water, after which the toluene was evaporated. 2.88 g of an oily brown-red residue was obtained. The oil was extracted ten times with 100 ml of n-hexane under reflux. The combined n-hexane solutions give, after cooling, 1.53 g (+) 3',4',5,7-■ O-tetra(methoxyethoxymethyl)-cyanidan-3"-ol in the form of a yellowish oil. Decomposition by 150°C/0.02 mnrHg..
Eksempel 53Example 53
En oppløsning av 52 g (+) 3',4',5,7-0-tetraben-zyl-cyanidan-3-ol .i 300 ml vannfri pyridin ble tilsatt en 4-halset 50 ml rundkolbe utstyrt med dråpetrakt med trykkutjevner, en kjøler lukket med et kalsiumkloridrør, en dyse for tilførsel av nitrogen og en magnetrører. Med røring under nitrogen ble 18 g etylklorformat tilsatt dråpevis gjennom dråpetrakten, og blandingen ble holdt på 60°C i 7 timer. Den ble så avkjølt og blandet med 500 ml av en blanding av vann og is. Det dannede bunnfall ble frafiltrert og blandet med 500 ml vannfri 0,5M NaHCO^. Bunnfallet ble frafiltrert, vasket med vann og tørket i vakuum over natten. Det ble så oppløst i 550 ml aceton, filtrert og filtratet oppvarmet under svak koking med tilbakeløp i 3,3 liter etanol. Etter at blandingen var hensatt ved romtemperatur i 2 døgn ble bunnfallet frafiltrert og omkrystallisert fra en blanding av 250 ml aceton og 1,5 liter' etanol. Etter tørking fikk man A solution of 52 g of (+) 3',4',5,7-0-tetraben-zyl-cyanidan-3-ol in 300 ml of anhydrous pyridine was added to a 4-necked 50 ml round-bottomed flask equipped with a dropping funnel with a pressure equaliser, a cooler closed with a calcium chloride tube, a nozzle for supplying nitrogen and a magnetic stirrer. With stirring under nitrogen, 18 g of ethyl chloroformate was added dropwise through the dropping funnel, and the mixture was kept at 60°C for 7 hours. It was then cooled and mixed with 500 ml of a mixture of water and ice. The precipitate formed was filtered off and mixed with 500 ml of anhydrous 0.5 M NaHCO 3 . The precipitate was filtered off, washed with water and dried in vacuum overnight. It was then dissolved in 550 ml of acetone, filtered and the filtrate heated under gentle reflux in 3.3 liters of ethanol. After the mixture had been left at room temperature for 2 days, the precipitate was filtered off and recrystallized from a mixture of 250 ml of acetone and 1.5 liters of ethanol. After drying, one got
( + ) 3'',4' ,5,7-0-tetrabenzyl-3_0-etoksykarbonyl-cyanidan-3-ol i et utbytte på 42 g, dvs. 73 Smeltepunkt: 33-84°C.. ( + ) 3'',4',5,7-0-tetrabenzyl-3_0-ethoxycarbonyl-cyanidan-3-ol in a yield of 42 g, i.e. 73 Melting point: 33-84°C..
Eksempel 34Example 34
En palladiumkatalysator ble fremstilt fra 4 .g palladiumklorid som i eksempel 1.- En oppløsning av 15 g (0,021 mol) av ( + ) 3',4 *,5,7-0-tetrabenzyl-3-0-etoksykarbonyl-cyanidan-3-ol i 600 ml etylacetat ble så tilsatt. Hydrogenering ble.utført i 2\ time og man forbrukte 2,33 liter A palladium catalyst was prepared from 4 g of palladium chloride as in example 1.- A solution of 15 g (0.021 mol) of ( + ) 3',4 *,5,7-0-tetrabenzyl-3-0-ethoxycarbonyl-cyanidan- 3-ol in 600 ml of ethyl acetate was then added. Hydrogenation was carried out for 2 hours and 2.33 liters were consumed
•hydrogen. Katalysatoren ble frafiltrert, vasket to ganger med 200 ml etylacetat og de samlede etylacetatoppløsninger ble fordampet til tørrhet. 500 ml etanol ble tilsatt residuet og fordampet til ca. 50 ml, hvoretter man tilsatte 200 ml etanol og 250 ml vann og fordampet det hele til 50 ml •hydrogen. The catalyst was filtered off, washed twice with 200 ml of ethyl acetate and the combined ethyl acetate solutions were evaporated to dryness. 500 ml of ethanol was added to the residue and evaporated to approx. 50 ml, after which 200 ml of ethanol and 250 ml of water were added and the whole evaporated to 50 ml
og igjen tilsatte man 500 ml vann og fordampet det hele tiland again 500 ml of water was added and the whole thing evaporated
50 ml. Dette ble .gjentatt, og bunnfallet ble frafiltrert50 ml. This was repeated, and the precipitate was filtered off
og tørket under høyvakuum til konstant vekt. Man oppnåddeand dried under high vacuum to constant weight. One achieved
7,4 g (97 %) av (+) 3_0-etoksykarbonyl-cyanidan-3-ol. Smeltepunkt: 123-124°C. 7.4 g (97%) of (+) 3_O-ethoxycarbonyl-cyanidan-3-ol. Melting point: 123-124°C.
Eksempel 55Example 55
En oppløsning av 65 g (+) 3',4',5,7-0-tetra-benzyl-cyanidan-3-ol i 350 ml vannfri pyridin- ble tilsatt en' 3-halset 750 ml rundkolbe utstyrt med dråpetrakt med trykkutjevner, en kjøler lukket med kalsiumkloridrør, en dyse for tilførsel av nitrogen og en magnetrører. Oppløsningen ble oppvarmet til 60°C og under nitrogen tilsatte..man 31 g fenylacetylklorid dråpevis. Blandingen ble hensatt under samme betingelser i 6 timer og så avkjølt og helt over i 1 kg knust is. Blandingen ble hensatt inntil isen var smeltet,' vannet ble så helt av for å isolere det kakede bunnfallet. Dette ble vasket to ganger med 1- liter vandig IN NaHCO^ og A solution of 65 g of (+) 3',4',5,7-0-tetra-benzyl-cyanidan-3-ol in 350 ml of anhydrous pyridine was added to a 3-necked 750 ml round-bottomed flask equipped with a dropping funnel with pressure equalization , a cooler closed with calcium chloride tubes, a nozzle for supplying nitrogen and a magnetic stirrer. The solution was heated to 60°C and, under nitrogen, 31 g of phenylacetyl chloride were added dropwise. The mixture was left under the same conditions for 6 hours and then cooled and poured into 1 kg of crushed ice. The mixture was allowed to stand until the ice had melted, then the water was poured off to isolate the caked precipitate. This was washed twice with 1 liter of aqueous IN NaHCO^ and
så to ganger med 1 liter vann. Det ble tørket i vakuum over natten og produktet omkrystallisert fra 1,2 liter metoksyetanol. Etter tørking fikk man (+) 3',4',5,7~0-tetrabenzyl-3-0-fenylacetyl-cyariidan-3-oli i et utbytte på 57,4 g (75 %). - Smeltepunkt: 83-85°C. so twice with 1 liter of water. It was dried in vacuum overnight and the product recrystallized from 1.2 liters of methoxyethanol. After drying (+) 3',4',5,7~0-tetrabenzyl-3-0-phenylacetyl-cyariidan-3-ol was obtained in a yield of 57.4 g (75%). - Melting point: 83-85°C.
Eksempel 56Example 56
6,5 g (+) 3<1>,4',5,7_0-tetrabenzyl-cyanidan-3-ol, 1,9 g 2,4-dinitrofluorbenzen, 3.g kaliumfluorid, 500 mg 6.5 g (+) 3<1>,4',5,7_0-tetrabenzyl-cyanidan-3-ol, 1.9 g 2,4-dinitrofluorobenzene, 3.g potassium fluoride, 500 mg
l8-krone-6 og 100 ml vannfri tetrahydrofuran ble tilsatt en 2-halset 250 ml rundkolbe utstyrt med kjøler lukket med et kalsiumkloridrør, en dyse for tilførsel av nitrogen og en magnetrørter. Blandingen ble kokt under tilbakeløp under nitrogen i 24 timer. Etter avkjøling ble det tilsatt 250 ml toluen, og blandingen ble vasket fire ganger med 300 ml av en mettet vandig oppløsning av NaCl. Den organiske fasen ble tørket over magnesiumsulfat og oppløsningsmidlene fjernet ved fordampning i vakuum. Residuet ble vasket to ganger med 25 ml petroleter (BP. 30-45°C), oppløst i 65 ml kloroform og så langsomt tilsatt 325 ml kokende absolutt etanol.. Blandingen ble avkjølt og oljen ble avhelt ved.dekantering. Den ble vasket med litt etanol og tørket.under høyvakuum i 24 timer. Man fikk 5,1 g (62 %) fast (+) 3 ' , 4 ' , 5 ,7-0-tetrabenzyl-'3-0-(2,4-dinitrofenyl)-cyanidan-3-ol. Smeltepunkt: 6l-62°C. 18-crown-6 and 100 ml of anhydrous tetrahydrofuran were added to a 2-necked 250 ml round bottom flask equipped with a condenser closed with a calcium chloride tube, a nozzle for supplying nitrogen and a magnetic stirrer. The mixture was refluxed under nitrogen for 24 hours. After cooling, 250 ml of toluene was added, and the mixture was washed four times with 300 ml of a saturated aqueous solution of NaCl. The organic phase was dried over magnesium sulfate and the solvents removed by evaporation in vacuo. The residue was washed twice with 25 ml of petroleum ether (BP. 30-45°C), dissolved in 65 ml of chloroform and then slowly added with 325 ml of boiling absolute ethanol. The mixture was cooled and the oil was decanted off. It was washed with a little ethanol and dried under high vacuum for 24 hours. 5.1 g (62%) of solid (+) 3' , 4' , 5,7-0-tetrabenzyl-'3-0-(2,4-dinitrophenyl)-cyanidan-3-ol were obtained. Melting point: 6l-62°C.
Eksempel 57Example 57
400 mg av en 55 % dispersjon av natriumhydrid i olje ble tilsatt en 3-halset 50 ml rundkolbe utstyrt med kjøler, lukket med kalsiumkloridrør, en dyse for tilførsel av nitrogen, en membranlukking og en magnetrører. En sterk strøm av nitrogen ble ført gjennom i 5 minutter, hvoretter nitrogentilførselen ble redusert og man tilsatte 5 ml vannfri tetrahydrofuran nylig■destillert over natrium. Blandingen'ble holdt på 40°C 400 mg of a 55% dispersion of sodium hydride in oil was added to a 3-necked 50 ml round bottom flask equipped with a condenser, closed with calcium chloride tubing, a nozzle for the supply of nitrogen, a membrane closure and a magnetic stirrer. A strong stream of nitrogen was passed through for 5 minutes, after which the nitrogen supply was reduced and 5 ml of anhydrous tetrahydrofuran freshly distilled over sodium was added. The mixture was kept at 40°C
og ved hjelp av en sprøyte ble først en oppløsning av 0,5 ml nylig destillert metyljodid i 10 ml.vannfri tetrahydrofuran tilsatt, hvoretter man tilsatte en oppløsning av 2,3 g 3',4',5,7,-0-tetrametoksymetyl-cyanidan-3-ol i 10 ml vannfri tetrahydrofuran. Blandingen ble rørt ved 40°C i en time og så filtrert. 20 ml toluen og 40 ml vann ble tilsatt, og det hele rørt og så hensatt for utskilling av den organiske fase som igjen ble vasket med 10 ml vann. De samlede vandige faser ble ekstrahert med 30 ml metylenklorid. De samlede organiske ekstrakter ble så tørket 'over magnesiumsulfat, filtrert og så fordampet i en roterende fordamper, og man fikk en olje som ikke stivnet. Denne ble oppløst i 55 ml metanol og behandlet med aktivert karbon og etter fordampning av metanolen ble oljen ekstrahert to ganger med 25 ml petrol- and using a syringe, a solution of 0.5 ml of recently distilled methyl iodide in 10 ml of anhydrous tetrahydrofuran was first added, after which a solution of 2.3 g of 3',4',5,7,-0-tetramethoxymethyl was added -cyanidan-3-ol in 10 ml of anhydrous tetrahydrofuran. The mixture was stirred at 40°C for one hour and then filtered. 20 ml of toluene and 40 ml of water were added, and the whole was stirred and then set aside for separation of the organic phase, which was again washed with 10 ml of water. The combined aqueous phases were extracted with 30 ml of methylene chloride. The combined organic extracts were then dried over magnesium sulfate, filtered and then evaporated in a rotary evaporator to give an oil which did not solidify. This was dissolved in 55 ml of methanol and treated with activated carbon and, after evaporation of the methanol, the oil was extracted twice with 25 ml of petrol
eter (BP 50-70°C) under oppvarming. De samlede petroleter-fraksjoner ble fordampet i en roterende fordamper ved rom- ether (BP 50-70°C) under heating. The combined petroleum ether fractions were evaporated in a rotary evaporator at room
temperatur, og den gjenværende olje som består av (+) 3',4'-5,7-0-tetra(metoksymetyl)-3-0-metyl-cyanidan-3-ol ble tørket under høyvakuum til konstant vekt. temperature, and the remaining oil consisting of (+) 3',4'-5,7-0-tetra(methoxymethyl)-3-0-methyl-cyanidan-3-ol was dried under high vacuum to constant weight.
IR (Nujol) S (cm<-1>): 2920, l6l5, 1590, 1507, 1494 , 1440, 1400, 1260, 1220, 1155, 1070, 1000, 920, 822.'IR (Nujol) S (cm<-1>): 2920, l6l5, 1590, 1507, 1494 , 1440, 1400, 1260, 1220, 1155, 1070, 1000, 920, 822.'
Eksempel 58Example 58
En 1 liters rundkolbe ble utstyrt med en rører, et termometer, en kjøler lukket med et silisiumdioksydgel-rør, en dyse for tilførsel av nitrogen og en 250 ml dråpetrakt, og apparatet ble tørket ved 100°C i vakuum over natten. Den ble så oppvarmet på et termostatstyrt oljebad. 110 g tørr kaliumkarbonat ble så tilsatt under en svak nitrogen-strøm, deretter fulgte 250 ml tørr dimetylformamid. En opp-løsning av 29,0 g .( + )-cyanidan-3_ol i 250 ml tørr dimetyl-■formamid var tørket.over natten på en molekylær sil (4 Å),' A 1 liter round bottom flask was equipped with a stirrer, a thermometer, a condenser closed with a silica gel tube, a nozzle for supplying nitrogen and a 250 ml dropping funnel, and the apparatus was dried at 100°C in vacuum overnight. It was then heated in a thermostatically controlled oil bath. 110 g of dry potassium carbonate were then added under a gentle stream of nitrogen, followed by 250 ml of dry dimethylformamide. A solution of 29.0 g of (+)-cyanidan-3-ol in 250 ml of dry dimethylformamide was dried overnight on a molecular sieve (4 Å).
og ble'så tilsatt, hvoretter man: tilsatte 71,25 ml benzylbromid fortynnet i 100 ml tørr dimetylformamid.' Blandingen ble holdt på 100°C i 5§time under røring og gjennomføring av nitrogen. Suspensjonen ble filtrert varm, og filtratet fordampet i vakuum i en roterende fordamper ved 80°C og deretter oppløst i 250 ml kloroform. Kloroformoppløsningen ble filtrert og overført til en 1 liters skilletrakt og der ble den vasket tre ganger med 250 ml vann og så tørket over magnesiumsulfat og fordampet til tørrhet.. Residuet ble oppløst i 750 ml karbontetraklorid under koking med tilbakeløp. Det sammenkakede brune residuum ble utskilt og hensatt for utkrystallisering ved røring med normal temperatur ved avkjøling fra tid til annen i et kjøleskap. Man fikk 31,2 g av et produkt som var identisk med. det som er angitt i eksempel 37. Smeltepunkt:'l44-l45°C. and was then added, after which: 71.25 ml of benzyl bromide diluted in 100 ml of dry dimethylformamide was added. The mixture was kept at 100°C for 5 hours while stirring and passing nitrogen. The suspension was filtered hot, and the filtrate evaporated in vacuo in a rotary evaporator at 80°C and then dissolved in 250 ml of chloroform. The chloroform solution was filtered and transferred to a 1 liter separatory funnel where it was washed three times with 250 ml of water and then dried over magnesium sulfate and evaporated to dryness. The residue was dissolved in 750 ml of carbon tetrachloride under reflux. The caked brown residue was separated and set aside for crystallization by stirring at normal temperature with cooling from time to time in a refrigerator. 31.2 g of a product identical to that stated in example 37. Melting point: 144-145°C.
Eksempel 59Example 59
Palladium-svart ble fremstilt fra 15 g palladiumklorid som i eksempel 1. Man tilsatte så en oppløsning av 40 g (+) 3',4',5,7-0-tetrabenzyl-3-O-fenylacetyl-cyanidan-3-ol i 2,25 liter etylacetat. Blandingen ble hydrogenert i Palladium black was prepared from 15 g of palladium chloride as in example 1. A solution of 40 g of (+) 3',4',5,7-0-tetrabenzyl-3-O-phenylacetyl-cyanidan-3-ol was then added in 2.25 liters of ethyl acetate. The mixture was hydrogenated in
3 timer og 1,25 liter hydrogen ble brukt. Katalysatoren ble frafiltrert og vasket to ganger'med 300 ml etylacetat, og de samlede etylacetatoppløsninger ble fordampet til tørrhet under redusert trykk. 500 ml etanol ble tilsatt residuet og fordampet under redusert trykk til ca. 50 ml, og dette ble gjentatt en gang. 250 ml etanol og 250 ml vann ble tilsatt og fordampet til 50 ml. 500 ml vann b.le tilsatt og fordampet igjen til 50 ml, hvoretter 500 ml vann ble tilsatt igjen og fordampet under redusert trykk. Residuet ble tørket til konstant vekt under høyvakuum over natten, noe som ga (+) 3-0-fenylacetylcyanidan-3-ol. Smeltepunkt: 102-103°C. 3 hours and 1.25 liters of hydrogen were used. The catalyst was filtered off and washed twice with 300 ml of ethyl acetate, and the combined ethyl acetate solutions were evaporated to dryness under reduced pressure. 500 ml of ethanol was added to the residue and evaporated under reduced pressure to approx. 50 ml, and this was repeated once. 250 ml of ethanol and 250 ml of water were added and evaporated to 50 ml. 500 ml of water was added and evaporated again to 50 ml, after which 500 ml of water was added again and evaporated under reduced pressure. The residue was dried to constant weight under high vacuum overnight to give (+) 3-O-phenylacetylcyanidan-3-ol. Melting point: 102-103°C.
Eksempel 60Example 60
En oppløsning av 24,8 g nikotinoylklorid iA solution of 24.8 g of nicotinoyl chloride i
100 ml vannfri pyridin ble tilsatt en 3-halset 250 ml rundt-kolbe utstyrt med en dråpetrakt med trykkutjevner, en kjøler' lukket med et kalsiumkloridrør, en dyse for tilførsel av nitrogen og en magnetisk rører. 56 g (+) 3',4',5,7_0-tetra-benzyl-cyanidan-3-ol i fire porsjoner, en på 26 g og tre på 10 g ble tilsatt dråpevis under røring og under nitrogen, 100 ml of anhydrous pyridine was added to a 3-necked 250 ml round bottom flask equipped with a dropping funnel with pressure equaliser, a condenser closed with a calcium chloride tube, a nozzle for the supply of nitrogen and a magnetic stirrer. 56 g of (+) 3',4',5,7_0-tetra-benzyl-cyanidan-3-ol in four portions, one of 26 g and three of 10 g were added dropwise with stirring and under nitrogen,
og det var en time mellom hver tilsetning. Blandingen ble holdt på'60°C i 20 timer. Etter avkjøling ble oppløsningen helt over i 1 kg is og hensatt der inntil isen var smeltet. Væsken ble helt av og man fikk et kåket bunnfall. Dette ble vasket to ganger med vann, to ganger med IN .riatriumbikarbonat, og to ganger med vann. Den uoppløselige delen som enda var en slags kake, ble tørket i vakuum over natten. 120 ml aceton ble tilsatt, og blandingen rørt i 10 minutter og hensatt i 2 timer ved -30°C. Bunnfallet ble' frafiltrert og igjen behandlet med aceton på samme måten. Produktet ble omkrystallisert fra 950 ml metoksyetanol, og 1,9 liter absolutt etanol. Man fikk fremstilt '(+) 3',4',5,7-0-tetrabenzyl-3-0-nikotinoy1-cyanidan-3-ol. Smeltepunkt: 137-138°C. and there was an hour between each addition. The mixture was kept at 60°C for 20 hours. After cooling, the solution was poured into 1 kg of ice and left there until the ice had melted. The liquid ran off completely and a lumpy precipitate was obtained. This was washed twice with water, twice with IN sodium bicarbonate, and twice with water. The insoluble part, which was still a kind of cake, was dried in vacuum overnight. 120 ml of acetone was added, and the mixture was stirred for 10 minutes and left for 2 hours at -30°C. The precipitate was filtered off and again treated with acetone in the same way. The product was recrystallized from 950 ml of methoxyethanol, and 1.9 liters of absolute ethanol. '(+) 3',4',5,7-0-tetrabenzyl-3-0-nicotinoyl-cyanidan-3-ol was produced. Melting point: 137-138°C.
Eksempel 6lExample 6l
1,5 g ( + ) 3' ,4-' ,5,7-0-tetrabenzyl-3-0-nikotinoyl-cyanidan-3-ol.ble hydrogenert i nærvær av 100 ml vannfri etanol, 300 mg trifluormetansulfonsyre og 1,0 g 10 % palladium på aktivert karbon ved 50°C. Reaksjonen varte i 5 timer og 500 ml hydrogen ble brukt. Blandingen'ble avkjølt, så filtrert og filtratet fordampet til tørrhet. 100 ml destillert vann ble tilsatt og fordampet til et volum på ca. 10 ml. Dette ble gjentatt tre ganger og produktet ble slå lyofilisert. Man 1.5 g (+ ) 3' ,4-' ,5,7-0-tetrabenzyl-3-0-nicotinoyl-cyanidan-3-ol. were hydrogenated in the presence of 100 ml of anhydrous ethanol, 300 mg of trifluoromethanesulfonic acid and 1, 0 g 10% palladium on activated carbon at 50°C. The reaction lasted for 5 hours and 500 ml of hydrogen was used. The mixture was cooled, then filtered and the filtrate evaporated to dryness. 100 ml of distilled water was added and evaporated to a volume of approx. 10 ml. This was repeated three times and the product was flash lyophilized. Mon
.fikk et kvantitativt utbytte av.(+) 3-0-(3-piperidylkarbonyl)- .got a quantitative yield of.(+) 3-0-(3-piperidylcarbonyl)-
cyanidan-3-ol-trifluormetansulfonat. (Blanding av 2 diastereo-lsomerer. ) Smeltepunkt: 125-130 C (ikke skarpt). cyanidan-3-ol trifluoromethanesulfonate. (Mixture of 2 diastereo-lisomers. ) Melting point: 125-130 C (not sharp).
Eksempel 62Example 62
5,2 g (+) 3',4',5,7-0-tetrabenzyl-cyanidan-3-ol og 200 ml toluen ble tilsatt en 500 ml rundkolbe utstyrt med en kjøler og en rører. Blandingen ble holdt på 90°C inntil man fikk en oppløsning, hvoretter man tilsatte 200 ml av en 50 % oppløsning av natriumhydroksyd, 2,7 g tetrabutylammonium-bisulfat og 3,0 g 2-cykloheksyletylbromid. Temperaturen ble holdt på 90°C i 10 timer under kraftig røring, hvoretter man tilsatte 1,5 g 2-cykloheksyletylbromid.'Temperaturen ble holdt på 90°C i 15 timer under røring, og blandingen ble så hensatt til avkjøling. To faser skilte seg ut, og den organiske fasen ble vasket tre ganger med 250 ml vann. Toluenen ble tørket over magnesiumsulfat og fordampet til tørrhet. Residuet ble oppløst i 60 ml absolutt etanol på 60°C, rørt i 15 minutter og den uoppløselige delen frafiltrert i varmen. Dette bunnfall ble. tørket i vakuum og så omkrystallisert fra 80 ml metoksyetanol.. Man fikk fremstilt (+) 3',V,5,7-0-tetrabenzy1-3-0-(2-cykloheksylety1)-cyanidan-3-ol. Smeltepunkt: 110°C. 5.2 g of (+) 3',4',5,7-0-tetrabenzyl-cyanidan-3-ol and 200 ml of toluene were added to a 500 ml round bottom flask equipped with a condenser and a stirrer. The mixture was kept at 90°C until a solution was obtained, after which 200 ml of a 50% solution of sodium hydroxide, 2.7 g of tetrabutylammonium bisulphate and 3.0 g of 2-cyclohexylethyl bromide were added. The temperature was kept at 90°C for 10 hours with vigorous stirring, after which 1.5 g of 2-cyclohexylethyl bromide was added. The temperature was kept at 90°C for 15 hours with stirring, and the mixture was then set aside to cool. Two phases separated and the organic phase was washed three times with 250 ml of water. The toluene was dried over magnesium sulfate and evaporated to dryness. The residue was dissolved in 60 ml of absolute ethanol at 60°C, stirred for 15 minutes and the insoluble part filtered off in the heat. This precipitate became dried in vacuum and then recrystallized from 80 ml of methoxyethanol. (+) 3',V,5,7-0-tetrabenzy1-3-0-(2-cyclohexylethyl1)-cyanidan-3-ol was prepared. Melting point: 110°C.
Eksempel 63Example 63
1,0 g (+) 3',V,5,7-0-tetrabenzyl-3-0-(2-cyklo-heksylety1)-cyanidan-3-ol oppløst i 90 ml etylacetat ble hydrogenert i nærvær av 400 mg 10 % palladium på aktivert karbon. l80 ml hydrogen ble forbrukt. Blandingen ble filtrert, og oppløsningsmidlet og toluenen ble fordampet. Det oljeaktige residuum ble oppløst i 100 ml etanol, fordampet til nesten tørrhet og 100 ml etanol igjen tilsatt og igjen fordampet. 50 ml etanol o.g 50 ml vann ble tilsatt, og blandingen ble fordampet. Residuet ble oppløst i 150 ml vann som ble fordampet til tørrhet og residuet ble tørket over fosforpenta-oksyd under høyvakuum til konstant vekt. Man fikk et kvantitativt utbytte av (+) 3-0-(2-cykloheksylety1)-cyanidan-3-ol. Smeltepunkt: 99-102°C. 1.0 g of (+) 3',V,5,7-0-tetrabenzyl-3-0-(2-cyclohexylethyl)-cyanidan-3-ol dissolved in 90 ml of ethyl acetate was hydrogenated in the presence of 400 mg of 10 % palladium on activated carbon. 180 ml of hydrogen were consumed. The mixture was filtered and the solvent and toluene were evaporated. The oily residue was dissolved in 100 ml of ethanol, evaporated to near dryness and 100 ml of ethanol again added and evaporated again. 50 ml of ethanol and 50 ml of water were added, and the mixture was evaporated. The residue was dissolved in 150 ml of water which was evaporated to dryness and the residue was dried over phosphorus pentaoxide under high vacuum to constant weight. A quantitative yield of (+) 3-O-(2-cyclohexylethyl)-cyanidan-3-ol was obtained. Melting point: 99-102°C.
Eksempel SkExample Sk
65 g ( + )■ 3 ' , 4 ' ,5,7-0-tetrabenzyl-cyanidan-3~ol65 g ( + )■ 3 ' , 4 ' ,5,7-0-tetrabenzyl-cyanidan-3~ol
og 2 liter toluen ble tilsatt en 6 liters rundkolbe utstyrt med en kjøler og en mekanisk rører. Oppvarming■ble utført inntil and 2 liters of toluene were added to a 6 liter round bottom flask equipped with a condenser and a mechanical stirrer. Heating■was carried out until
man fikk en oppløsning, hvoretter man tilsatte 1,5 litera solution was obtained, after which 1.5 liters were added
50 % natriumhydroksydoppløsning, 3-4 g tetrabutylammonium-bisulfat og 40 g 3-fenyl-propylbromid. Blandingen ble holdt på 50°C under røring i 48 timer, og så avkjølt til romtemperatur. De to fasene ble adskilt, og den organiske fasen vasket tre ganger- med 1 liter vann. Toluenfasen ble tørket over magnesiumsulfat og fordampet. Det oljeaktige residuum ble vasket med 200 ml petroleter og så med 150 ml vannfri etanol. Produktet ble omkrystallisert fra 600 ml metoksyetanol. Man fikk fremstilt (+) 3',4',5,7-0-tetrabensyl-3-0-(3-fenylpropy1)-cyanidan-3-ol. Smeltepunkt: 96-97°C 50% sodium hydroxide solution, 3-4 g of tetrabutylammonium bisulphate and 40 g of 3-phenyl-propyl bromide. The mixture was kept at 50°C with stirring for 48 hours, and then cooled to room temperature. The two phases were separated, and the organic phase was washed three times with 1 liter of water. The toluene phase was dried over magnesium sulfate and evaporated. The oily residue was washed with 200 ml of petroleum ether and then with 150 ml of anhydrous ethanol. The product was recrystallized from 600 ml of methoxyethanol. (+) 3',4',5,7-0-tetrabenzyl-3-0-(3-phenylpropyl)-cyanidan-3-ol was produced. Melting point: 96-97°C
Eksempel 65Example 65
40,0 g (+) 3',4',5,7-0-tetrabenzyl-3-0-(3-fenylpropyl)-cyanidan-3-ol oppløst i 3 liter etylacetat ble hydrogenert i nærvær av 16 g 10 % palladium på aktivert karbon. Reaksjonen varer i 6 timer og 6,2 liter hydrogen ble brukt. Blandingen ble filtrert og oppløsningsmidlet og toluenen fordampet. 250 ml vann ble tilsatt og blandingen ble rørt og fordampet i vakuum inntil det faste stoff koa-gulerer. Filtrering ble utført, bunnfallet vasket med vann.-Etter tørking til konstant vekt fikk man fremstilt (+) 3-0-(3-fenylpropyl)-cyanidan-3-ol. Smeltepunkt: 190-192°C. 40.0 g of (+) 3',4',5,7-0-tetrabenzyl-3-0-(3-phenylpropyl)-cyanidan-3-ol dissolved in 3 liters of ethyl acetate was hydrogenated in the presence of 16 g of 10% palladium on activated carbon. The reaction lasts for 6 hours and 6.2 liters of hydrogen were used. The mixture was filtered and the solvent and toluene evaporated. 250 ml of water was added and the mixture was stirred and evaporated in vacuo until the solid coagulated. Filtration was carried out, the precipitate washed with water.-After drying to constant weight (+) 3-0-(3-phenylpropyl)-cyanidan-3-ol was produced. Melting point: 190-192°C.
Eksempel 66Example 66
52 g av 3 ', 4 ' , 5, 7-0-tetrabenzy 1-cyanidan-3-ol og 500 ml toluen ble tilsatt en 3 liters rundkolbe utstyrt med en kjøler og en mekanisk rører. Blandingen ble oppvarmet inntil man fikk oppløsningen, hvoretter man tilsatte 187 g propylklorid, 750 ml av en 50 % natriumhydroksyd-oppløsningen og 6,8 g tetrabutylammoniumbisulfat. Blandingen ble holdt på 50°C i 24 timer, så avkjølt til romtemperatur. Av de to .fasene ble den organiske vasket- tre ganger med 500 ml av en mettet vandig oppløsning av natriumklorid. Den ble så- tørket over magnesiumsulfat inntil oppløsnings-midlet var fordampet. 100 ml karbontetraklorid ble tilsatt og det hele fordampet til tørrhet. Produktet ble omkrystallisert fra en blanding av 1,8 liter etanol og 0,3 liter aceton. Man fikk fremstilt (+) 3',4',5,7-0-tetrabenzy1-3-O-propyl-cyanidan-3-ol. Smeltepunkt: 92z93°C 52 g of 3',4',5,7-O-tetrabenzy 1-cyanidan-3-ol and 500 ml of toluene were added to a 3 liter round bottom flask equipped with a condenser and a mechanical stirrer. The mixture was heated until the solution was obtained, after which 187 g of propyl chloride, 750 ml of a 50% sodium hydroxide solution and 6.8 g of tetrabutylammonium bisulphate were added. The mixture was held at 50°C for 24 hours, then cooled to room temperature. Of the two phases, the organic phase was washed three times with 500 ml of a saturated aqueous solution of sodium chloride. It was then dried over magnesium sulphate until the solvent had evaporated. 100 ml of carbon tetrachloride was added and the whole evaporated to dryness. The product was recrystallized from a mixture of 1.8 liters of ethanol and 0.3 liters of acetone. (+) 3',4',5,7-0-tetrabenzyl-3-O-propyl-cyanidan-3-ol was produced. Melting point: 92z93°C
Eksempel 67Example 67
Palladium-svart ble fremstilt- fra 12 g palladiumklorid som beskrevet i eksempel 1. En oppløsning av 41,6 g (+) 3<1>,4',5,7-0-tetrabenzyl-3-0-propyl-cyanidan-3-ol i 1,8 liter etylacetat ble så tilsatt. Hydrogenering ble så ut-ført i 6 timer, det ble brukt 6,25 liter hydrogen. Katalysatoren ble frafiltrert og vasket to ganger med 200 ml etylacetat. De samlede organiske oppløsninger ble så fordampet til tørrhet. 500 ml vann ble tilsatt<p>g fordampet under redusert trykk til et volum på ca. 50 ml. Dette ble gjentatt tre ganger, hvoretter produktet ble lyofilisert. Man fikk et kvantitativt utbytte av (+) 3-0-propyl-cyanidan-3-ol. Smeltepunkt: 94-96°C. Palladium black was prepared from 12 g of palladium chloride as described in Example 1. A solution of 41.6 g of (+) 3<1>,4',5,7-0-tetrabenzyl-3-0-propyl-cyanidan- 3-ol in 1.8 liters of ethyl acetate was then added. Hydrogenation was then carried out for 6 hours, 6.25 liters of hydrogen were used. The catalyst was filtered off and washed twice with 200 ml of ethyl acetate. The combined organic solutions were then evaporated to dryness. 500 ml of water was added<p>g evaporated under reduced pressure to a volume of approx. 50 ml. This was repeated three times, after which the product was lyophilized. A quantitative yield of (+) 3-0-propyl-cyanidan-3-ol was obtained. Melting point: 94-96°C.
Eksempel 68Example 68
En oppløsning av 65,0 g (+) 3',4',5,7-0-tetra-benzyl-cyanidan-3-ol i 500 ml vannfri pyridin ble tilsatt en 4-halset 1 liters rundkolbe utstyrt med en kjøler lukket med et kalsiumkloridrør, en dråpetrakt med trykkutjevner, en rører samt en dyse for tilførsel av nitrogen. 34,5 g dietylklor-fosfat ble så tilsatt dråpevis under nitrogen.. Blandingen ble rørt under nitrogen ved romtemperatur i .,8 timer. Den. A solution of 65.0 g of (+) 3',4',5,7-0-tetra-benzyl-cyanidan-3-ol in 500 ml of anhydrous pyridine was added to a 4-necked 1 liter round bottom flask equipped with a condenser closed with a calcium chloride tube, a drop funnel with pressure equaliser, a stirrer and a nozzle for supplying nitrogen. 34.5 g of diethyl chlorophosphate was then added dropwise under nitrogen. The mixture was stirred under nitrogen at room temperature for .8 hours. It.
ble så helt over i 1 liter isvann. Vannet ble helt av den sammenkakede massen, og denne ble vasket fem ganger med 500 was then completely poured into 1 liter of ice water. The water was poured off the caked mass, and this was washed five times with 500
ml vann hver gang og så hensatt i vakuum over natten ved 40°C hvoretter den stivnet. Produktet ble omkrystallisert fra ml of water each time and then left in vacuum overnight at 40°C after which it solidified. The product was recrystallized from
720 ml karbontetraklorid og 2,8 liter petroleter. Man fikk fremstilt dietylfosfat og 2R,3S 3',4',5,7-tetrabenzyloksy-flavan-3-ylfosfat etter tørking under høyvakuum til konstant vekt. Smeltepunkt: 96°C. 720 ml of carbon tetrachloride and 2.8 liters of petroleum ether. Diethyl phosphate and 2R,3S 3',4',5,7-tetrabenzyloxy-flavan-3-yl phosphate were produced after drying under high vacuum to constant weight. Melting point: 96°C.
Eksempel 69Example 69
Palladiumkatalysatoren ble fremstilt fra 13 g palladiumklorid som beskrevet i eksempel 1. Man tilsatte deretter en oppløsning av 30,0 g dietylfosfat og 2R,3S 3',4'-5,7-tetrabenzyloksy-flavan-3-yl-fosfat i 1,3 liter etylacetat. Hydrogenerihgen ble utført i 3 timer og det ble brukt 3,9 liter hydrogen. Katalysatoren ble frafiltrert og vasket to ganger med 200 ml etylacetat. De samlede oppløsninger ble fordampet til tørrhet. 750 ml vann ble tilsatt residuet og fordampet under redusert trykk til ca. 100 ml. Dette ble gjentatt to ganger og produktet ble så lyofilisert. Man fikk fremstilt dietylfosfat og 2R,3S 3 ' , 4 ' , 5, 7-tetrahydroksy-f lavan-.3-yl-fosfat. Smeltepunkt: 121-123°C. The palladium catalyst was prepared from 13 g of palladium chloride as described in example 1. A solution of 30.0 g of diethyl phosphate and 2R,3S 3',4'-5,7-tetrabenzyloxy-flavan-3-yl-phosphate was then added in 1, 3 liters of ethyl acetate. Hydrogenation was carried out for 3 hours and 3.9 liters of hydrogen were used. The catalyst was filtered off and washed twice with 200 ml of ethyl acetate. The combined solutions were evaporated to dryness. 750 ml of water was added to the residue and evaporated under reduced pressure to approx. 100 ml. This was repeated twice and the product was then lyophilized. Diethyl phosphate and 2R,3S 3',4',5,7-tetrahydroxy-flavan-3-yl phosphate were produced. Melting point: 121-123°C.
Eksempel 70Example 70
1,30 g (+) 3',4',5,7-0-tetrabenzyl-cyanidan-3-ol, 100 ml toluen, 100 ml av en 50 % vandig natrium-hydroksydoppløsning, 500 mg dimetylsulfat og 68 mg tetrabutylammoniumbisulfat ble tilsatt en 500 ml rundkolbe utstyrt med en kjøler og en mekanisk rører. Blandingen ble holdt på 50°C i en time ved kraftig røring og ble så avkjølt til romtemperatur og man fikk to faser. Den organiske fasen ble vasket tre ganger med 100 ml vann og så tørket over magnesiumsulfat før fordampning av oppløsningsmidlet. Residuet ble omkrystallisert fra 13 ml'metoksyetanol. Man fikk fremstilt (+) 3',4',5,7-0-tetrabenzyl-3-0-metyl-cyanidån-3-ol, identisk med produktet fra eksempel 19- Smeltepunkt: 124-125°C, 1.30 g of (+) 3',4',5,7-0-tetrabenzyl-cyanidan-3-ol, 100 ml of toluene, 100 ml of a 50% aqueous sodium hydroxide solution, 500 mg of dimethyl sulfate and 68 mg of tetrabutylammonium bisulfate were added to a 500 ml round bottom flask fitted with a condenser and a mechanical stirrer. The mixture was kept at 50°C for one hour with vigorous stirring and was then cooled to room temperature and two phases were obtained. The organic phase was washed three times with 100 ml of water and then dried over magnesium sulfate before evaporation of the solvent. The residue was recrystallized from 13 ml of methoxyethanol. (+) 3',4',5,7-0-tetrabenzyl-3-0-methyl-cyanidan-3-ol was produced, identical to the product from example 19 - Melting point: 124-125°C,
E ksempel 71 Example 71
500 mg palladiumkatalysator, 120 ml etanol,500 mg palladium catalyst, 120 ml ethanol,
650 mg ( + ) 3 ' , 4',5,7_0-tetrabenzyl-cyanidan-3-ol og 60 ml 650 mg (+ ) 3 ' , 4',5,7_0-tetrabenzyl-cyanidan-3-ol and 60 ml
cykloheksen ble plassert i, en 250 ml' rundkolbe. Under røring ble blandingen kokt under tilbakeløp i 4 timer. Tynnsjiktskromatografi over silisiumdioksydgel Merck 60'(mobilfase: etylacetat/kloroform/maursyre 5:5:1 v/v/v) viser at fjerningen av benzylgruppen ér kvantitativ. Ved romtemperatur ble palladiumkatalysatoren fjernet ved filtrering og filtratet destillert under redusert trykk. Residuet ble omkrystallisert fra vann og er (+)-cyanidan-3-ol. Smeltepunkt: 207-210°C. The cyclohexene was placed in a 250 ml round bottom flask. While stirring, the mixture was refluxed for 4 hours. Thin-layer chromatography over silicon dioxide gel Merck 60' (mobile phase: ethyl acetate/chloroform/formic acid 5:5:1 v/v/v) shows that the removal of the benzyl group is quantitative. At room temperature, the palladium catalyst was removed by filtration and the filtrate distilled under reduced pressure. The residue was recrystallized from water and is (+)-cyanidan-3-ol. Melting point: 207-210°C.
Eksempel 72Example 72
En 4-halset 500 ml rundkolbe ble utstyrt medA 4-necked 500 ml round bottom flask was fitted with
en effektiv mekanisk rører, en 250 ml dråpetrakt, et kalsium-kloridrør og et rør for tilførsel av nitrogen. Hele apparatet ble tørket og nitrogen ble sirkulert 'gjennom det før man tilsatte 100 ml vannfri DMF. Denne ble avkjølt til -3°C og man tilsatte 9,28 g av en 55 % dispersjon av NaH i olje. Under røring tilsatte man så først en oppløsning av 14,5' g (+)-cyanidan-3-ol i 200 ml vannfri DMF og deretter 1,698 g tetra-n-butylammoniumbisulfat og røringen ble fortsatt i en an efficient mechanical stirrer, a 250 ml dropping funnel, a calcium chloride tube and a tube for supplying nitrogen. The entire apparatus was dried and nitrogen was circulated through it before adding 100 ml of anhydrous DMF. This was cooled to -3°C and 9.28 g of a 55% dispersion of NaH in oil was added. While stirring, first a solution of 14.5 g of (+)-cyanidan-3-ol in 200 ml of anhydrous DMF and then 1.698 g of tetra-n-butylammonium bisulphate were added and the stirring was continued for a
time ved 0°C. I løpet av 15 minutter tilsatte man så en opp-løsning av 25,9 ml benzylklorid i 25 «il vannfri DMF, og blandingen ble rørt i 30 minutter ved 0°C, og under røring lot man temperaturen stige til romtemperatur og der ble blandingen hensatt, i 24 timer under kraftig røring.. Blandingen ble så filtrert, og filtratet fordampet under redusert trykk, noe som ga et residuum 'som ble oppløst i 250 ml kloroform. Kloroformoppløsningen ble vasket fire ganger med 250 ml hour at 0°C. In the course of 15 minutes, a solution of 25.9 ml of benzyl chloride in 25 µl of anhydrous DMF was then added, and the mixture was stirred for 30 minutes at 0°C, and during stirring the temperature was allowed to rise to room temperature, where the mixture set aside, for 24 hours with vigorous stirring. The mixture was then filtered and the filtrate evaporated under reduced pressure to give a residue which was dissolved in 250 ml of chloroform. The chloroform solution was washed four times with 250 ml
destillert vann, og etter tørking over vannfritt magnesium-, sulfat og filtrering ble kloroformen fordampet under redusert trykk. Residuet ble vasket med 50 ml heksan og så tørket til konstant vekt. En masse på 37,4 g ble oppløst under varme i 500 ml karbontetraklorid, og oppløsningen ble filtrert i varm tilstand og avkjølt til romtemperatur og så suksessivt konsentrert til 350 og 150 ml. Man fikk fremstilt 23,6 g ( + ) 3' ,4',5,7-0-tetrabenzyl-cyanidan-3_ol, identisk med produktet fra eksempel 37- distilled water, and after drying over anhydrous magnesium sulfate and filtration, the chloroform was evaporated under reduced pressure. The residue was washed with 50 ml of hexane and then dried to constant weight. A mass of 37.4 g was dissolved under heat in 500 ml of carbon tetrachloride, and the solution was filtered while hot and cooled to room temperature and then successively concentrated to 350 and 150 ml. 23.6 g of ( + ) 3' ,4',5,7-0-tetrabenzyl-cyanidan-3-ol were produced, identical to the product from example 37-
Eksempel 73Example 73
Fremgangsmåten er som i eksempel 58, bortsett fra at man etter tilsetningen av oppløsningen av (+)-cyanidan-3-01 i DMF brukte 13,22 g l8-krone-6 og.erstattet benzylbromid med 69 ml benzylklorid. Blandingen ble så holdt på 60°C i 20 timer under kraftig røring. The procedure is as in Example 58, except that after the addition of the solution of (+)-cyanidan-3-O1 in DMF, 13.22 g of 18-crown-6 was used and 69 ml of benzyl chloride was substituted for benzyl bromide. The mixture was then kept at 60°C for 20 hours with vigorous stirring.
45,5 g av ( + ) 3 ' , 4 ' ,.5 , 7-0-tetrabenzyl-cyanidan-3-ol, er identisk med produktet fra eksempel 37- 45.5 g of ( + ) 3 ' , 4 ' ,.5 , 7-0-tetrabenzyl-cyanidan-3-ol, is identical to the product from example 37-
Eksempel 74Example 74
Fremgangsmåten er som i eksempel 73, bortsettThe procedure is as in example 73, except
fra at ...l8-krone-6 ble erstattet med 16,98 g tetra-n-butyl-ammonium-bisulfat. from that ...18-crown-6 was replaced by 16.98 g of tetra-n-butyl-ammonium bisulphate.
Man fikk fremstilt 44,5 g ( + ). 3' , 4 • , 5, 7-0-tetra-benzyl-cyanidan-3'-ol, identisk med produktet fra eksempel 37. 44.5 g ( + ) were produced. 3' , 4 • , 5, 7-0-tetra-benzyl-cyanidan-3'-ol, identical to the product from example 37.
Eksempel 75Example 75
130 g (+) 3',4',5,7_0-tetrabenzyl-cyanidan-3-ol, 250 g 1-klorheptan og 25 g tetrabutylammoniurn-bisulfat ble tilsatt en 5 .liters rundkolbe utstyrt med kjøler og en mekanisk rører. 3,75 1 av en 50 % N.aOH-oppløsning ble så tilsatt, og blandingen holdt på 50°C under.kraftig røring i 6 timer. Den ble avkjølt til romtemperatur, 1,25 liter diklormetan ble tilsatt og to faser ble dannet. Den organiske fase ble 130 g of (+) 3',4',5,7_0-tetrabenzyl-cyanidan-3-ol, 250 g of 1-chloroheptane and 25 g of tetrabutylammonium bisulphate were added to a 5 liter round bottom flask equipped with a condenser and a mechanical stirrer. 3.75 L of a 50% N.aOH solution was then added, and the mixture was kept at 50°C with vigorous stirring for 6 hours. It was cooled to room temperature, 1.25 liters of dichloromethane was added and two phases were formed. The organic phase was
vasket tre ganger med 750 ml vann, tørket over magnesiumsulfat, hvoretter oppløsningsmidlet ble avdampet. 4 liter petroleter (kokepunkt 40-60°C) ble så tilsatt residuet, og blandingen rørt over natten. Den ble så avkjølt til -20°C i \ time, washed three times with 750 ml of water, dried over magnesium sulfate, after which the solvent was evaporated. 4 liters of petroleum ether (boiling point 40-60°C) were then added to the residue, and the mixture stirred overnight. It was then cooled to -20°C for \ hour,
og det faste stoff ble frafiltrert og vasket med 500 ml petroleter. Etter tørking ble omkrystallisering utført to ganger fra en blanding av 1,5 liter etanol og 400 ml etylacetat. Etter tørking til konstant vekt- i vakuum fikk man fremstilt 132 g (+) 3',4',5,7-0-tetrabenzy1-3-0-heptyl-cyani-dan-3-ol. Smeltepunkt: 65°C. and the solid was filtered off and washed with 500 ml of petroleum ether. After drying, recrystallization was carried out twice from a mixture of 1.5 liters of ethanol and 400 ml of ethyl acetate. After drying to constant weight in vacuum, 132 g of (+) 3',4',5,7-0-tetrabenzyl-3-0-heptyl-cyani-dan-3-ol were produced. Melting point: 65°C.
Eksempel 76Example 76
52 g ( + ) 3 ' ,4',5,7-0-tetrabenzyl-cyanidan-3-ol og 650 ml toluen ble tilsatt en 3-halset rundkolbe utstyrt med kjøler og en mekanisk-rører. Blandingen ble oppvarmet inntil man fikk oppløsning, hvoretter man tilsatte 115 g 1-klordodekan,"27 g tetrabutylammonium-bisulfat og 750 ml 52 g (+ ) 3' ,4',5,7-0-tetrabenzyl-cyanidan-3-ol and 650 ml of toluene were added to a 3-neck round-bottomed flask equipped with a condenser and a mechanical stirrer. The mixture was heated until a solution was obtained, after which 115 g of 1-chlorododecane, 27 g of tetrabutylammonium bisulphate and 750 ml
av en 50 % NaOH-oppløsning. Blandingen ble holdt på 50°Cof a 50% NaOH soln. The mixture was kept at 50°C
i fire døgn under kraftig røring, og ble så avkjølt til romtemperatur. Man fikk to faser, og den organiske ble vasket tre ganger med 500 ml vann. Den ble så tørket over magnesiumsulfat og oppløsningsmidlet fordampet. Residuet ble blandet to ganger med 500 ml petroleter (kokepunkt 40-60°C). Etter, filtrering og tørking ble produktet omkrystallisert fra 800 ml aceton og 3,2 liter etanol. Etter tørking til konstant vekt i vakuum, fikk man 54 g (+) 3',4',5,7-0-tetra-benzyl-3-0-dodekyl-cyanidan-3-ol. Smeltepunkt: 9.8-99°C. for four days under vigorous stirring, and was then cooled to room temperature. Two phases were obtained, and the organic phase was washed three times with 500 ml of water. It was then dried over magnesium sulfate and the solvent evaporated. The residue was mixed twice with 500 ml of petroleum ether (boiling point 40-60°C). After filtration and drying, the product was recrystallized from 800 ml of acetone and 3.2 liters of ethanol. After drying to constant weight in vacuum, 54 g of (+) 3',4',5,7-0-tetra-benzyl-3-0-dodecyl-cyanidan-3-ol were obtained. Melting point: 9.8-99°C.
Eksempel 77Example 77
En blanding av 26 g (+) 3',4 ' ,5,7-0-tetrabenzyl-cyanidan-3-ol, 73 g 1-klorhe.ksadekan og 5 g tetrabutylammonium-bisulfat ble tilsatt en 1 liters rundkolbe utstyrt med kjøler og mekanisk rører. 750 ml av en 50 % vandig NaOH-oppløsning ble så tilsatt, og blandingen ble holdt på 50°C med kraftig røring i 24 timer. Den ble så avkjølt til romtemperatur og 250 ml diklormetan ble tilsatt. De to fasene ble skilt, og den organiske vasket med 250 ml vann. Oppløsningsmidlet ble fordampet, og man tilsatte '375 ml etanol og røring ble ,så ut-ført i 2 timer. Blandingen ble avkjølt til -10°C, det faste bunnfall frafiltrert og vasket med 50 ml etanol og tørket i vakuum. Produktet ble omkrystallisert fra 300 ml etanol og 70 ml etylacetat og så tørket til konstant vekt i vakuum. A mixture of 26 g of (+) 3',4',5,7-0-tetrabenzyl-cyanidan-3-ol, 73 g of 1-chlorohexadecane and 5 g of tetrabutylammonium bisulfate was added to a 1 liter round bottom flask equipped with a condenser and mechanical stirring. 750 ml of a 50% aqueous NaOH solution was then added and the mixture was kept at 50°C with vigorous stirring for 24 hours. It was then cooled to room temperature and 250 ml of dichloromethane was added. The two phases were separated, and the organic phase was washed with 250 ml of water. The solvent was evaporated, and 375 ml of ethanol were added and stirring was then carried out for 2 hours. The mixture was cooled to -10°C, the solid precipitate was filtered off and washed with 50 ml of ethanol and dried in vacuo. The product was recrystallized from 300 ml of ethanol and 70 ml of ethyl acetate and then dried to constant weight in vacuo.
Man fikk ialt 30 g (+) 3',4',5,7-0-tetrabenzyl-3-0-heksa-dekyl-cyanidan-3-ol. Smeltepunkt: 88-89°C. A total of 30 g of (+) 3',4',5,7-0-tetrabenzyl-3-0-hexa-decyl-cyanidan-3-ol was obtained. Melting point: 88-89°C.
Eksempel 78Example 78
52 g (+) 3',4',5,7_0-tetrabenzyl-cyanidan-3-ol, . .162 g 1-kloroktadekan og. 10 g tetrabutylammonium-bisulfat ble tilsatt en 3 liters rundkolbe utstyrt med mekanisk rører og kjøler. Man tilsatte 1,5 liter av en 50 % NaOH-oppløsning, og blandingen ble holdt på 50°C i 28 timer under kraftig røring. Den ble så avkjølt til romtemperatur, 500 ml diklormetan ble tilsatt og man fikk to faser. Den organiske fase ble vasket med 500 ml vann. Det dannet seg en emulsjon, og de to fasene- ble skilt ved filtrering på et faseseparator-papir. Den organiske fase ble tørket over magnesiumsulfat og så ble oppløsningsmidlet fordampet. 750 ml etanol ble tilsatt og røring utført i 2 timer. Det faste stoff ble frafiltrert og vasket med 100 ml etanol. Produktet ble omkrystallisert to ganger fra en' blanding av 600 ml etanol og 260 ml etylacetat. Etter tørking til konstant vekt i vakuum fikk man 60 g (+) 3',4',5,7-0-tetrabenzyl-3-0-oktadeky1-cyanidan-3-ol. Smeltepunkt 86°C. 52 g (+) 3',4',5,7_0-tetrabenzyl-cyanidan-3-ol, . .162 g of 1-chlorooctadecane and. 10 g of tetrabutylammonium bisulphate was added to a 3 liter round bottom flask equipped with a mechanical stirrer and cooler. 1.5 liters of a 50% NaOH solution were added and the mixture was kept at 50°C for 28 hours with vigorous stirring. It was then cooled to room temperature, 500 ml of dichloromethane was added and two phases were obtained. The organic phase was washed with 500 ml of water. An emulsion formed, and the two phases were separated by filtration on a phase separator paper. The organic phase was dried over magnesium sulfate and then the solvent was evaporated. 750 ml of ethanol was added and stirring was carried out for 2 hours. The solid was filtered off and washed with 100 ml of ethanol. The product was recrystallized twice from a mixture of 600 ml of ethanol and 260 ml of ethyl acetate. After drying to constant weight in vacuum, 60 g of (+) 3',4',5,7-0-tetrabenzyl-3-0-octadecylin-cyanidan-3-ol were obtained. Melting point 86°C.
Eksempel 79Example 79
56 g (+) 3 ' , V ,5,7-0-tetrabenzyl-3-0-heptyl-cyanidan-3-ol oppløst i 2,25 liter etylacetat ble hydrogenert i en 5 liters rundkolbe i nærvær av 40 g 10 % palladium på aktivert karbon. Katalysatoren ble frafiltrert og vasket to ganger med 300 ml etylacetat. De samlede oppløsninger ble fordampet til tørrhet, og residuet behandlet med 250 ml vann, 56 g of (+) 3 ' , V ,5,7-0-tetrabenzyl-3-0-heptyl-cyanidan-3-ol dissolved in 2.25 liters of ethyl acetate was hydrogenated in a 5 liter round bottom flask in the presence of 40 g of 10% palladium on activated carbon. The catalyst was filtered off and washed twice with 300 ml of ethyl acetate. The combined solutions were evaporated to dryness, and the residue treated with 250 ml of water,
som deretter ble fordampet til ca. 50 ml. Dette ble gjentatt to ganger før fordampning til tørrhet, hvoretter residuet which was then evaporated to approx. 50 ml. This was repeated twice before evaporation to dryness, after which the residue
ble tørket til konstant vekt under h<zSyvakuum over Po0r.was dried to constant weight under h<zSyvacuum over Po0r.
25 25
Man fikk ialt 25 g (+) 3_0-heptyl-cyanidan-3-ol.A total of 25 g of (+) 3_0-heptyl-cyanidan-3-ol was obtained.
Smeltepunkt: 157-159°CMelting point: 157-159°C
Eksempel 80Example 80
40 g (+) 3',4',5,7-0-tetrabenzyl-3-0-dodekyl-cyanidan-3-ol oppløst i 3 liter etylacetat ble hydrogenert i en 6 liters rundkolbe i nærvær av 20 g 10 ■% palladium på aktivert karbon. Reaksjonen varer i 6 timer og 6,2 liter hydrogen ble forbrukt. Katalysatoren ble frafiltrert og vasket to ganger med 300 ml etylacetat. De samlede oppløs-ninger ble fordampet til tørrhet, og det oljeaktige residuum oppløst i 1 liter etanol. Oppløsningsmidlet ble fordampet til ca. 50 ml, hvoretter 1 liter vann ble tilsatt og igjen fordampet til ca. 50 ml.'En liter vann ble så igjen tilsatt og fordampet til ca. 100 ml, hvoretter det faste stoff ble frafiltrert og vasket med vann. Etter tørking til konstant vekt under høyvakuum over P2°rfikk man 21,5 g (+) 3-0-dodekyl-cyanidan-3-ol. Smeltepunkt: 158-160 oC. 40 g of (+) 3',4',5,7-0-tetrabenzyl-3-0-dodecyl-cyanidan-3-ol dissolved in 3 liters of ethyl acetate was hydrogenated in a 6 liter round bottom flask in the presence of 20 g of 10 ■% palladium on activated carbon. The reaction lasts for 6 hours and 6.2 liters of hydrogen were consumed. The catalyst was filtered off and washed twice with 300 ml of ethyl acetate. The combined solutions were evaporated to dryness, and the oily residue dissolved in 1 liter of ethanol. The solvent was evaporated to approx. 50 ml, after which 1 liter of water was added and evaporated again to approx. 50 ml.'One liter of water was then again added and evaporated to approx. 100 ml, after which the solid was filtered off and washed with water. After drying to constant weight under high vacuum over P2°, 21.5 g of (+) 3-0-dodecyl-cyanidan-3-ol were obtained. Melting point: 158-160 oC.
Eksempel 8lExample 8l
26,3 g (+) 3',4',5,7-0-tetrabenzyl-3-O-heksa-dekyl-cyanidan-3-ol oppløst i 1,5 liter etylacetat ble hydrogenert i.en 3 liters rundkolbe i nærvær av 16 g 10 % palladium på aktivert karbon. Katalysatoren ble frafiltrert og vasket to ganger med 100 ml etylacetat. De samlede oppløs-ninger ble fordampet til tørrhet, hvoretter residuet ble behandlet med 5 g aktivert karbon i 100 ml eter i en time. Blandingen ble filtrert, og filtratet fordampet til tørrhet, hvoretter residuet ble behandlet i 60 ml vann og vannet så fordampet til ca. 10 ml. Dette ble gjentatt to ganger, hvoretter blandingen ble fordampet til tørrhet og residuet tørket til konstant vekt under høyvakuum over ^ 2°^' Man fikk 10,5 g ( + ). 3-0-heksadekyl-cyanidan-3-ol. Smeltepunkt: 152-154°C. 26.3 g of (+) 3',4',5,7-0-tetrabenzyl-3-O-hexa-decyl-cyanidan-3-ol dissolved in 1.5 liters of ethyl acetate was hydrogenated in a 3 liter round bottom flask in presence of 16 g of 10% palladium on activated carbon. The catalyst was filtered off and washed twice with 100 ml of ethyl acetate. The combined solutions were evaporated to dryness, after which the residue was treated with 5 g of activated carbon in 100 ml of ether for one hour. The mixture was filtered, and the filtrate evaporated to dryness, after which the residue was treated in 60 ml of water and the water then evaporated to approx. 10 ml. This was repeated twice, after which the mixture was evaporated to dryness and the residue dried to constant weight under high vacuum above ^ 2°^' 10.5 g ( + ) were obtained. 3-O-hexadecyl-cyanidan-3-ol. Melting point: 152-154°C.
Eksempel 82Example 82
83,7 g (+) 3',4',5,7-0-tetrabenzyl-3-0-okta-dekyl-cyanidan-3-ol oppløst i 4,5 liter etylacetat ble hydrogenert i en 8 liters rundkolbe i nærvær av 48 g 10 % palladium på aktivert karbon. Katalysatoren ble frafiltrert og vasket to ganger med 400 ml etylacetat. De samlede oppløsninger ble fordampet til tørrhet. Residuet ble omkrystallisert fra 260 ml kloro'form inneholdende 4 % metanol. Det-faste stoff ble behandlet i 100 ml vann, hvoretter vannet ble fordampet til ca. 25 ml. Dette ble.gjentatt to ganger, og vannet ble så fordampet, og det faste stoff tørket til konstant vekt under høyvakuum over f^^R"r'^an ^ikk 34,1 g ( + ) 3_0-oktadekyl-cyanidan-3-ol. Smeltepunkt: 162-164 oC. 83.7 g of (+) 3',4',5,7-0-tetrabenzyl-3-0-octa-decyl-cyanidan-3-ol dissolved in 4.5 liters of ethyl acetate was hydrogenated in an 8 liter round bottom flask in the presence of 48 g of 10% palladium on activated carbon. The catalyst was filtered off and washed twice with 400 ml of ethyl acetate. The combined solutions were evaporated to dryness. The residue was recrystallized from 260 ml of chloroform containing 4% methanol. The solid was treated in 100 ml of water, after which the water was evaporated to approx. 25 ml. This was repeated twice, and the water was then evaporated, and the solid dried to constant weight under high vacuum over f^^R"r'^an ^ikk 34.1 g ( + ) 3_0-octadecyl-cyanidan-3- etc. Melting point: 162-164 oC.
Eksempel 83Example 83
En oppløsning av 52 g ( + ) .3 ' ,4 ' , 5, 7-0-tetrabenzy 1-cyanidan-3-ol. i 300 ml diklormetan, - 150 ml 50 % vandig opp-løsning av NaOH og 6,8 g tetrabutylammonium-bisulfat ble tilsatt en 750 ml rundkolbe utstyrt med kjøler og en mekanisk rører. Blandingen ble kokt under tilbakeløp i 24 timer under kraftig røring, ble så avkjølt til romtemperatur og to faser ble utskilt. Den organiske fasen ble vasket tre'ganger med 300 ml vann og så tørket over magnesiumsulfat. Oppløsningsmidlet ble fordampet, og residuet omkrystallisert fra en blanding av 2,4 liter etanol og 1,2 liter aceton. Man fikk 39 g di(3',4',5,7-0-tetrabenzyl-cyanidan-3-yloksy)-metan. Smeltepunkt: 103-104°C. A solution of 52 g of ( + ) .3' ,4' , 5, 7-0-tetrabenzy 1-cyanidan-3-ol. in 300 ml of dichloromethane, - 150 ml of a 50% aqueous solution of NaOH and 6.8 g of tetrabutylammonium bisulphate were added to a 750 ml round bottom flask equipped with a condenser and a mechanical stirrer. The mixture was refluxed for 24 hours with vigorous stirring, then cooled to room temperature and two phases were separated. The organic phase was washed three times with 300 ml of water and then dried over magnesium sulfate. The solvent was evaporated and the residue recrystallized from a mixture of 2.4 liters of ethanol and 1.2 liters of acetone. 39 g of di(3',4',5,7-0-tetrabenzyl-cyanidan-3-yloxy)-methane were obtained. Melting point: 103-104°C.
Eksempel 84Example 84
Palladium-svart ble fremstilt fra 5 g palladiumklorid' som beskrevet i eksempel 1. Man tilsatte deretter.en oppløsning av 31,0 g di(3',4',5,7-0-tetrabenzyl-cyanidan-3~yloksy)metan i 700 ml etylacetat. Hydrogenering ble utført Palladium black was prepared from 5 g of palladium chloride as described in example 1. A solution of 31.0 g of di(3',4',5,7-0-tetrabenzyl-cyanidan-3-yloxy)methane was then added in 700 ml of ethyl acetate. Hydrogenation was carried out
i 3 timer og 4,8 liter hydrogen ble brukt. Katalysatoren ble frafiltrert, vasket to ganger med 100 ml etylacetat, for 3 hours and 4.8 liters of hydrogen were used. The catalyst was filtered off, washed twice with 100 ml of ethyl acetate,
og de samlede organiske oppløsninger ble fordampet til tørr-het. 1 liter vann ble nøytralisert til pH 7 med flere dråper pyridin ble så tilsatt residuet. Blandingen ble konsentrert til ca. 100 ml under redusert trykk. Dette ble gjentatt to ganger hvoretter 900 ml rent vann ble tilsatt og dette igjen . 'fordampet til ca. 200 ml. Blandingen ble så lyofilisert og man fikk 12,9 g di(cyanidan-3-yloksy)metan. and the combined organic solutions were evaporated to dryness. 1 liter of water was neutralized to pH 7 with several drops of pyridine then added to the residue. The mixture was concentrated to approx. 100 ml under reduced pressure. This was repeated twice, after which 900 ml of clean water was added and this again. 'evaporated to approx. 200 ml. The mixture was then lyophilized and 12.9 g of di(cyanidan-3-yloxy)methane was obtained.
Smeltepunkt: l62-l65°C.Melting point: l62-l65°C.
Eksempel 85Example 85
På samme måte som beskrevet i de foregående eksempler ble følgende forbindelser fremstilt: In the same way as described in the previous examples, the following compounds were prepared:
( + ) 3,3',4 ' , 5 , 7-0-pent a-(metoksyrnety1)-cyanidan-3-01,( + ) 3,3',4' , 5 , 7-0-pent α-(methoxyrnethy1)-cyanidan-3-01,
(+) 3,3',4',5,7-0-pentaallyl-cyanidan-3-ol,(+) 3,3',4',5,7-0-pentaallyl-cyanidan-3-ol,
(+) 3',4',5,7-0-tetra-(trimetylsilly1)-cyanidan-3-01,(+) 3',4',5,7-0-tetra-(trimethylsilyl)-cyanidan-3-O1,
(+) 3' ,4 ' ,5,7-0-tetrabenzyl-3-0-(3-(N,N-dimetylamino,)propyl] - (+) 3' ,4' ,5,7-0-tetrabenzyl-3-0-(3-(N,N-dimethylamino,)propyl] -
cyanidan-3-ol,cyanidan-3-ol,
(+) 3-0-(3-(N,N-dimetylamino)-propyl]-cyanidan-3-ol i form av (+) 3-O-(3-(N,N-dimethylamino)-propyl]-cyanidan-3-ol in the form of
dets hydroklorid,its hydrochloride,
(+) 3',4',5,7-0-tetrabenzyl-3-0-[4-(4,4-etylendioksy-p- (+) 3',4',5,7-0-tetrabenzyl-3-0-[4-(4,4-ethylenedioxy-p-
f luorf enyl)-buty lj -cyanidan-3-ol,fluoro-enyl)-butyl l -cyanidan-3-ol,
3-0- 4-(4,4-etylendioksy-p-fluorfenyl]-butyl - 3-0- 4-(4,4-ethylenedioxy-p-fluorophenyl]-butyl -
cyanidan-3-ol,cyanidan-3-ol,
(+) 3',4'35,7-0-tetrabenzyl-3-0-(233-dihydroksypropyl)-cyanidan-3-ol og .(+) 3-0-(2,3-dihydrpksypropyl)-cyanidan-3-o1. (+) 3',4'35,7-0-tetrabenzyl-3-0-(233-dihydroxypropyl)-cyanidan-3-ol and .(+) 3-0-(2,3-dihydroxypropyl)-cyanidan- 3-o1.
Claims (31)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
NO773968A NO773968L (en) | 1977-11-21 | 1977-11-21 | LITHIUM SALTS OF 1,4-BENZDIAZEPINES AND PROCEDURES FOR PRODUCING THE SAME |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
NO773968A NO773968L (en) | 1977-11-21 | 1977-11-21 | LITHIUM SALTS OF 1,4-BENZDIAZEPINES AND PROCEDURES FOR PRODUCING THE SAME |
Publications (1)
Publication Number | Publication Date |
---|---|
NO773968L true NO773968L (en) | 1979-05-22 |
Family
ID=19883857
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO773968A NO773968L (en) | 1977-11-21 | 1977-11-21 | LITHIUM SALTS OF 1,4-BENZDIAZEPINES AND PROCEDURES FOR PRODUCING THE SAME |
Country Status (1)
Country | Link |
---|---|
NO (1) | NO773968L (en) |
-
1977
- 1977-11-21 NO NO773968A patent/NO773968L/en unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4255336A (en) | Process for the preparation of O-substituted derivatives of (+)-cyanidan-3-01 | |
CA3029857C (en) | Aromatic acetylene or aromatic ethylene compound, intermediate, preparation method, pharmaceutical composition and use thereof | |
AU2004238521B2 (en) | Isoquinoline derivatives and their use as GFAT inhibitors | |
JP5237938B2 (en) | Novel CXCR2 inhibitor | |
US4929636A (en) | Positive inotrophic benzothiazole and benzothiophene compositions and method of use therefor | |
AU599029B2 (en) | Ascorbic acid derivatives, production and use thereof | |
JPS6056705B2 (en) | Method for producing proline derivatives and related compounds | |
JP2000516252A (en) | 1,4-heterocyclic metalloprotease inhibitors | |
CN101921279A (en) | Spirocyclic heterocyclic derivatives and methods of their use | |
KR950001633B1 (en) | Octah ydronaphthalene oxime derivatives for cholesterol synthesis inhibition process for their preparation and compositions containing them | |
EP0189690A1 (en) | Substituted aromatic sulfonamides, their preparation and ophthalmic compositions containing them | |
NO158379B (en) | ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE NITROALIFATIC COMPOUNDS. | |
JPH0585933A (en) | Pharmaceutical for treating cataract | |
SU831074A3 (en) | Method of preparing benzimidazole derivatives | |
AU620037B2 (en) | Leukotriene antagonists | |
NO773968L (en) | LITHIUM SALTS OF 1,4-BENZDIAZEPINES AND PROCEDURES FOR PRODUCING THE SAME | |
US5145868A (en) | Alkanophenones useful for treating allergies | |
SU1072801A3 (en) | Process of preparing derivatives of prostacycline or their epimers | |
JP2006248938A (en) | Boron-containing quinazoline derivative | |
CA1176267A (en) | Aminocarboxylic acids, amino alcohols, or the derivatives thereof, processes for production thereof, and pharmaceutical uses thereof | |
JPH0320264A (en) | Gem-substituted thiaheterocyclic carboxylic acid and its derivative | |
EP3049392A1 (en) | Compounds and methods for skin repair | |
US4171375A (en) | Cyclopentane derivatives and their pharmaceutical compositions | |
US4258053A (en) | Thienyl-prostaglandins and process for their manufacture | |
PT95362B (en) | PROCESS FOR PREPARING SUBSTITUTED DIBENZOFURANES AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM |